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Studies on Experimental Porphyria
Ann E. Holley
Intraperitoneal administration of 3,5-diethoxy- 
carbonyl-1,4-dihydrocollidine (DDC) to female C3H/He/01a 
and NIH/Ola inbred mice produced a marked dose-dependent 
loss of hepatic ferrochelatase (FK) activity, induction 
of 5-aminolaevulinic acid synthetase (ALA-S) and 
accumulation of protoporphyrin. There was no strain 
difference in the degree of FK inhibition. However, 
induction of ALA-S was greater in C3H/He/01a mice. The 
strain difference in ALA-S response was most marked when 
inhibition of FK (the "specific" effect of DDC) was 
maximal and this suggests that a genetic variation exists 
in the sensitivity of ALA-S to a second, "non-specific" 
action of DDC, possibly related to its property of 
lipid-solubility.
A sex difference in griseofulvin (GF)-induced 
porphyria was found with a greater hepatic protoporphyrin 
accumulation in male mice of all three strains examined. 
Stimulation of ALA-S activity was slightly greater in 
males, but when porphyria was very marked, ALA-S levels 
were significantly lower in this sex. These, and other, 
results demonstrated a two-way relationship between ALA-S 
activity and porphyrin accumulation, with a repression of 
ALA-S activity occuring at high liver protoporphyrin 
concentrations.
Using a new method to add drugs in solution to 
cultures of chick embryo hepatocytes, the porphyrogenic 
effects of various drugs was compared. DDC and ISO- 
griseofulvin markedly inhibited FK activity and caused 
accumulation of protoporphyrin. In this system, ISO- 
griseofulvin was a more potent inhibitor of FK activity 
than either GF or HET-griseofulvin and also produced a 
greater accumulation of protoporphyrin, as previously 
reported in rodents.
The hepatic green pigment accumulating in DDC, GF and 
ISO-griseofulvin-treated mice has been isolated, purified 
and identified as N-MePP, a previously established 
inhibitor of FK. All four possible structural isomers 
were demonstrated and each drug produced primarily the 
same isomer. An additional hepatic green pigment has 
been isolated from GF-treated mice, and spectral 
characteristics suggest this pigment is also an N-mono- 
substituted porphyrin, but its identity has not yet been 
established.
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ABBREVIATIONS
In addition to the widely accepted biochemical 
abbreviations, the following are present in the text:-
AIA - 2-Allyl-2-isopropylacetamide
AIP - Acute intermittent porphyria
ALA - 5-Aminolaevulinic acid
ALA-D - S-Aminolaevulinic acid dehydratase
ALA-S - ^-Aminolaevulinic acid synthetase
DDC - 3,5-Diethoxycarbonyl-l,4-dihydrocollidine
DMSO - Dimethyl sulphoxide
DTE - Dithioerythritol
FK - Ferrochelatase
GF - Griseofulvin
HBSS - Hanks balanced salt solution
HCB - Hexachlorobenzene
HCIO4 ” Perchloric acid
HCP - Hereditary coproporphyria
HETGF - Hydroxyethylthio-griseofulvin
ISOGF - Isogriseofulvin
N-EthylPP - - N-ethyl protoporphyrin
N-MePP - N-methyl protoporphyrin
PBG - Porphobilinogen
PBS - Phosphate buffered saline
PCT - Porphyria cutanea tarda
PIA - 2-Propyl-2-isopropylacetamide
SA - Succinyl acetone
SDS - Sodium dodecyl sulphate
SD - Standard deviation
TCA - Trichloracetic acid
VP - Variegate porphyria
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CHAPTER 1
Introduction
1.1 Structure of porphyrins and haem
Porphyrins are cyclic tetrapyrroles in which the 4 
pyrrole rings, conventionally designated A, B, C and D, 
are attached through 4 methene bridges labelled a, p,$ 
and h . The p-carbon atoms of the pyrrole rings are 
numbered 1 to 8 (Fig 1.1) and in most naturally occurring 
porphyrins the p-carbon atoms have side chain substituents 
such as methyl (-CH3), acetate (-CH2COO”'), propionate 
(-CH2CH2COO” ) and vinyl (-CH=CH2 ) (Falk, 1964; Kappas et 
al., 1983; Maines, 1984).
Free porphyrins normally occur in nature in only small 
amounts,and most of the porphyrin occurs instead as metal 
complexes. In animals, the most important of these is 
protohaem (usually termed haem), the complex of the por­
phyrin protoporphyrin IX, and ferrous iron, in which the 
iron atom is co-ordinated to the 4 pyrrole nitrogen atoms 
of the porphyrin nucleus. Haem functions as the prosthe­
tic group of various haemoproteins including cytochromes 
P-450 and b$, mitochrondrial cytochromes (including 
cytochrome c oxidase, where a modified haem is present), 
haemoglobin, myoglobin, catalase, peroxidase and 
tryptophan pyrrolase (Tait, 1978; Maines, 1984). In the 
majority of haemo-proteins) haem is associated with its 
apoprotein non- covalently through co-ordination between 
its iron atom and nitrogen atoms of the amino acid side 
chains (Tait, 1978), but in cytochrome c, covalent 
attachment of haem to 2 cysteine residues of the protein 
are present, through 2 thioether linkages.
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Fig 1.1 Structure of the porphyrin nucleus
a
N H
Protoporphyrin IX, the immediate precursor of haem, has 
both methyl and vinyl groups on rings A and B, and both 
methyl and propionic acid side chains on rings C and D 
(see also Fig 1.2).
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1.2 Biosynthesis of porphyrins and haem
In the 1950's, Shemin and his co-workers in the USA, 
and Neuberger and Rimington in this country, established 
that the porphyrins are synthesized entirely from glycine 
and succinyl-CoA (for reviews see Meyer and Schmid, 1978; 
Kappas et ad.. , 1983; Maines, 1984). The synthesis occurs 
through a seqeuence of reactions catalyzed by enzymes 
present in the mitochrondrial and cytosolic fractions of 
all nucleated cells and the pathway is schematically 
presented in Fig 1.2. The first step involves the 
condensation of succinyl-CoA with glycine to form an 
unstable intermediate (a-amino-p-ketoadipic acid) which is 
rapidly decarboxylated to yield 5 -aminolaevulinic acid 
(ALA) (Neuberger, 1961; Zaman et al., 1973). The reaction 
is catalyzed by mitochondrial ALA-synthetase (ALA-S)., a 
pyridoxal phosphate requiring enzyme (Scholnick et al., 
1972), which is normally present in liver in relatively 
low amounts, and is the rate-limiting enzyme in the haem 
biosynthetic pathway (Granick and Urata, 1963). ALA-S is 
synthesized in the cytosol and transported into 
mitochondria where it is functionally active; the enzyme 
is subject to negative feedback regulation by haem and 
this aspect will be discussed in more detail in Section 
1.4.
More recently it has been suggested that the
mitochondrial enzyme L-alanine:4,5-dioxovalerate (DOVA)
Cec.
transaminase^may play a role in the biosynthesis of ALA in 
mammalian liver. The activity of this enzyme is reported 
to be considerably greater than that of ALA-S in vitro
4
Fig 1.2 The haem biosynthetic pathway
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(Varticovski et al ., 1980), and evidence has been 
presented that, like ALA-S, DOVA transaminase is inhibited 
by haem in vitro and in vivo (Shanker and Datta, 1986; 
Chhabra et al., 1986). However, Noguchi and Mori (1981) 
reported that DOVA transaminase is associated with another 
enzymic activity, i.e. alanine;glyoxylate transaminase? 
the activity of the latter reaction is much greater than 
that of the former, and the overall reaction would then 
tend to favour glycine formation rather than ALA 
synthesis. Further work is thus required to clarify the 
contribution of DOVA transaminase to ALA (and haem) 
formation in mammalian liver.
The second step of haem biosynthesis occurs in the
(EC 4..5U.2.U}
cytoplasm where ALA-dehydratase (ALA-D)^ catalyzes the
condensation of 2 molecules of ALA with each other to
yield the monopyrrole precursor, porphobilinogen (PBG),
with the loss of 2 molecules of water (Gibson et al.,
1955; Jordan and Seehra, 1980). The intermediates which
are formed from PBG and are converted to protoporphyrin
are not porphyrins, but hexahydroporphyrins. These
reduced forms of porphyrins are called porphyrinogens.
Unlike porphyrins, which are coloured and fluoresce under
UV light, porphyrinogens are colourless, non-fluorescent
compounds and are readily oxidized to the corresponding
porphyrins. The first porphyrinogen formed is
uroporphyrinogen III which is produced in a 2-step
reaction catalysed by the cytosolic enzymes PBG deaminase
(Ec J+/3.I.8')
(hydroxymethylbilane synthase )^  and uroporphyrinogen III 
(EC it.a.i.is'i
synthase PBG deaminase catalyzes the condensation of
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4 PBG molecules in a head-to-tail fashion, to generate a 
linear tetrapyrrole, hydroxymethylbilane (Battersby et 
al. , 1979; Burton et a_l., 1979; Jordan and Berry, 1980). 
The assembly of the 4 pyrrole rings has been shown to 
start with ring A, followed by the stepwise additions of 
rings B, C and D in a clockwise fashion (Battersby et al., 
1979). In the absence of uroporphyrinogen III synthase.
, hydroxymethylbilane is non-enzymatically cyclized to 
the symmetrical isomer uroporphyrinogen I . In the 
presence of the synthase. as well as the deaminase, 
hydroxymethylbilane is rapidly converted to uropor­
phyrinogen III, the asymmetrical isomer in which one of 
the PBG molecules (conventionally the one which will give 
rise to ring D) undergoes intramolecular rearrangement 
(Jordan et al^., 1979). Most tissues contain excess
synthase relative to deaminase activity, which favours 
the predominant synthesis of type III uroporphyrinogen 
(Kappas et ad.., 1983).
Further metabolism of octacarboxylic uroporphyrinogen 
III to coproporphyrinogen III proceeds by sequential 
decarboxylation of the 4 acetic acid side chains to methyl 
groups, catalyzed by cytosolic uroporphyrinogen decarboxy- 
lase^ . Both uroporphyrinogen isomers I and III are 
substrates for the enzyme, although isomer III appears to 
be decarboxylated more rapidly (Mauzerall and Granick,
1958; Smith and Francis, 1981). With uroporphyrinogen III 
as the substrate, the decarboxylation was proposed to 
proceed in a clockwise fashion, starting at the acetic 
acid group of ring D and ending with that of ring C
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(Jackson et al, 1976). However, more recently, all 
possible isomers of the decarboxylation intermediates of 
uroporphyrinogen III have been detected and this finding 
has cast doubt on the clockwise sequence of decarboxy­
lation (Lim et al., 1983).
With uroporphyrinogen I as the substrate, copropor­
phyrinogen I is the end product of the pathway since 
further decarboxylation does not occur. However 
coproporphyrinogen III, the product of decarboxylation of 
the physiological uroporphyrinogen III, is further 
metabolized; it readily enters the mitochondria where the 
remaining 3 steps of haem biosynthesis occur. The first 
of these, the conversion of coproporphyrinogen III to 
protoporphyrinogen IX, is catalyzed by coproporphyrinogen
(EC 1-33:5)
oxidase^, which has an absolute requirement for molecular
oxygen (Sano and Granick, 1961). In the course of this
reaction, propionic acid side chains on rings A and B of
coproporphyrinogen III are oxidatively decarboxylated to
vinyl groups, with the modification of ring A occurring
first (Yoshinga and Sano, 1980). Protoporphyrinogen IX is
then oxidized to protoporphyrin IX by the enzymic removal
of 6 hydrogen atoms from the porphyrinogen nucleus by
(EC 1.33. U-)
protoporphyrinogen oxidase^ (Poulson, 1976).
The final step in haem biosynthesis is the insertion
of ferrous iron into the protoporphyin IX ring and is
- (EC- 4. **9.1.1)
catalyzed by the enzyme ferrochelatase (FK), which is
/l
located on the matrix side of the inner mitochondrial 
membrane (Jones and Jones, 1969; Harbin and Dailey,
1985). The reaction in vitro appears to be substrate-
specific for porphyrins with free carboxylic groups in 
positions 6 and 7; copro- and uroporphyrin do not serve as 
substrates, nor is iron incorporated into porphyrinogens 
such as protoporphyrinogen (Porra and and Jones, 1963a; 
1963b). Moreover the iron must be in the reduced form; 
Fe^+ does not serve as a substrate for the enzyme (Porra 
and Jones, 1963a) and recently Taketani et al. (1985) 
suggested that the reduction of ferric iron to the ferrous 
form, which occurs inside the inner mitochondrial 
membrane, may be mediated by NADH-dehydrogenase.
Of the haem produced in rat liver mitochondria only 
about 6% is used for the formation of mitochondrial 
cytochromes; the majority is transported out of the 
mitochondria for utilization in the synthesis of other 
haemoproteins such as microsomal cytochromes P-450 (68%) 
and b 5 (7%), and peroxisomal catalase (17%) (Meyer and 
Schmid, 1978). The mechanism of the transport process is 
not yet known, although proteins in the mitochondrial 
matrix and the cytoplasm may be involved (Tait, 1978; 
Tangeras and Flatmark, 1979;Husby and Romslo, 1982).
1.3 Degradation of haem
The microsomal haem oxygenase system, which consists 
(EC U4-.W&
of haem oxygenase^ and NADPH-cytochrome c reductase (EC I.b.H.ti)
catalyzes the oxidative degradation of haem to biliverdin
IX oc at the expense of NADPH and molecular oxygen
(Tenhunen et al ., 1969). Biliverdin IX a is reduced to
bilirubin IXa by the cytosolic enzyme, bilverdin 
(£ C  i
reductase (Tenhunen et aJ.., 1970). The reaction sequence 
A
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has been suggested to proceed in the following way.
First, haem binds to haem oxygenase and is reduced to 
ferrous haem by NADPH-cytochrome c reductase. The 
haem-enzyme complex also functions to activate molecular 
02' generating a reactive oxygen species which attacks 
haem at the a bridge carbon to form a-hydroxyhaem. 
a-Hydroxyhaem then further reacts with 2 molecules of O2 
resulting in cleavage at the a meso bridge yielding carbon 
monoxide and a biliverdin IXa-iron complex. This complex 
is hydrolyzed and then reduced with NADPH to bilirubin IXot 
by biliverdin reductase, and iron is released in the 
process (Yoshida and Kikuchi, 1978; Yoshinaga et al.,
1982). '
The carboxyl groups on the propionic acid side chains 
of bilirubin are subsequently conjugated with glucuronic 
acid, glucose or xylose and the conjugated compounds are 
excreted in the bile (Tait, 1978).
i•4 Regulation of haem biosynthesis
Numerous studies in mammalian and avian liver have 
provided convincing evidence that ALA-S is under negative 
feedback regulation by haem (for reviews, see Meyer and 
Schmid, 1978; Kappas et al., 1983; Maines, 1984).
The turnover of ALA-S is very fast - a suitable 
property for its regulatory role in haem formation; 
half-lives of 35 min, 1 h and 3 h have been reported for 
the enzyme of rat and mouse liver mitochondria, and 
cultured chick embryo hepatocytes, respectively (Hayashi 
et al., 1980; Igarashi et.al., 1976; Sassa and Granick,
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1970). ALA-S activity in normal liver is very low 
compared to other enzymes of the haem biosynthetic pathway 
(Granick and Urata, 1963? De Matteis, 1975). Levels can 
be increased in rodents, chick embryos and cultured chick 
embryo hepatocytes by a number of compounds (see Section 
1.7), and the drug-mediated induction of ALA-S can be 
inhibited by jln vivo or jLn vitro administration of 
exogenous haem (for review see Kappas et al., 1983). 
Subsequently, many laboratories have therefore used drugs 
and chemicals, in particular DDC (3,5-diethoxycarbonyl- 
1,4-dihydrocollidine) and AIA (2-allyl-2-isopropylaceta- 
mide), to induce ALA-S, in order to study the regulatory 
role of haem on the enzyme. Three possible mechanisms of 
feedback regulation have been proposed:
1. Feedback repression of the synthesis of ALA-S by haem.
2. Feedback inhibition of ALA-S activity by haem.
3. Haem inhibition of the transfer of cytosolic ALA-S
into mitochondria.
1.4.1 Feedback repression of the synthesis of ALA-S by 
haem
Several lines of evidence suggest that haem inhibits 
the synthesis of ALA-S at both the transcriptional and 
translational steps of protein synthesis. Haem repression 
of ALA-S synthesis occurs at concentrations of 10”7 to 
10“8m  in cultured chick embryo liver cells (Sinclair and 
Granick, 1975), and findings in this system suggest that 
haem interferes specifically with the synthesis of ALA-S 
at the translational level (Sassa and Granick, 1970;
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Tyrrell and Marks, 1972). Evidence that the translational 
control by haem also exists in the rat liver was obtained 
by Yamamoto et al. (1981). Subsequent work from this 
laboratory suggested that haem inhibits a peptide chain 
elongation step in the synthesis of ALA-S, although the 
study did not exclude the possibility that haem may also 
interfere with the initiation step of enzyme synthesis 
(Yamamoto et al., 1983).
A transcriptional inhibition of ALA-S synthesis by 
haem was suggested by Whiting (1976) through a study with 
polysomes isolated from chick embryo liver, and by 
Srivastava et al. (1980a) in chick embryo liver cells in 
culture. More recently additional evidence for 
transcriptional inhibition of ALA-S synthesis was provided 
by Yamamoto et al. (1982) who demonstrated that 
administration of haem to AIA-pretreated rats was followed 
by a reduction in the ability of liver polysomes to direct 
cell-free synthesis of ALA-S in vitro in a reticulocyte 
lysate system.
1.4.2 Feedback inhibition of ALA-S activity by haem
A role for haem in inhibiting the activity of ALA-S is 
attractive since both ALA-S and FK are located at or near 
the inner mitochondrial membrane. This would thus appear 
an ideal arrangement for a direct control of ALA-S 
activity by the "local" concentration Of haem.
Inhibition of ALA-S activity by haem has been 
demonstrated only with partially purified enzyme
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preparations and with concentrations of haem between 10”^ 
and 10”5M (Scholnick et al., 1969: Whiting and Elliott, 
1972). A study by Wolfson et al. (1979) indicated that 
haem generated in mitochondria was not sufficient to 
inhibit ALA-S activity, and more recently Pirola et al. 
(1984) showed that purified chick embryo liver ALA-S was 
not inhibitied by concentrations of haem (or haemin) up to 
1 mM. These findings make it improbable that haem acts 
physiologically to control directly mitochondrial ALA-S 
activity.
1.4.3 Haem inhibition of the transfer of cytosolic ALA-S 
into mitochondria
ALA-S is synthesized originally on polyribosomes in 
the cytosol (Whiting, 1976) and is then transferred into 
mitochondria. The larger molecular weight cytosolic 
precursor is converted to the mature enzyme by a 
proteolytic processing during or after the translocation 
into mitochondria (Ades and Harpe, 1982; Srivastava et 
al., 1983a; Hayashi et al., 1983).
Induction of mitochondrial ALA-S produced by 
administration of AIA to rats is accompanied by an 
increase in the level of cytosolic ALA-S, and haem is 
reported to inhibit the transfer of the cytosolic 
precursor into the mitochondria: in rats treated with AIA 
and haem, a considerable increase of cytosolic ALA-S is 
observed with a concomitant decrease of mitochondrial 
ALA-S activity (and amount) in comparison with rats
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treated with AIA alone (Hayashi et al., 1972; Yamauchi et 
al., 1980). Similar findings have been reported in chick 
embryo hepatocyte cultures and chick embryo liver (Ades, 
1983; Srivastava et a]L. , 1983b) and inhibition by haem of 
the translocation of cytosolic ALA-S into mitochondria has 
also been demonstrated in a cell-free in vitro transfer 
system (Hayashi et al., 1983).
However, it should be noted that when rats or mice are 
treated with DDC, haem administration does not result in 
an increased accumulation of ALA-S in the cytosol, 
compared to animals treated with DDC alone (Kappas et a l .,
1983). This raises questions about the importance of 
inhibition of ALA-S translocation into mitochondria as a 
general mechanism by which haem regulates hepatic ALA-S 
and current evidence suggests that haem-mediated control 
of ALA-S is principally at the level of enzyme synthesis, 
at both the transcriptional and translational stages.
The human porphyrias
The porphyrias are a group of inherited or acquired 
disorders in which a disturbance in the regulation of haem 
biosynthesis occurs, biochemically characterized by 
increased formation, accumulation in body tissues, and 
excretion of porphyrins, their precursors, or both. These 
diseases have been classified as either hepatic or 
erythroid in origin, depending on the primary site of 
porphyrin or porphyrin precursor overproduction. Only the 
hepatic porphyrias will be discussed here.
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Hereditary hepatic porphyrias are inherited as 
autosomal dominant disorders, and include acute 
intermittent porphyria (AIP), hereditary coproporphyria 
(HCP), variegate porphyria (VP) and familial porphyria 
cutanea tarda (familial PCT) (for reviews see Meyer and 
Schmid, 1978; Kappas et al., 1983). In each of these 
disorders a partial deficiency in a specific enzyme distal 
to ALA-S represents the primary genetic defect (see 
later). Increased hepatic ALA-S, which is common to each 
of these porphyrias, has been proposed to be a secondary 
effect, resulting from a decreased negative feedback 
regulation byjhaem. The elevated ALA-S activity, together 
with decreased activity of an intermediary haem 
biosynthetic enzyme, leads to distinct patterns of 
porphyrin or porphyrin precursor excretion, by which the 
different forms of porphyria can be distinguished.
Symptomatically, the two most important clinical 
features of the disease are neuropsychiatric 
manifestations and/or cutaneous photosensitivity with 
increased skin fragility. Numerous hypothesis have been 
advanced to explain the neurological disturbances, 
including the suggestion that excess porphyrin precursors 
(ALA and PBG) formed in the liver may gain access to the 
nervous sytem and there exert a toxic effect. Although 
ALA and PBG have been shown to affect nerve function in 
vitro, the neurotoxicity of these precursors has not been 
conclusively shown in vivo (Maxwell and Meyer, 1978).
Thus the neurological dysfunction cannot yet be defined in
15
biochemical terms. However, porphyrin accumulation in 
plasma or skin is believed to be responsible for the 
photosensitivity: it is thought that absorbed light 
induces an excited energy state of the porphyrin molecule, 
and that this can be released as fluorescence or can 
produce chemical reactions leading to the formation of 
free oxygen radicals and singlet oxygen and ultimately to 
cell damage (Sandberg and Romslo, 1980; 1981; Kappas et 
al., 1983).
In all of the inherited forms of hepatic porphyria, 
environmental factors play a vital role in determining 
clinical expression of the gene abnormality. In AIP, HOP 
and VP, clinical symptoms appear in acute attacks, which 
may last several weeks, and are separated by long periods 
of remission during which the patients may exhibit no 
symptoms of the disease. Acute - and at times, fatal - 
attacks may be precipitated by normal, therapeutic doses 
of a variety of drugs, which may also aggravate the 
condition when symptoms are present. The barbiturate 
group of drugs are most commonly associated with acute 
attacks, but other drugs have been implicated, including 
non-barbiturate sedatives, sulphonamides, anticovulsants 
and hypoglycaemics (Marks, 1978; Maxwell and Meyer,
1978). In view of this, care must be taken in the 
treatment of patients with either a personal or family 
history of porphyria. Acute attacks may also be 
precipitated by steroids, infections or fasting (Kappas et 
al., 1983). Endogenous hormones play a role in the
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clinical expression of AIP, HCP and VP. This is reflected 
in the rarity of symptoms before puberty and, in AIP, the 
greater incidence of symptoms in women than men, and the 
fluctuation of severity of the disease in relation to the 
menstrual cycle and pregnancy in some women (Kappas et 
al. , 1983). The majority of these factors appear to act 
by inducing ALA-S, resulting in extensive overproduction 
of porphyrins and their precursors, which are responsible 
for the photosensitivity and possibly also for the 
neurological effects, as mentioned earlier.
Acute attacks do not feature in PCT, and other factors 
are involved in the expression of the disease, as will be 
discussed later.
Acute intermittent porphyria (AIP), is an autosomal 
dominant disorder in which the basic genetic defect is a 
deficiency of PBG deaminase activity, which is 
approxiamtely 50% of normal in all tissues examined (Meyer 
et al., 1972). More recent work has shown the genetic 
defect of AIP to be heterogenous: not only can patients of 
AIP be distinguished into 2 groups according to whether or 
not the enzymic defect can also be demonstrated in the 
erythrocytes [a family of AIP from Finland showing normal 
erythrocyte activity (Mustajoki, 1981)]? mutations can 
also be distinguished depending on the amount of cross 
reactive immunological material (CRIM) present in the 
erythrocyte lysates, 2 CRIM-positive and 2 CRIM-negative 
mutations having been identified (Mustajoki and Desnick, 
1985). In the CRIM-negative enzymic defect, the amount of 
CRIM is proportional to the enzymic activity, while in the
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CRIM-positive defect, non-catalytic but immunologically 
cross reactive enzyme protein is present.
During acute attacks of the disease, urinary excretion 
of ALA and PBG is markedly increased without a 
proportional increase in porphyrin excretion. In 
clinically expressed AIP, visceral autonomic neuropathy 
with abdominal pain and ileus and peripheral neuropathy 
that can progress to total paralysis are especially 
prominent manifestations. Other clinical symptoms include 
hypertension, tachycardia and mental disturbance. An 
important feature of AIP is the absence of cutaneous 
photosensitivity, which is generally observed in other 
forms of hepatic porphyria, and can be explained by the 
lack of porphyrin accumulation.
Hereditary coproporphyria (HCP) is less common than 
AIP. The fundamental biochemical abnormality is a partial 
(approximately 50 percent) deficiency of copropor­
phyrinogen oxidase which is inherited as an autosomal 
dominant trait. The exact nature of the enzyme defect has 
not been determined, but it is likely that the mutant gene 
product has little or no enzymic activity (Elder et al., 
1976). Biochemically, HCP is characterized by the 
unremitting excretion of large amounts of coproporphyrin 
III in the faeces, and to a lesser extent, in the urine. 
During acute attacks, increased urinary excretion of ALA, 
PBG and uroporphyrin occurs. Clinically, symptoms are 
similar to those of AIP but in addition, cutaneous 
photosensitivity due to accumulation of coproporphyrin 
occurs in some patients (Kappas et al., 1983).
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Variegate porphyria (VP) has been recognised in many 
populations but is particularly common among South African 
whites; here, most cases can be traced back to a Dutch 
couple who settled in the country in the 17th century. 
Inheritance is autosomal dominant in nature, and the 
underlying genetic defect involves a deficiency in 
activity of either PK (Viljoen et al ., 1979), or 
protoporphyrinogen oxidase (Brenner and Bloomer, 1980).
Biochemically VP is characterized by a continuously 
high urinary and faecal excretion of porphyrins, 
particularly faecal protoporphyrin. During acute attacks, 
urinary excretion of ALA and PBG is also markedly 
increased. As in AIP, neurological symptoms may be 
present but the most prominent feature of this form of 
porphyria is chronic skin sensitivity to light and 
mechanical trauma.
Porphyria cutanea tarda (PCT) is the most common form 
of porphyria. Biochemically, the disease is characterized 
by excessive urinary excretion of uroporphyrin and other 
highly carboxylated porphyrins, and cutaneous 
photosensitivity is’the major symptom. The disease does 
not produce neurological dysfunction. There are 3 types 
of the disease: (1) sporadic PCT, (2) familial PCT, and
(3 ) cases due to exposure of polyhalogenated 
hydrocarbons. Uroporphyrinogen decarboxylase is decreased 
in the liver in all cases and, in familial PCT, in other 
tissues as well (Kappas et al., 1983).
Uroporphyrinogen decarboxylase deficiency in familial 
PCT is inherited as an autosomal dominant trait and
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homozygotes have also been described. A parallel 
descrease in catalytic and immunoreactive enzyme has been 
reported in the erythrocytes of these patients (Elder et 
al., 1983). The enzyme decrease probably results from a 
rapid degradation of the enzyme in vivo (De Verneuil et 
al., 1986). These latter authors have recently cloned and 
sequenced a complementary DNA (cDNA) for the mutated gene 
and showed that cDNA with a mutation at nucleotide 860 
yielded a protein that was very rapidly degraded vitro. 
They suggested that this mutation may be the primary 
genetic defect in familial PCT.
In both familial and sporadic cases of PCT, ALA-S 
activity remains normal or is only minimally increased and 
probably accounts for the biochemical and clinical 
differences between this form of porphyria and the 
hereditary forms (AIP, HCP AND VP), that is, normal 
urinary excretion of ALA and PBG, the absence of 
neurovisceral symptoms, and the lack of sensitivity to 
drugs such as barbiturates.
Sporadic, or aquired PCT is the most common of all 
forms of porphyria and occurs late in adult life in 
patients who have no family history of PCT. Alcohol, 
hepatic siderosis and oestrogens are common predisposing 
factors, although how they contribute to the pathogenesis 
of the disease is not fully understood. Sporadic PCT is 
particularly common among the Bantu population of South 
Africa. Chronic liver disease and hepatic siderosis, 
which are common in this race, are thought to be due to 
the high consumption of home-brewed beer which has a high
iron content, and their porphyria has been attributed to 
hepatic iron overload. This is supported by the 
observation that remission can be achieved by lowering 
hepatic iron stores (Elder, 1978; Kappas et al., 1983). 
Cases of sporadic PCT in other areas of the world are 
usually associated with high alcohol consumption.
However, alcohol abuse and/or iron overload are not always 
accompanied by porphyria, and suggests a genetic 
predisposition to the disease, although this is not yet 
established (Kappas et al., 1983).
Evidence for the occurrence in man of a purely 
aquired, not genetically predetermined, form of hepatic 
porphyria is provided by the massive outbreak of a 
PCT-like syndrome which occurred in Southeastern Turkey in 
1956. Wheat seed intended for agricultural purposes, to 
which hexachlorobenzene (HCB) had been added as a 
fungicide, was used for food by a large impoverished 
population, and caused thousands of cases of cutaneous 
porphyria, many of which were severe. There were no 
neurological or acute abdominal symptoms, and 
biochemically a marked uroporphyrinuria was found because 
of depressed uroporphyrinogen decarboxylase activity 
(Kappas et al., 1983). The aetiology of the porphyria was 
confirmed by epidemiological investigations, by the 
absence of new cases within 2 years after withdrawal of 
the seed dressing, and by the demonstration that HCB 
feeding could inhibit hepatic uroporphyrinogen decarboxy­
lase and cause porphyria in rats and rabbits (Ockner and 
Schmid, 1961; De Matteis et al., 1961; Elder, 1978).
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1.6 Experimental porphyria
A few chemical agents can produce a disturbance of 
porphyrin metabolism in various animal species. These 
include the antifungal agent griseofulvin (GF), the 
fungicide HCB, the chemical DDC, and allyl-containing 
compounds such as AIA (Tschudy and Bonkowsky, 1972; De 
Matteis, 1978b). The biochemical similarity of the 
experimental porphyrias to one or other of the human 
hereditary forms (Table 1.1) has provided models for which 
the biochemical lesion in each type can be studied. The 
neuropsychiatric mainifestations observed in the human 
porphyrias are not reproduced in the experimental models, 
thus caution is required in extrapolating the data from 
the latter to the inherited disease. Nevertheless, the 
concepts derived from chemically-induced experimental 
porphyria have contributed immeasurably to our 
understanding of the pathogenesis of the human hereditary 
porphyrias; it is now possible (at least in some cases) to 
protect patients against drug^-induced attacks of the 
disease and to eleviate the neurologic dysfunction (Kappas 
et al., 1983).
In addition to intact animals, in vitro systems such 
as cultured chick embryo hepatocytes (Section 1.10), and 
more recently, isolated rat hepatocytes (Canepa et al., 
1934; De Matteis et al., 1986), have been used in the 
study of experimental porphyria. The in vitro systems 
offer the advantage that studies can be undertaken 
independently of the possible influence of extra-hepatic 
factors. The sensitivity of the different systems to
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induction of porphyria varies greatly, and findings in the 
in vivo and in vitro systems do not always agree (for 
reviews see Tschudy and Bonkowsky, 1972; Marks, 1978). 
Nevertheless, both have proved invaluable in the study of 
porphyria and of mechanisms of enzyme regulation, 
particularly ALA-S (see Section 1.4).
The concept of chemical induction of porphyria 
originated from the clinical observations of Stokvis in 
1889 when he described a patient who had ingested the 
sedative Sulphonal and then passed red urine and died of 
neurological dysfunction. A few years later, Stokvis 
(1895) produced the first experimental porphyria by 
administration of Sulphonal to rabbits and dogs.
Rimington and Hemmings (1938) subsequently reported that 
certain sulphonamides, including sulphanilamide, increased 
urinary coproporphyrin excretion by rats.
Experimental hepatic porphyria was first studied in 
detail by Schmid and Schwartz (1952) and was prompted by 
the reported porphyria in a patient who had ingested a 
large amount of Sedormid (2-allyl,2-isopropylacetyl- 
carbamide). Schmid and Schwartz demonstrated that 
administration of this drug to rabbits produced a form of 
porphyria that was characterized by increased excretion of 
PBG and uroporphyrin III in the urine. The finding in the 
liver of large amounts of porphyrins and PBG suggested 
that this organ was the principal site of the metabolic 
disturbance.
A more soluble analogue of Sedormid, AIA, which has 
less pronounced hypnotic effects, was later shown to be
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very active in producing hepatic porphyria in rabbits 
(Goldberg et a_l. , 1955). These workers investigated the 
relationship between chemical structure and the 
porphyrin-inducing activity of several analogues of 
Sedormid, and some barbiturate drugs, in rabbits. They 
concluded that the structural features required for 
producing this type of porphyria were an allyl group, 
together with either an acid amide (as in AIA), or a 
ureide (as in Sedormid), or a cyclic ureide (as in 
barbiturates such as 5,5-diallyl barbituric acid).
However, the relationship between structure and activity 
required re-examination, following the discovery that 
chemicals structurally unrelated to those mentioned above 
could also produce porphyria. In 1959, Soloman and Figge 
described an experimental porphyria in guinea pigs and 
mice caused by DDC. The porphyria was characterized by 
marked overproduction of primarily protoporphyrin which 
accumulated in the liver and was excreted in the faeces 
and thus resembled human VP. Subsequently, the compounds 
HCB (De Matteis et al., 1961; Ockner and Schmid, 1961) and 
GF (De Matteis and Rimington, 1963) were found to induce a 
condition of porphyria in animals, characterized by 
increased liver production and excretion of uroporphyrin 
and protoporphyrin, respectively.
Despite the considerable difference in chemical 
structure of the porphyrogenic compounds mentioned (Fig
1 .3 ), it was subsequently demonstrated that they all 
caused an induction of hepatic ALA-S. Extensive research 
on the effects of these drugs, and the use of structural
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Fig 1.3 Structure of some porphyrogenic drugs and
their non-porphyrogenic analogues
Porphyrogenic
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analogues which do not cause porphyria (Fig 1.3), has lead 
to the realization of the importance of certain structural 
features for the induction of ALA-S and porphyria in 
animals. The mechanisms by which different groups of 
drugs induce ALA-S, and factors which can modify the 
response of the enzyme will be discussed in the following 
sections.
1.7 Induction of ALA-S in porphyria
Significant progress was achieved in the understanding
optoork
of the mechanism of porphyria mainly as a result^ from 
Granicks laboratory. In 1963, Granick and Urata reported 
a forty-fold increase in the level of mitochondrial ALA-S 
in the livers of guinea pigs fed DDC. This observation 
was later extended to the experimental porphyria caused by 
AIA, GF, HCB and related compounds (see Tschudy and 
Bonkowsky, 1972; Meyer and Schmid, 1978). An increased 
ALA-S thus provided an explanation for the elevated 
excretion of ALA which had been reported in experimental 
porphyria (De Matteis and Prior, 1962) and later, 
increased levels of hepatic ALA-S were found in patients 
with clinically expressed AIP (Tschudy et al., 1965).
Granick (1963; 1966) reported that a number of drugs 
which caused porphyria in animals in vivo could also 
induce ALA-S in cultured chick embryo hepatocytes; he 
demonstrated that the drug-mediated increase of ALA-S 
activity in this in vitro system could be prevented by 
inhibitors of RNA or protein synthesis. This suggested 
that the increased enzyme activity resulted from de novo
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synthesis of the enzyme, rather than a direct activation 
of the enzyme by the inducing chemicals. Definite proof 
of increased enzyme protein synthesis was provided by 
immunological studies of Whiting and Granick (1976). They 
demonstrated that increases in mitochondrial ALA-S 
activity, produced by AIA and DDC, were accompanied by 
proportional increases in the amount of enzyme protein, 
and suggested this was achieved primarily through 
stimulation of the rate of synthesis of ALA-S.
As mentioned earlier (Section 1.4.3), ALA-S is 
synthesized originally on cytoplasmic polyribosomes and is 
then translocated into the mitochondrial matrix. By use 
of a specific antibody to identify ALA-S synthesized in a 
cell-free mRNA translation system, Brooker et al. (1980) 
demonstrated that the drug-induced increase of ALA-S 
activity in chick embryo livers correlated with a large 
increase in the translational capacity of isolated 
polyadenylated mRNA for the enzyme, without a concomitant 
increase in the translation of most other proteins.
Similar findings were reported by Ades and Harpe (1981) 
and Srivastava et al. (1983a). In addition, Brooker et 
al. (1980) presented evidence which indicated that the AIA 
plus DDC-mediated increase in ALA-S was due to an increase 
in the level Of ALA-S mRNA.
1.8 Mechanisms by which porphyrogenic drugs induce ALA-S 
Three of the most widely studied porphyrogenic 
compounds, AIA, DDC and GF, all cause a rapid loss of
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hepatic microsomal cytochrome P-450 in various animal 
species (Wada et al., 1968; Waterfield et al. 1969). It 
was subsequently demonstrated that the transient decline 
in the total haem content of the microsomal fraction 
observed after a single dose of AIA or DDC to rats was 
coincidental with the rise in ALA-S activity (De Matteis, 
1970; De Matteis and Gibbs, 1972). In view of the 
regulatory role of haem on ALA-S (Section 1.4) and the 
observation that haem administration to animals can 
prevent the induction of ALA-S by pflr&phyrogenic drugs, 
drug-mediated depletion of liver haem has been proposed as 
a mechanism by which these compounds induce ALA-S (De 
Matteis, 1970; Sinclair and Granick, 1975; Srivastava et 
al., 1980b). With AIA, DDC, GF and other related 
porphyrogenic compounds, the first stage of the process 
leading to a reduction of intracellular haem levels is an 
irreversible interaction between the drug and the haem 
prosthetic group of cytochrome P-450, which results in the 
production of abnormal porphyrins (or green pigments).
The mechanism of production, the structure, and the 
properties of the green pigments arising from AIA and 
other unsaturated compounds are distinct to those produced 
by DDC and GF. Consequently, the different types of 
porphyrogenic compounds deplete intracellular haem levels 
by different mechanism, as will be discussed later. In 
order to appreciate how a drug-mediated modification of 
cytochrome P-450 haem: can ultimately lead to an induction
of ALA-S, it is necessary to consider the regulatory role
29
of haem with respect to its own biosynthesis, use and 
catabolism.
1*8.1 The role of a "regulatory" haem pool in liver haem 
metabolism
Haem regulates its own synthesis at the level of ALA-S 
(Section 1.4), and also controls its own degradation by 
modulating the activity and amount of haem oxygenase, for 
which it can act as an inducer (Schmid and McDonagh,
1975). In addition, haem is used for the synthesis of 
microsomal, mitochondrial and cytoplasmic haemoproteins.
To explain the regulation of hepatic haem (and 
haemoprotein) synthesis and catabolism, a "regulatory" 
haem pool has been postulated (De Matteis, 1975? Granick 
et al., 1975). On purely theoretical grounds, the 
"regulatory" haem has been visualized as a small 
(10-8_io“7m) haem pool (Granick et al., 1975) with a rapid 
rate of turnover, into which newly synthesized haem is 
fed, and out of which haem is withdrawn for combination 
with apoproteins of the various haemoproteins, or for 
degradation. It could be free haem, or one or more pools 
in rapid equilibrium with free haem; there is evidence 
that a certain fraction of haem of cytochrome P-450 and 
cytochrome b5 exist as an exchangeable haem pool (Correia 
et al., 1979; Kappas et al., 1983). According to the 
model represented schematically in Fig 1.4, the regulatory 
systems for ALA-S and haem oxygenase, the apoproteins of 
the haemoproteins, and the pathways of haem degradation,
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may all compete with each other for the same pool of 
"regulatory" haem. Thus under conditions where the 
concentration of liver free haem decreases, the activity 
and amount of ALA-S will tend to increase, and vice versa: 
in either case, the changes in ALA-S activity bring the 
concentration of liver free haem back to normal.
Theoretically, the concentration of "regulatory" haem 
can be reduced by the following mechanisms: (1 ) increased 
haem degradation; (2) impaired synthesis of haem, and (3) 
increased haem utilization. In the case of porphyrogenic 
drugs such as AIA, DDC and GF, the first 2 mechanisms are 
the most important for the loss of liver haem, and the 
subsequent marked stimulation of ALA-S (see below). As 
mentioned earlier, a large proportion of the haem 
synthesized in the liver is incorporated into cytochrome 
P-450, and the third mechanism by which haem levels may be 
reduced (by increased utilization) occurs when cytochrome 
P-450 is induced by phenobarbitone and related compounds. 
The primary event in drug-mediated induction of cytochrome 
P-450 is increased synthesis of the apocytochrome which, 
through its haem-binding capacity, withdraws haem from the 
"regulatory" haem pool (Correia and Meyer, 1975; 
Rajamanickam et al., 1975; Giger and Meyer, 1981a). Only 
a small increase in ALA-S activity is observed and this is 
regarded as a compensatory stimulation to provide the 
additional haem required for cytochrome P-450 synthesis 
(Meyer and Schmid, 1978), although the exact manner by 
which induction of apocytochrome and haem synthesis are 
coordinated remains to be elucidated.
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1.8.2 Loss of liver haem by increased destruction
Several porphyrogenic compounds deplete liver haem 
levels by causing destruction of cytochrome P-450. These 
include allyl-containing barbiturates and acetamides 
(e.g. secobarbital, AIA); simple olefins (e.g. ethylene); 
and drugs containing the acetylenic (-C=C) grouping (e.g. 
norethindrone, ethynyl estradiol), including acetylene 
itself (for reviews see De Matteis, 1978a; Ortiz de 
Montellano and Correia, 1983; Ortiz de Montellano, 1985). 
The destruction of cytochrome P-450 by these compounds is 
the result of an interaction between the enzyme and the 
drug, whereby the drug is oxidatively metabolized to a 
reactive derivative which irreversibly converts the haem 
prosthetic group of the cytochrome into green pigments 
(White and Muller-Eberhard, 1977; White, 1978; Ortiz de 
Montellano and Mico, 1981; Ortiz de Montellano et al., 
1982). Consequently, cytochrome P-450 is inactivated, and 
drugs which have this effect are thus termed "suicide" 
substrates.
Spectroscopic studies identified the green pigments 
produced by unsaturated compounds as N-alkylated 
protoporphyrins, where the cyclic tetrapyrrole nucleus of 
haem is retained, but one of its pyrrole ring nitrogens is 
alkylated by a metabolite of the drug (De Matteis and 
Cantoni, 1979; De Matteis and Gibbs, 1980). More recent 
mass and NMR spectroscopic studies on green pigments 
derived from several allylie or acetylenic compounds have 
shown that the covalently-bound haem adduct is a
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mono-oxygenatedderivative of the drug (Kunze et al ., 1983; 
Ortiz de Montellano, 1985; White £t al., 1986).
The general pathway for cytochrome P-450-dependent 
metabolism of an olefin is its oxidation to an epoxide 
(Ortiz de Montellano, 1985). There is much evidence 
against epoxide metabolites being responsible for 
cytochrome P-450 inactivation, and it has thus been 
postulated that the alkylating metabolite maybe a free 
radical intermediate, which either alkylates the haem 
prosthetic group, or rearranges to form the epoxide (Ortiz 
de Montellano et al., 1982). With AIA, the partition 
ratio of this reaction is such that for every 200 
molecules of the epoxide formed, one haem-AIA adduct is 
generated thereby sacrificing a cytochrome P-450 haem 
(Ortiz de Montellano and Mico, 1981? Loosemore et a l ., 
1981).
The AIA-dependent loss of hepatic cytochrome P-450 
content and function can be partially restored by 
exogenous haem in vivo and in vitro (Ortiz de Montellano 
and Correia, 1983; Bornheim et al., 1985), and exogenous 
haem, or the haem analogue, mesohaem, can also be utilized 
in the N-alkylation reaction in vivo and in vitro (Correia 
et al., 1979; De Matteis et al., 1986). It has been 
suggested that exogenously administered haem, and other 
exchangeable pools of haem, including the endogenous 
"regulatory" haem pool, must first be taken up by the 
apoprotein of cytochrome P-450 in order to be subjected to 
N-alkylation (Correia et al., 1979; 1981; De Matteis et 
al., 1986) and induction of ALA-S and porphyria by
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unsaturated drugs has thus been proposed to occur by the 
following mechanism: selective alkylation of the haem
prosthetic group of cytochrome P-450 generates a relative 
excess of free apoprotein, which, through its haem-binding 
capacity, withdraws haem from the "regulatory" haem pool 
to form cytochrome P-450, some of which is subsequently 
converted to N-alkylated porphyrins. Haem is therefore 
diverted into the drug-dependent degradation pathway, away 
from its regulatory role on ALA-S, and ALA-S activity is 
induced to sustain accelerated haem turnover.
Subsequently, the production of ALA becomes so large that 
the 2 subsequent enzymes of the haem biosynthetic pathway, 
that is ALA-D and PBG deaminase, become rate limiting, and 
both ALA and PBG accumulate in excess in the liver (De 
Matteis, 1978b).
1.8.3 Loss of liver haem by inhibition of haem 
biosynthesis
Compounds like DDC and GF, and their porphyrogenic 
analogues, 4-ethyl DDC and isogriseofulvin (ISOGF) 
decrease intracellular hepatic haem levels by causing a 
rapid inhibition of Fk activity in vivo (Onisawa and 
Labbe, 1963; Lockhead et al., 1967, De Matteis and Gibbs, 
1975; De Matteis et al., 1981a). Animals treated with 
these drugs accumulate green pigments in the liver. These 
pigments are N-alkylated haems and originate from the 
reaction of the drug with the haem of cytochrome P-450 
(see Chapter 6 ). Only a small portion of the drug is
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transferred to one of the pyrrole ring nitrogens of 
cytochrome P-450 prosthetic haem (De Matteis and Gibbs, 
1980) unlike the case of the green pigments produced by 
unsaturated drugs, where the haem adduct is the drug plus 
an oxygen atom (Section 1.8.2). It has been conclusively 
established that the green pigments produced from DDC and 
4-ethyl DDC are N-methyl and N-ethyl protoporphyrin 
(N-MePP, N-ethyl PP) respectively and that the N-alkyl 
substituent originates from the 4-alkyl group of the drug 
(De Matteis et al., 1981a; Ortiz de Montellano et al., 
1981a; Tephly et al., 1981; and see Chapter 6 ).
These green pigments, and those arising from GF and 
ISOGF, display a profound inhibitory activity toward FK. in 
vitro (Tephly et al., 1979; De Matteis and Gibbs, 1980; De 
Matteis et al., 1981a). In contrast, green pigments 
derived from unsaturated drugs such as AIA, secobarbitone 
or ethylene, do not inhibit this enzyme either in vivo or 
in vitro (De Matteis ^t al., 1980b, 1980c). It was 
originally suggested that size of the substituent on the 
pyrrole nitrogen was important for the inhibitory effect 
on FK (De Matteis and Gibbs, 1980), and compatible with 
this was the finding that authentic N-methylmesoporphyrin 
was more active than N-ethylmesoporphyrin as an inhibitor 
of the enzyme (De Matteis et al_. , 1980b). More recently, 
evidence has been presented that in addition to the size, 
the position of the N-alkyl group is also important in 
determining the potency of N-alkylated porphyrins as 
inhibitors of FK/ with alkyl groups larger than a methyl
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leading to less marked inhibition of the enzyme, 
particularly when bound to the nitrogen of either ring C 
or D of protoporhyrin (the rings where a propionate side 
chain is present) (Ortiz de Montellano et al., 1981b; De 
Matteis et aJL. , 1985). These steric factors which reduce 
the affinity of the inhibitor for the active site of FK 
explain why unsaturated drugs do not inhibit the enzyme, 
as the N-alkylated porphyrins produced by these latter 
drugs all bear N-alkyl groups larger than a methyl and 
these are present on propionate substituted rings (Ortiz 
de Montellano, 1985).
Although cytochrome P-450-dependent metabolism of DDC 
to produce N-MePP results in some destruction of 
microsomal haem, the profound inhibition of FK activity, 
mediated by N-MePP, is the most important mechanism by 
which the concentration of "regulatory" haem is reduced. 
This subsequently leads to a marked induction of ALA-S,
i ■
and, since FK activity is reduced, an excessive 
accumulation of protoporphyrin occurs (De Matteis,
1978b). Evidence that DDC promotes loss of liver haem and 
induction of ALA-S primarily by inhibiting haem 
biosynthesis is provided by the finding that inhibition of 
FK activity precedes the induction of ALA-S (De Matteis 
and Gibbs, 1972), and that mice, which are more sensitive 
than rats to the stimulation of ALA-S caused by DDC, are 
also more sensitive with respect to the decrease of FK 
activity (De Matteis et al., 1973). In addition, 
authentic N-MePP causes a pronounced FK inhibition in
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cultured chick embryo hepatocytes and this is accompanied 
by a marked stimulation of ALA-S and protoporphyrin 
accumulation (De Matteis and Marks, 1983).
The porphyrogenic agent HCB and other polyhalogenated 
aromatic compounds such as TCDD (3,3,7,8-tetrachloro- 
dibenzo-£-dioxin), polychlorinated and polybrominated 
biphenyls and hexabromobenzene inhibit haem biosynthesis 
at the level of uroporphyrinogen decarboxylase (Elder, 
1978). The mechanism by which these chemicals produce the 
enzymic defect is not yet known. There is evidence 
implicating the involvement of non haem iron: in rodents 
the inhibition of the enzyme and the degree of porphyria 
in response to HCB is both more rapid and more pronounced 
in the presence of increasing amounts of liver non haem 
iron - whether the increase is due to iron overload (Smith 
and Francis, 1983), or is genetically determined (Smith 
et al., 1979). Inhibition of uroporphyrinogen 
decarboxylase by HCB is also associated with the induction 
of certain cytochrome P-450 isoenzymes and it has been 
suggested that HCB may be metabolized, in a process 
stimulated by iron, to a product which inhibits, or 
covalently binds with uroporphyrinogen decarboxylase. 
However, a recent study by Smith et al. (1986) suggests 
that enzyme inhibition is unlikely to result from a direct 
effect of an HCB metabolite. An alternative hypothesis 
which is favoured at present (Ferioli et al., 1984) is 
that polyhalogenated drugs may cause the metabolite block 
indirectly, for example, by stimulating production of 
reactive species such as peroxides and free radicals.
These could then modify the enzyme itself, or 
alternatively, modify the uroporphyrinogen substrate. The 
synergistic role of iron could then result from the 
ability of ferrous iron to participate in peroxidative and 
free radical reactions.
The polyhalogenated compounds induce hepatic ALA-S and 
porphyria by a mechanism analogous to that described for 
DDC and GF. Thus, inhibition of uroporphyrinogen 
decarboxylase, by reducing the concentration of 
intracellular "regulatory" haem, leads to a stimulation of 
ALA-S, and uroporphyrin, the substrate of the inhibited 
enzyme, subsequently accumulates in excess.
1.9 Factors which influence the induction of ALA-S in 
experimental porphyria
1.9.1 Nutritional status
Glucose in large doses, or a high carbohydrate diet, 
can markedly inhibit the AIA-mediated induction of hepatic 
ALA-S in rodents (Tschudy et al., 1964; DeLoskey and 
Beattie, 1984). This so-called "glucose effect" has also 
been reported in vitro in cultured chick embryo 
hepatocytes and isolated rat hepatocytes (Giger and Meyer, 
1981b; Canepa et al., 1984), but the biochemical basis of 
the effect has remained unexplained. A number of 
mechanisms,including catabolite repression and mediation 
by cyclic AMP have been suggested, but are unlikely 
(Tschudy, 1978; Friedland and Ades, 1985). Recently, 
DeLoskey and Beattie (1984) provided evidence that glucose
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treatment inhibits translocation of ALA-S from the cytosol 
into the mitochondrial matrix but did not establish 
whether or not this was a direct effect of glucose.
Starvation and iron, on the other hand, can potentiate 
the effect of porphyrogenic drugs in animals (Rose et al., 
1961; Stein et al., 1970) and alone can stimulate ALA-S 
without any significant increase in porphyrin concen­
tration. These effects may be related to an increased 
degradation of liver haem which could occur either by a 
stimulation of haem oxygenase, or by an increase in the 
NADPH-dependent peroxidation of lipids in microsomal 
membranes, with the subsequent loss of cytochrome P-450 
haem (De Matteis and Sparks, 1973; De Matteis, 1978a). 
According to the model of regulation of haem metabolism 
(Fig 1.4), enhanced degradation of haem will reduce the 
concentration of free "regulatory" haem, and result in a 
stimulation of ALA-S. When the "regulatory" haem is 
partially depleted by a porphyrogenic agent such as AIA, 
the increased liver haem turnover produced by starvation 
or iron will subsequently enhance the drug-mediated 
stimulation of ALA-S.
1.9.2 Lipid-soluble effects of drugs
In rodents, lipophilic drugs such as phenobarbitone 
and phenylbutazone stimulate ALA-S only slightly without 
causing accumulation of porphyrin intermediates. However, 
either of them, when given together with a relatively 
small dose of DDC, produces a much greater stimulation of 
ALA-S and porphyria than observed with DDC alone (De
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Matteis, 1978b). This synergistic, or potentiation, 
-ihedruqson
effect of^the porphyria produced by DDC is shared by a 
large number of lipid-soluble compounds including the 
non-porphyrogenic analogues of either AIA, DDC or GF (De 
Matteis, 1973, De Matteis and Gibbs, 1975), all of which 
are relatively ineffective when given on their own. 
Phenobarbitone also potentiates the porphyria produced by 
AIA (De Matteis, 1973), and additionally, other agents 
that produce inhibition of haem synthesis in either 
cultured chick embryo hepatocytes (e.g. acetate, 
desferrioxamine) or in the liver of rodents (e.g. lead) 
can increase synergistically the response of ALA-S to 
lipid-soluble drugs (Sinclair and Granick, 1975? Maxwell 
and Meyer, 1976; Giger and Meyer, 1981a).
These observations lead to the postulation that 
induction of ALA-S by drugs occurs by a 2-stage mechanism 
(Sinclair and Granick, 1975; Maxwell and Meyer, 1976? De 
Matteis, 1978b). The first stage involves a "specific" 
drug action which causes a depletion of the "regulatory" 
haem pool (either by inhibition of haem synthesis, or by 
increased haem degradation). Subsequently, stimulation of 
ALA-S - the second stage - occurs because the enzyme is 
subject to negative feedback control by haem (Section
1.4). The "specific" depletion of "regulatory" haem is 
somehow responsible for increasing the sensitivity of 
hepatic ALA-S to stimulation (see below) and enzyme 
induction is potentiated. This potentiation effect is 
sometimes termed the "non-specific" action of a drug
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because it is shared by a large number of compounds, which 
share the property of lipid-solubility.
Agents such as AIA and DDC produce extensive induction 
of ALA-S since they are capable of "specifically" 
depleting regulatory haem (Section 1.8) and, by virtue of 
their own lipid-solubility, exert the "non-specific" drug 
effect.
The mechanism underlying the "non-specific" effect is 
not clear, but may be related to the property possessed by 
many lipid soluble compounds like phenobarbitone of 
inducing apocytochrome P-450 (De Matteis, 1978b). This 
would result in an increased haem utilization out of the 
"regulatory" haem pool for the formation of the cytochrome 
(See Fig 1.4). Only a small stimulation of ALA-S occurs, 
which suggests that the amount of haem normally made by 
the liver is sufficient to meet this increased demand.
When, however, the "regulatory" haem pool is already 
depleted by a drug like AIA or DDC, the same stimulus to 
increased haem utilization may lead to a further marked 
depletion of the "regulatory" pool and therefore 
ultimately to a marked stimulation of ALA-S (De Matteis, 
1978b). In support of increased synthesis of 
apocytochrome P-450 as a mechanism for the "non-specific", 
lipid-soluble effect, it has been reported that the amount 
of mRNA for the apocytochrome is increased by 
phenobarbitone (Bhat and Padmanaban, 1979) and also by AIA 
and DDC (Brooker and O'Connor, 1982). More recently, this 
laboratory have presented evidence that phenobarbitone,
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AIA and DDC all cause increased levels of the same 
apocytochrome P-450 mRNA (Brooker et al., 1983).
Alternatively, the "non-specific" effect may be 
related to the well-known ability of many lipid-soluble 
compounds to stimulate liver protein synthesis and liver 
growth. It has been suggested that the lipid-soluble 
effect of drugs may result primarily in increased 
synthesis of the mRNA for several liver enzyme proteins, 
including that for ALA-S (i.e. increased transcription), 
whereas a depletion of liver haem may lead more 
specifically to an increased translation of the mRNA for 
ALA-S (De Matteis, 1978b). These 2 different actions may 
thus produce a marked increase in the synthesis of ALA-S 
in a synergistic fashion. In favour of this mechanism, 
there is evidence that the effect of haem on ALA-S is at 
the level of translation (see Section 1.4). In addition, 
AIA, DDC and GF (which exert both "specific" and 
"non-specific" effects) have been reported to stimulate 
the synthesis of several liver enzymes (e.g. NADPH 
cytochrome c reductase, UDPG-dehydrogenase, 
glucose-6-phosphate dehydrogenase, enzymes involved in 
cholesterol and fatty acid synthesis) while exerting a 
particularly marked effect on the formation of ALA-S 
(Tschudy and Bonkowsky, 1972? Del Favero et al. , 1975; 
Denk et al., 1977). Recently, more direct evidence has 
been obtained to show that the AIA plus DDC-mediated 
increase in ALA-S activity in chick embryos correlates 
with an increase in the level of ALA-S mRNA and a large
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increase in the translational capacity for the enzyme, 
without a concomittant increase in the translation of most 
other proteins (Brooker et al., 1980).
Further investigations are required to conclusively 
establish whether the "non-specific" potentiation of ALA-S 
by lipid-soluble drugs is mediated by induction of 
apocytochrome P-450, or by a more direct increase in the 
synthesis of ALA-S itself. Both mechanisms involve de 
novo synthesis of protein and thus provide an explanation 
for the observation that inhibitors of protein synthesis 
can prevent ALA-S induction (Granick, 1966; De Matteis et 
al., 1973).
It has been reported that differences exist in the 
inducibility of hepatic ALA-S by DDC and AIA in selected 
inbred strains of mice (Gross and Hutton, 1971). 
Experiments to be described in Chapter 3 provide evidence 
that with DDC, this genetic difference is not due to a 
difference between mice strains in their response to 
"specific" action of the drug (that is, the inhibition of 
Fk), and this finding may perhaps suggest that the strains 
differ in their sensitivity to the "non-specific", lipid- 
soluble effect of DDC.
1.10 Cultured chick embryo hepatocytes as an 
experimental model for porphyria
In 1966, Granick developed a method for the primary 
culture of chick embryo hepatocytes and showed that the 
system was very sensitive to the porphyria-inducing 
effects of drugs. In contrast to the small number of
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agents which are highly porphyrogenic in rodents, a wide 
variety of drugs, chemicals and steroids induce ALA-S and 
porphyrin accumulation in cultured chick embryo 
hepatocytes (for review, see Marks, 1978). Specific 
structural features (such as an allyl group), which are 
important for the marked induction of hepatic ALA-S in 
rodents by producing a depletion of cellular haem (Section 
1 .8 ), are not required for enzyme induction in the culture 
system; rather, other factors appear to be involved: in 
this system a common property shared by inducing chemicals 
is lipophilicity (De Matteis, 1978b; Marks, 1978; Sinclair 
et al., 1986). Other factors suggested to increase the 
porphyrogenicity of chemicals include resistance to 
metabolism to compounds of lower lipophilicity, and 
electron-donating properties of substances (Marks, 1978).
A possible reason for the differences between rodents and 
chick hepatocytes is that the latter already possess 
intrinsically a liability in the regulation of the haem 
biosynthetic pathway (for example a partial block in the 
pathway at the level of Fk, or a greater rate of haem 
turnover) which makes its ALA-S very sensitive to 
stimulation by a large variety of lipid-soluble drugs; in 
rodent liver this liability must first be produced by a 
drug like DDC or AIA (De Matteis, 1973). Cultured chick 
embryo hepatocytes thus resemble the liver of patients 
with hepatic porphyria, where a genetically determined 
defect in haem biosynthesis renders the ALA-S very 
sensitive to induction by lipid-soluble compounds.
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Consequently, the culture system has proved useful in 
detecting drugs capable of precipitating attacks in 
patients with genetic porphyria (Marks, 1978? Kappas et 
al., 1983).
The main advantage of the chick hepatocyte culture 
system over animal models in the study of porphyrogenic 
agents is that in addition to serving as their own 
controls, many identical cell samples can be studied 
simultaneously. This is ideally suited to rapid screening 
of many drugs and for performing complex biochemical 
experiments requiring rigorously controlled conditions.
The in vitro system has proved useful in the study of the 
mechanisms of control of hepatic haem biosynthesis 
(Section 1.4), and determination of the pattern of 
porphyrin accumulation in response to drugs can indicate 
whether an enzyme has become rate-limiting, thus providing 
information on the mechanism of action of a porphyrogenic 
compound. However since so many drugs can induce ALA-S in 
cultured chick hepatocytes, results obtained with this 
sytem have to be interpreted carefully.
The in vitro culture system has been used to study the 
porphyrogenic effects of GF, ISOGF (the GF analogue which 
is porphyrogenic in rodents) and the non-porphyrogenic 
analogue HETGF, and results of these studies are presented 
in Chapter 5.
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CHAPTER 2
Material and methods
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2.1 Material and methods for Chapters 3 and 4
2.1.1 Materials
DDC was kindly prepared and purified by A.H. Gibbs 
(MRC, Carshalton), by the method described by De Matteis 
and Prior (1962) and GF was a gift to Dr. F. De Matteis 
from ICI Ltd., Macclesfield, Cheshire.
Dowex AG 50W - X8 cation exchange resin (H+ form, 
200-400 mesh) purchased from Bio-Rad Laboratories, 
Richmond, California, USA, was converted to the Na+ form 
by hydrating thoroughly in water and extensively washing 
in 2N NaOH until pH 12. It was finally resuspended in 
0.1 M Na acetate buffer, pH 3.9.
Mesoporphyrin IX dimethyl ester (Kock-Light 
Laboratories Ltd., Colnbrook, Bucks.) was converted to the 
free acid by overnight hydrolysis with 6N HC1. The 
mesoporphyrin IX was then dried in a desiccator under 
vacuum for 2 days, and a solution prepared in 50 mM 
Tris-HCl, pH 8.2, containing 2% (v/v) Tween 80. An 
aliquot of the solution was diluted with 0.1N HC1, the 
absorbance at 399 nm measured and the concentration 
calculated from EmM = 445 (Falk, 1964 ). The stock 
mesoporphyrin IX solution was diluted to a concentration 
of 1 mM with Tris/Tween solution and stored in the dark at 
4°C.
The following materials were obtained from the sources 
indicated:-
Agarose-Hexane-Coenzyme A type V
P-L Biochemicals, Milwaukee, U.S.A.
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Low molecular weight markers
Bio-Rad Laboratories Ltd., U.S.A.
MP scintillation fluid
Beckman, High Wycombe, U.K.
Polybuffer Exchanger 94, Polybuffer 96, pH 6.6 and 
Sephacryl S200
Pharmacia Fine Chemicals, Milton Keynes, U.K. 
[2,3-!4c]-succinic acid (specific radioactivity 47.8 
Ci/mol)
New England Nuclear, Boston, U.S.A.
Succinyl CoA synthetase (Porcine Heart)
Sigma Chemical Co. Ltd., Poole, U.K.
All other biochemicals were of the highest grade 
available and were purchased from one of the following 
sources:-
Aldrich Chemical Co. Ltd., Gillingham, Kent.
BDH Chemicals Ltd., Poole, U.K.
Fisons pic, Loughborough, U.K.
Sigma Chemical Co. Ltd., Poole, U.K.
2.1.2 Animals
Inbred mice of the C3H/He/01a and NIH/Ola strains 
obtained from Olac Ltd. (Blackthorn, Oxon, 0X6 OTP), and 
MF1 mice (MRC, Carshalton) were 6-12 weeks of age at the 
time of the experiments; they were housed in cages with 
sawdust bedding, and kept in a room with controlled 
lighting (12 hours light and 12 hours dark), and
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temperature (19 ± 2°C). Animals were fed expanded R and M 
No. 3 diet (Labsure, Cambs), except during the course of 
drug treatment, and received water ad libitum; they were 
allowed at least 2 weeks to adjust to the conditions 
before experiments.
a) Treatment with DDC
DDC was administered intraperitoneally, dissolved in 
arachis oil (5 ml/kg body wt), at doses of 25-200 mg/kg, 
Control mice received arachis oil alone. Animals (except 
controls) were then transferred to clean cages and killed 
after a 16 h fast.
b) Treatment with succinyl acetone (SA)
Mice were starved overnight and then received SA (100 
mg/kg, intraperitoneally) dissolved in saline, and were 
killed after a further 4 h fast. Controls received saline 
intraperitoneally.
c) Treatment with* GF or DDC in the diet
GF and DDC were given at a concentration of 1% and 
0.1% (w/w) respectively, in powdered expanded R and M 
No. 3 diet containing 2% (v/w) arachis oil. After a 
preliminary period of 3-4 days on the powdered diet alone, 
mice received the diet containing the drug for the period 
of time indicated in the relevant tables. Control mice 
received the powdered diet alone for the same period of 
time. Food consumption was measured and found to be 
similar in control and treated groups.
In all experiments, mice were weighed prior to, and at 
the end of treatment.
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2.1.3 Preparation of tissue
Mice were killed by cervical dislocation, their livers 
were quickly removed and placed in ice-cold 1.15% (w/v) 
KC1, after removal of the gall bladder. The livers were 
weighed and individual homogenates (10% w/v) were prepared 
in 0.25 M sucrose using an Ultra-Turrax homogenizer (15 
sec at 0°C). ALA-S activity and porphyrin levels were 
measured on the-10% homogenates; aliquots of homogenates 
were diluted with 0.25 M sucrose to obtained 2% 
homogenates which were used to determine Fk activity. In 
the experiments where mice were treated intraperitoneally 
with DDC, the 10% homogenates were stored at -70°C for one 
or two days prior to dilution and assay of Fk activity. 
ALA-D activity was measured using 5% liver homogenates.
2.1.4 Enzyme assays 
a) ALA-S
ALA-S activity was assayed in liver homogenates by the 
radiochemical method of Condie and Tephly (1978), as 
modified by De Matteis et al_. (1981b).
The assay is based on the incorporation of
[2,3-14c]-succinate into ALA. The 14c ALA formed is 
isolated from contaminants by column chromatography and 
further purified by condensation with acetyl acetone to 
form the pyrrole derivative. An outline of the enzymic 
and chemical reactions involved is shown in Fig 2.1.
The reaction mixture (0.5 ml) contained the following
components, with final concentrations in parentheses:
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Legend to Fig 2.1
Succinate can be converted into succinyl-CoA,the immediate 
precursor of ALA, by 2 different pathways (Shemin, 1955);
(1) direct generation by the enzyme succinyl-CoA 
synthetase^ and
(2) succinate enters the tricarboxylic acid cycle and 
succinyl-CoA is generated from the oxidative 
decarboxylation of a-ketoglutarate.
De Matteis et al. (1981) have shown that most of the 
succinate is utilized via the first pathway under the 
standard conditions of the enzyme assay.
The 14C ALA formed during the in vitro incubation is 
condensed with acetylacetone, in the presence of acetate 
at pH 4.6, to form the ALA-pyrrole (Mauzerall and Granick, 
1956).
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liver homogenate (250 pi, containing 5-6 mg protein), 
Tris-HCl buffer, pH 7.5 (75 mM), glycine (100 mM), EDTA 
(7.5 mM), pyridoxal phosphate (0.4 mM), ATP (1.5 mM) and 
[2,3-14c]-succinate (specific radioactivity, 2.63 Ci/Mol; 
0.38 mM). Incubations were performed for 30 min at 37 °C. 
The reaction was terminated by the addition of 125 pi of 
25% (w/v) TCA and 25 pi of 10 mM ALA was added as a 
carrier. Zero time samples and incubation blanks 
(containing no enzyme) were routinely run. The product, 
ALA, was separated from 14c succinate and other 
metabolic intermediates that might be produced from 
[2,3-14c]-succinate during the incubation, by Dowex 
AG50W-X8 ion-exchange chromatography, as described by 
Condie and Tephly (1978). The 14C ALA was eluted with 1 M 
Na acetate, and an aliquot was taken for counting 
radio-activity in a Packard TriCarb Model 460C liquid 
scintillation spectrometer with MP as the scintillant.
The Na acetate eluate contained in addition to *14c ALA, 
one or more contaminants; thus 14c ALA was further 
purified by treatment with acetyl acetone to form the 
pyrrole derivative (Mauzerall and Granick, 1956) and by 
extracting the pyrrole into ethyl acetate at pH 4.6 
(Condie and Tephly, 1978). Portions of the ethyl acetate 
extract were then taken for counting radioactivity.
The yield of 14c ALA was determined from the specific 
activity of [2,3-14c]-succinate on a 1:1 molar ratio, 
allowing for the fact that recovery of 14c ALA taken 
through the whole procedure is 60%. 14c ALA production
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by liver homogenates was a linear function of time up to 
60 min of in vitro incubation, and of protein 
concentration up to 24 mg/ml. Assays were routinely 
performed in duplicate with 30 min incubation, and ALA-S 
activity expressed as nmol ALA formed/h/g liver, or pmol 
ALA/min/mg protein.
b) Partially purified ALA-S
This was measured by the procedure of Brooker et al. 
(1982) in which succinyl-CoA was generated enzymically 
from succinate and coenzyme A using succinyl-CoA 
synthetase. Incubations (150 jil) contained the following 
reagents, with final concentrations in parentheses: 
Tris-HCl buffer, pH 7.4 (50 mM), glycine (100 mM), (CaMg) 
EDTA (1 mM), MgCl2 (20 mM), laevulinic acid (27.6 mM),
NaCl (250 mM), DTE (1 m M ), pyridoxal phosphate (0.25 mM), 
[2,3-14c]-succinate (1 mM), CoA (0.78 mM), GTP (5 mM), 2 
units of succinyl-CoA synthetase, and enzyme. After 30 
minutes incubations at 37°C, the reaction was terminated 
by the addition of 40 jil of 25% (w/v) TCA and 10 jil of 
10 mM ALA was added. The amount of 14c ALA formed was 
determined as described in the previous section.
c) FK
FK activity was assayed anaerobically in Thunberg 
tubes, with mesoporphyrin IX and Fe2+ as the substrates by 
the method described by Cole et al. (1979) with the 
exception that whole liver homogenate was used as the 
source of enzyme (rather than a solubilised mitochondrial 
preparation). Reagents were added to each tube in the
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following order: mesoporphyrin IX (120 nmoles), 1% (w/v)
Tween 80 (0.3 ml), ethanol (0.3 ml), 0.2 M Tris-HCl
buffer, pH 8.2 (1.5 ml), 0.2 M DTE (60 pi) and 1 mM FeS04
(120 pi). 0.8 ml of 2% liver homogenate (3-5mg protein)
was placed in the side arm. Total incubation volume was
3.2 ml. The Thunberg tubes were repeatedly evacuated and
flushed with 02-free N2 and finally sealed under N 2 » The
tubes were transferred to a water bath at 37°C, and 5
min later the incubation was started by tipping the enzyme
into the reaction mixture. Incubations were terminated by
opening the Thunberg tubes and adding
0.5 ml of 0.4 M iodoacetamide.
The amount of product (mesohaem IX) formed was
determined by the pyridine haemochromogen method of Porra
and Jones (1963a). The reduced minus oxidised pyridine
mesohaemochromogen spectrum was recorded between 500 and
600 nm on a Cary Model 2200 spectrometer. The 
547-531
AEicm value was measured and the very small
contribution made by endogenous protohaem IX, measured in
a zero time control was subtracted (Porra, 1976). The
547-531mesohaem IX formed was then calculated using E ^
= 2 1 . 7  (Porra and Jones, 1963a).
The production of mesohaem by mouse liver homogenates 
was not strictly linear with time (Fig 2.2a) and 30 min 
incubations were chosen in order to obtain a measurable 
amount of mesohaem when FK activity was inhibited as a 
result of in vivo drug treatment. The assay was linear 
with amount of protein (up to 6 mg) when 30 min
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incubations were performed and activity was expressed as 
nmol mesohaem formed/30 min/mg protein.
In later studies a shorter incubation time (10 min) 
was used to minimize substrate-dependent regeneration of 
Fk activity which had been inhibited following in vivo 
drug treatment (see Section 3.3.3). 
d) ALA-D
The colorimetric assay described by Gibson et al. 
(1955) was used to determine the ALA-D activity of 5% 
liver homogenates. The homogenate (equivalent to 100 mg 
wet wt liver) was preincubated ija vacuo in a Thunberg tube 
for 1 h at 38°C in a 3 ml reaction mixture containing 67 
mM phosphate buffer (pH 6 .8 ) and 10 mM reduced glutathione 
to activate the enzyme. After the preincubation, 0.33 ml 
of 0.1 M ALA was added from the side arm of the Thunberg 
tube and the incubation was continued for 1 h. The 
reaction was stopped by pouring the incubation mixture 
into dialysed iron solution, adding two drops of saturated 
CUSO4 solution in order to discharge the colloidal iron 
and centrifuging to precipitate protein. The amount of 
product (PBG) was measured in a suitable dilution of the 
supernatant by mixing with an equal volume of modified 
Ehrlich's reagent (containing 2 N perchloric acid), 
followed by measuring the absorbance at 555 nm. The 
amount of PGB was calculated using EmM = 61 (Mauzerall and 
Granick, 1956). PBG production by liver homogenates was a 
linear function of time up to 60 min, and of the amount of
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liver taken (up to 230 mg wet weight), and ALA-D activity 
was expressed-as ;imol PBG formed/h/g liver.
2.1.5 Additional methods
a) Determination of hepatic porphyrins
The method of Grandchamp et al. (1980) was followed: 
Porphyrins were extracted from 10% liver homogenates into 
20 vol of 1M perchloric acid/methanol (HClO^MeOH, 1:1, 
v/v), and the mixture was left in the dark for at least 20 
min. After centrifugation at 2,500 rpm for 5 min to 
remove the precipitated protein, the fluorescence of the 
supernatant was measured on a Perkin-Elmer LS-5 
Luminescence spectrometer with both slit widths set at 10 
nm, at the following three excitation/emission wavelength 
pairs: 400 nm/595 nm; 405 nm/595 nm and 410 nm/605 nm.
The fluorescence of a 100 nM coproporphyrin standard was 
also measured. The concentrations of uroporphyrin, 
coproporphyrin and protoporphyrin in the samples were 
calculated using a computer program containing a matrix 
constructed with standard solutions of the three 
porphyrins, and run on an Apple microcomputer,
b) Protein determination
Protein content of liver homogenates, mitochondria and 
mitoplasts were estimated according to the method of Lowry 
et al. (1951). During purification of ALA-S, protein was 
measured essentially by the Bradford method (1976).
Bovine albumin serum was used as the standard, and
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absorption of 'solutions was measured using a Cecil CE 393 
digital spectrophotometer.
c) Purification of ALA-S from liver mitochrondria
The procedure of Borthwick et ad (1983) was followed 
in an attempt to purify liver mitochrondrial ALA-S from 
drug-induced mice. An outline of the steps are given in 
Fig 2.3 and some modifications to the method are discussed 
in Chapter 3. Briefly, liver mitochrondria were converted 
to mitoplasts and a soluble extract from freeze-dried 
mitoplasts chromatographed on Sephacryl S-200 in high salt 
buffer. Enzyme was subjected to chromatofocusing on a 
column of Polybuffer Exchanger 94 and eluted with a 
Polybuffer gradient of pH 8 .6-6 .6 , with ALA-S eluting at a 
pH of about 7.4. Finally the enzyme was subjected to 
affinity chromatography on CoA-agarose in the presence of 
100 mM glycine and eluted with 50 mM 5' AMP.
Aliquots of appropriate fractions were taken and 
stored at -20°C for up to 1 week prior to assay of ALA-S 
activity using a succinyl-CoA generating system (see 
Section 2.1.4).
d) Sodium dodecyl (SDS) polyacrylamide gel
e1ectrophores is ~
Discontinuous SDS gel electrophoresis was performed 
essentially according to the method of Laemmli (1970).
The resolving gel contained 10% (w/v) acrylamide, 0.27% 
(w/v) N,N'-methylene bisacrylamide, 0.1% (w/v) ammonium 
persulphate, 0.1% (w/v) SDS and 0.05% (v/v)
N,N,N',N'-tetramethylene diamine (TEMED) in 0.375 M Tris
Fig 2.3 Outline of the procedure for the purification 
o£ ALA-S from liver mitochrondria of mice
Increase ALA-S levels by treatment 
with DDC and PIAi
Mitochrondriai
Mitoplastsi
Freeze-dried overnighti
Resuspend free-dried mitoplasts 
and centrifugei
Gel filtration on Sephacryl S200t
Ultrafiltrate enzyme-active fractions 
to reduce volumet
Chromatofocusing on Polybuffer 
Exchanger 94
\
Enzyme active fractions eluting at 
around pH 7.4j
Affinity chromatography on Agarose- 
Hexane-Coenzyme A, type V column
\
ALA-S eluted with buffer containing 
5' AMP
Pyridoxal phosphate was present throughout the 
purification, and protease inhibitors were added to either 
buffers or fraction collection tubes, as appropriate, with 
final concentrations in parentheses:
PMSF (1 mM), O-phenanthroline (1 mM), chymostatin (5-10 
jug/ml), leupeptin (5-10 pg/ml). O-phenanthroline was not 
present after mitoplast preparation. All procedures were 
carried out at pH 7.6 except for chromatofocusing (see 
Chapter 6 ), at 4°C and, where possible, in the dark.
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buffer (pH 8 .8 ). The stacking gel contained 3% (w/v) 
acrylamide, 0.05% (w/v) N,N'-methylene bisacrylamide, 0.1% 
(w/v) ammonium persulphate, 0.1% (w/v) SDS and 0.05% (v/v) 
TEMED in 0.125 M Tris buffer (pH 6 .8 ). Gels were 
electrophoresed at a constant current of 40 mA in 
electrode buffer (0.3% (w/v) Tris, 1.5% (w/v) glycine and 
0.1% (w/v) SDS).
Samples were incubated at 100°C for 3-4 min with 4 
volumes of buffer containing the following: 20% (v/v) 
glycerol; 2% (w/v) SDS, 2% (v/v) p-mercaptoethanol,
0.25% (w/v) Bromophenol Blue in 0.125 M Tris buffer, 
pH 6 .8 .
e) Staining of gels
SDS PAGE gels were stained overnight in 0.15% (w/v) 
Coomassie Brilliant Blue R.250 in 50% (v/v) methanol, 10% 
(v/v) acetic acid. They were then destained by successive 
washes in 20% (v/v) methanol, 7% (v/v) acetic acid until 
the stained bands were clearly visible.
2.1.6 Analysis of Data
Results have been expressed as means ± SD. The 
students t-test was used to calculate the probability, P, 
of a difference between 2 sets of results. A degree of 
freedom (N]_ + N 2)”2 has been used throughout. Values of 
p<0.05 were considered to indicate that 2 sets of results 
were significantly different.
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2.2 Materials and Methods for Chapter 5
2.2.1 Materials
The following were obtained from the sources 
indicated:
17-day old chick embryos (Rhode Island Red x White Rock) 
Orchards Farm, Pinner 
Ca2+ and Mg2+-free Hanks Balanced Salt Solution (HBSS, 
lOx), foetal calf serum, gentamycin, Williams E culture 
medium and "Nunclon" culture dishes (10 cm diam.)
GIBCO Ltd., Paisley, Scotland 
Collagenase (Clostridium histolyticum, lypholysed) 
Boehringer, Mannehim, Germany 
"Lux" multiwell plates (2 cm diam. wells)
Flow Laboratories, Rickmansworth, Herts 
Glutamine
Imperial Laboratories 
Hydrocortisone 21-hemisuccinate (Na salt) and insulin 
(Bovine Pancreas)
Sigma Chemical Co. Ltd.
Solutions were prepared in a vertical laminar flow 
bench unit and placed in sterile bottles, as follows (with 
final concentrations in parenthesis);
HBSS was diluted 10-fold with de-ionised water and NaHC03 
added (0.0375%, w/v).
Collagenase dissolved in HBSS/NaHC03 solution (0.05%, w/v) 
was sterilized by millipore filtration.
63
Modified Williams E culture medium was supplemented with 
foetal calf serum (5% v/v), gentamycin (0.005%, w/v), 
glutamine (2 mM), hydrocortisone (1 mM) and insulin (10 
pm). The medium was warmed to 37°C prior to use.
2.2.2 Preparation and culture of chick embryo hepatocytes 
Hepatocyte cultures of 17-day embryonic livers in 
serum—free medium were prepared under sterile conditions 
essentially by the technique described by Fischer et al. 
(1976). 10-15 embryos were sacrificed by decapitation
and the liver perfused in situ through the heart with 
HBSS. After removal of the gall bladder, livers were 
sliced into fragments with a razor blade, placed in a 
conical flask and digested with 75 ml of collagenase in 
HBSS, by incubation for 45 min in a shaking water bath at 
37°C. The cells were then strained through nylon bolting 
cloth (125 p mesh) and to remove contaminating 
erythrocytes the cell suspension was centrifuged for 5 min 
at 300 g. The supernatant was aspirated, the cells were 
resuspended in HBSS and centrifuged again. Cells were 
washed twice more using a solution of 2.5% BSA in HBSS.
The isolated cells were resuspended in about 15 ml of 
Williams E modified medium containing serum. 100 pi was 
taken for estimation of cell number and viability using 
the trypan blue exclusion test (Seglen, 1972). Viability 
was measured as the percentage of cells viewed in a 
haemocytometer which resisted trypan blue uptake and was 
always greater than 96%. The isolated cells were diluted
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to about 0.9 x 106 cells/ml of Williams E modified medium, 
and plated in either 10 cm diameter disposable plastic 
culture dishes, or in multiwell plates, containing 10 ml 
and 2 ml medium per well, respectively.
Dishes were placed in a humidified incubator at 37°C 
in a CC>2/air (1:19) atmosphere. After 24 h incubation, 
the medium was discarded (to remove erythrocytes and dead 
cells which did not attach) and replaced with fresh medium 
without serum. The medium was changed 4 hours later when 
the various drugs were added and incubations continued for 
a further 22-24 h.
2.2.3 Treatment of cells in culture with drugs
DDC, GF, ISOGF and HETGF were added to cell cultures 
by two methods. In initial experiments the drugs were 
added directly, dissolved in DMSO (20 pl/10 ml dish, and 5 
Ul/2 ml well) at concentrations given in the relevant 
tables and figures, and control dishes received the 
solvent only. The second method involved addition of the 
drugs (dissolved in DMSO) to the medium itself, prior to 
addition to the cell cultures. The reasons for the 
development of the alternative method are discussed in 
Chapter 5.
2.2.4 Assays and analytical methods
a ) Estimation of porphyrins
To assay porphyrins and porphyrin profiles, cells were 
grown in multiwell plates. Porphyrins present in both the 
medium and the cells were determined as follows
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i) Porphyrins in the medium
10 vol. of 1 M HClC>4/MeOH (1:1, v/v) were added to an 
aliquot of the medium in soda glass test tubes (50 x 6 
mm) and left in the dark for at least 15 min.
Porphyrin content of the solution was determined as 
described_in Section 2.1.5. 
ii) Porphyrins in cells
The remaining medium was discarded and the cells were 
washed with PBS. Porphyrins were extracted from the 
cells of each well with 1.5 ml HClC^/MeOH for 15 min 
in the dark, and quantitatively estimated from the 
fluorescence of the solution as described in Section 
2.1.5.
The combined porphyrin values (i.e. total porphyrins) 
have been reported and are expressed as pmol 
porphyrins/mg protein. In some experiments the 
porphyrin content of cell homogenates (prepared for 
the assay of Fk activity) was estimated after 
extraction into 20 vol of the HClC>4./MeC)H mixture. In 
these experiments, porphyrins in the medium were also 
measured to obtain total porphyrin values,
b) Measurement of FK activity
Cells were grown in 10 cm plates and Fk activity 
measured in cell homogenates prepared as follows: The
medium was discarded and the cells washed with 5 ml PBS.
2.5 ml of 0.25 M sucrose was added to each dish and the 
cells were removed by scraping with a rubber policeman. 
Cells from 4 identically treated dishes were combined and
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centrifuged (500 g for 5 min). The cell pellet was 
suspended in about 2 ml of ice-cold 0.02 M Tris-HCl, pH 
8.2, and homogenised using a Potter-type homogenizer. Fk 
activity was measured as decribed in Section 2.1.4 with 
duplicate assays for each treatment. The assay was not 
linear with incubation time (see Fig 2.2b), and 30 min 
incubations were chosen to obtain readily measurable 
activity. The assay was linear with amount of protein (up 
to 3 mg/assay) when 30 min incubations were used. Enzyme 
activity was calculated as nmol mesohaem formed/30 min/mg 
protein and results presented as a percent of the control 
enzyme activity,
c) Protein determination
Protein content of cell homogenates and of cells grown 
in multiwell plates was estimated by the method of Lowry 
et al. (1951). In the wells, cellular protein was 
determined after extraction of porphyrins and aspiration 
of the remaining HC104/Me0H solution: 1 ml of 0.5N NaOH 
was added to each well, left for 30 min and the cells 
removed by scraping with a rubber policeman. After 
leaving in the NaOH solution for a further hour, with 
occasional mixing, an aliquot was taken for protein 
estimation.
2.3 Materials and Methods for Chapter 6
2.3.1 Materials
Sephadex LH-20 (Pharmacia Fine Chemicals) was swollen 
in acetone and packed into a 30 cm x 1 cm column.
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Silica-gel 60 TLC plates (20 cm x 20 cm, 0.25 mm thick) 
were purchased from E. Merck, Darmstadt, Germany.
Nucleosil 5 analytical HPLC column (4.6 x 250 mm) and 
Partisil 10-PAC semipreparative HPLC column (4.6 x 250 mm) 
were obtained from Macherey-Nagel, Duren, Germany and 
Whatman respectively.
Methanol and dichloromethane (Rathburn Chemicals), 
hexane (Finsons-Scientific Apparatus) and tetrahydrofuran 
(Chromatographic Services) were all HPLC grade. 
Tetrahydrofuran was made peroxide-free and dry, 
immediately before use, by filtration through aluminium 
oxide (type UG, Koch-Light Laboratories), previously 
activiated by heating at 100°C overnight.
N-methylprotoporphyrin IX dimethyl ester was prepared 
from protoporphyrin IX dimethylester (Sigma) by A.H.
Gibbs, using the method described by De Matteis et al. 
(1980a).
2.3.2 Production of green pigments in vivo
Green pigments were produced in the livers of male and 
female mice by treatment with drugs as follows:
a) DDC was given intraperitoneally (100 mg/kg body wt) 
dissolved in arachis oil, after a 16 h fast and mice 
were killed 1.5 h later.
b) GF, ISOGF and DDC were fed in the diet for 3 or 7 days 
at a concentration of 1%, 1% and 0 .1% (w/w), 
respectively.
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2.3.3 Extraction and isolation of green pigments:
Method~Tl
Green pigments were extracted twice from liver 
homogenates with an equal volume of acetone containing 
1.7% (v/v) conc. HC1 and chromatographed on freshly 
prepared Sephadex LH-20 using acetone to elute fractions, 
as described by De Matteis et aJL. (1980c). By this 
technique the green pigments could be separated from haem 
(see Chapter 6 ) and were obtained as the free carboxylic 
acids. Fractions containing green pigments were combined 
and defatted by cooling at -70°C overnight. The whitish 
precipitate was separated from the green-coloured 
supernatant by centrifugation (2000 g for 5 min) at 
-20°C. The supernatant was evaporated to dryness under N2 
and dissolved in chloroform for TLC.
The chloroform used in the following procedures was 
first washed with water, to remove ethanol present as a 
preservative, and then dried over anhydrous Na2SC>4, which 
was removed by filtration through a triple layer of 
chloroform-wetted papers. The washed, dried chloroform 
was used within 24 h of preparation.
2.3.4 Separation of green pigment from haem by TLC
TLC of the green pigments (as the free carboxylic 
acids) was performed using silica-gel 60 plates, and 
developed with chloroform/methanol/acetic acid (40:10:3, 
v/v) for 45 min (De Matteis et ad.., 1980b). The plates 
were allowed to dry at room temperature, and after
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examination under UV light and by the naked eye, the 
positions of the bands were marked.
With one batch of TLC plates, complete resolution of 
green pigment from protoporphyrin was not always 
achieved. It was also noted that the system took twice as 
long as normal to run. Since this could have been due to 
the presence of water in the silica gel, some plates were 
dried overnight in an oven. However, as this did not 
decrease.^ the time taken to develop the plates, partially 
purified green pigments were routinely treated as follows: 
After elution from silica with methanol/conc HC1 (10:0.25, 
v/v), pigments were methylated by reaction with BF3 (14%, 
w/v) in methanol at 70°C for 30 min (Smith and Francis, 
1979). The dimethyl esters were transferred to 
chloroform,washed, dried and further purified by TLC with 
the developing system chloroform/methanol (20:3, v/v) (De 
Matteis et al., 1985). The major band was eluted from the 
silica with acidified methanol, extracted into chloroform, 
evaporated to dryness and either a) subjected to HPLC, or
b) dissolved in chloroform for spectral studies. An 
outline of the whole procedure and a second method, to be 
described below under 2.3.5., are given in Fig 2.4.
2.3.5 Extraction and isolation of green pigments:
Method 2.
In one experiment, green pigments were isolated from 
the liver by an alternative procedure (Unseld and De 
Matteis, 1976) in which the porphyrin carboxyl groups are
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Fig 2.4 Outline of experimental procedures for 
isolation, purification and characterization of 
green pigments in the liver
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esterified prior to isolation and purification. 50% (w/v) 
liver homogenates (equivalent to 6 g of liver) were 
extracted twice with acetone, to remove lipid. The pellet 
was resuspended in a small volume of sucrose and slowly 
added, with mixing, to 20 vol of methanol/5% (v/v) conc. 
H2SO4 . After 22 h at 4°C in the dark the mixture was 
filtered. To the filtrate in a separating funnel was 
added 0.2 vol of chloroform, and 2 vol. of IN NaCl. The 
combined dark brown chloroform phases from 3 extractions 
were filtered through a triple layer of chloroform-wetted 
paper, dried on a rotary evaporator and purified by TLC on 
silica gel plates using the developing system chloroform/ 
methanol (20:3, v/v). The procedures outlined in Fig 2.4 
were then followed.
The method described above was not generally used 
because of two major disadvantages:
1) A large volume of methylating reagent is required, 
which in turn makes extraction rather cumbersome;
2) The extraction procedure is complicated by the 
formation of emulsion and the time taken for 
separation of the phases is both time consuming and 
detrimental to the green pigment(s ).
2.3.6 Analysis of green pigments by HPLC
The porphyrin methyl esters obtained from TLC were 
purified further by HPLC on a Nucleosil 5 column developed 
isocratically with dichloromethane/methanol/conc NH3 
(sp.gr. 0.88) (50:50:0.1, v/v) and a flow rate of 2
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ml/min (Gibbs and De Matteis, 1986). The eluate was 
monitored at 417 nm. The individual porphyrins were 
collected separately and taken for either
a) characterization by absorption studies and comparison 
with authentic samples, or
b) further analysis on a second HPLC column of Partisil 
10-PAC, as described by Ortiz de Montellano et a l . 
(1981a), using isocratic elution with tetrahydro- 
furan/hexane/methanol (97:97:6, v/v), a flow rate of 1 
ml/min and again monitoring the eluate at 417 nm.
2.3.7 Spectral studies
Fractions from Sephadex LH-20 gel filtration were 
scanned between 360-460 nm and the Soret absorbance peak 
noted. Absorption spectra of porphyrin dimethyl esters 
and synthetic porphyrins were obtained by using a Varian 
Cary 2200 recording spectrophotometer calibrated with a 
holmium filter, and the spectra recorded between 360 and 
700 nm.
a) Neutral spectra
The dried porphyrin methyl ester, in a glass vial, was 
exposed to NH3 fumes for 30 min to neutralize any acid 
present, and then dissolved in chloroform.
b) Dication spectra
The dication derivative was obtained by the addition 
of trifluoracetic acid (final concentration 21 mM) to a 
solution of the porphyrin methyl ester in chloroform and 
the spectrum determined immediately.
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c ) Zinc-complex spectra
The Zn^+ complexes of green pigments were prepared by 
adding to 3 ml of a solution of the porphyrin methyl ester 
in chloroform, 0.2 ml of a 5% (w/v) methanolic solution of 
zinc acetate; when the reaction was complete the 
chloroform phase was washed with water and dried (De 
Matteis and Gibbs, 1980).
2.3.8 Inhibition of FK activity by green pigments
In one experiment the in vitro inhibitory activity of 
the GF green pigments on mouse hepatic FK was studied, 
after hydrolysis of the methyl esters (obtained from HPLC) 
by aqueous 6 M HC1 for 16 h. Varying dilutions of the 
green pigments were added to the incubation mixtures 
dissolved in ethanol and FK activity was measured as
described in Section 2.1.4. The enzyme activity in nmol
mesohaem formed/10 min/mg protein was expressed as a 
percent of the activity in control incubations.
2.3.9 Calculation of amount of purified green pigment 
extracted from the liver
The amount of each green pigment was estimated from 
the Soret absorbance of the dimethyl esters in chloroform,
using EmM^ “ 128 (De Matteis et al., 1982b) for the
Soret absorption of N-MePP IX dimethyl ester and was 
expressed as nmol N-MePP equivalents per liver. 
Alternatively, the amount of green pigment was calculated 
from the area under the HPLC elution profile (integrated
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by a Shimadzu C-RIA Chromatopac instrument) by comparison 
with the area obtained for a known amount of N-MePP 
standard.
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CHAPTER 3
Differences between inbred strains of mice 
in their sensitivity to porphyrogenic drugs
76
3.1 Introduction
Strains of female inbred mice have been shown to 
differ in their response to the porphyria-inducing 
chemicals DDC and AIA, with respect to induction of 
hepatic ALA-S (Gross and Hutton, 1971); a marked 
difference in the induced activity levels of ALA-S among 
the strains was demonstrated following DDC treatment, with 
some strains manifesting levels three times higher than 
others. Among different strains of rats there is also a 
variable sensitivity of induction of hepatic ALA-S to AIA, 
with Buffalo rats significantly less sensitive than 
Sprague-Dawley rats (Tschudy and Bonkowsky, 1972).
Hutton and Gross (1970) systematically examined the 
haem biosynthetic pathway of inbred mice for additional 
differences in response to DDC. The activities of the 
enzymes ALA-D and PBG deaminase, and the accumulation of 
intermediates of the pathway were studied, but the 
activity of the Fk enzyme, known to be inhibited following 
DDC treatment (Onisawa and Labbe, 1963), was not 
determined. Only strain differences in protoporphyrin 
accumulation were noted and this was directly correlated 
with the inducibility of ALA-S activity. It was concluded 
that the interstrain variation in ALA-S activity and 
porhyrin levels after DDC treatment was attributable to 
genetic differences among the inbred strains of mice.
As strains which were more sensitive to DDC were also 
more sensitive to AIA (Gross and Hutton, 1971), it was 
suggested that the genetic variation applied to some step
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involved in the induction of ALA-S by both drugs (De 
Matteis et cil. , 1973). Considering the 2 stage model for 
induction of ALA-S by drugs, put forward by De Matteis and 
Gibbs (1972) (and see Chapter 1), the genetic difference 
could be either at the first stage, where "regulatory" 
haem is depleted due to a specific effect of a drug, or at 
the second, "non-specific" stage, which is related to the 
lipid soluble properties of drugs.
The strain-specific variation in the induction of 
hepatic ALA-S by DDC has now been confirmed, and use has 
been made of the genetic difference between 2 strains of 
mice to examine at which stage - "specific" or 
"non-specific" - the difference in response exists. The 
experiments described in this chapter demonstrate that the 
"specific" inhibitory effect of DDC on FK activity is the 
same in the two strains, and suggests that a stage further 
on in the induction of ALA-S, related to the lipid soluble 
effects of the drug, is genetically controlled. In order 
to obtain some information on genetic factors controlling 
the level and catalytic activity of ALA-S, attempts were 
made to purify the hepatic enzyme; it was intended to 
utilize the purified enzyme in in vitro studies aimed at 
determining whether there are differences between the 
strains in the amount of enzyme protein synthesised, or in 
enzyme activity, in response to porphyrogenic drugs. 
Unfortunately attempts to raise a homogenous preparation 
of enzyme failed and in view of limited time available, 
efforts in this direction were discontinued.
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Results are also presented on strain-specific 
variations in the response of ALA-S activity to another 
porphyrogenic drug, GF. This drug was chosen because it 
also causes porphyria in mice by inhibiting the 
ferrochelatase activity (Lockhead et aJL. , 1967), and the 
studies provide further information on the "specific" 
inhibition of the chelatase in relation to the induction 
of ALA-S activity.
3.2 Strain differences in the response of inbred mice to
DDC.
Female mice were used in the studies so that results 
could be compared to those of Gross and Hutton (1971). 
Choice of the 2 inbred strains was based on the induced 
hepatic ALA-S activities observed by these workers 
following DDC treatment: C3H/He/01a had high enzyme 
activity in response to the drug; SWR/J and SJL/J strains 
(both low ALA-S activity) could not be obtained, therefore 
the NIH/Ola strain was used. This strain, like the SWR/J 
and SJL/J strains, is derived from Swiss Webster mice 
(Rice and O'Brien, 1980), and was also found to have a low 
level of induced ALA-S activity in response to DDC.
Preliminary experiments demonstrated that female 
C3H/He/01a and NIH/Ola mice have measurable hepatic ALA-S 
activity of 24-48 nmol ALA per h per g of liver. Enzyme 
activity could be increiased approximately 3-4 fold by 
withholding food for 16 h (Table 3.1), confirming the 
observations of Gross and Hutton (1971). Injection with
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Table 3.1 Hepatic ALA-S activity in inbred strains of 
female mice
ALA-S Activity 
(nmol ALA/h/g liver)
Treatment ---- -----------------------------------
C3H/He/01a NIH/Ola
None 29.12 ± 1.13 43.32 ± 6.62*
Fasted 134.17 ± 17.52 127.88 ± 21.00
Arachis Oil 95.97 ± 6.61 90.11 db 23.62
DDC 25 mg/kg 521.05 ± 89.69 246.33 db 28.85**
DDC 50 mg/kg 550.93 ± 28.65 418.36 ± 28.98**
DDC 100 mg/kg 509.25 db 167.62 359.63 ± 137.33
DDC 200 mg/kg 626.50 db 290.36 368.13 db 122.77
Mice (3 in each group) were injected intraperitoneally 
with arachis oil (5 ml/kg) or 25-200 mg per kg of DDC (in 
arachis oil), transferred to clean cages and killed after 
a 16 h fast. ALA-S activity was assayed, in duplicate, on 
individual liver homogenates and results are presented as 
mean ± SD of 6 determinations.
* p<0.05 and ** p<0.01, when compared with the value for
C3H/He/01a mice.
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arachis oil, the drug vehicle, followed by starvation, 
resulted in levels of hepatic ALA-S activity intermediary 
to those of control and starved mice (Table 3.1). There 
was no significant difference between the strains in the 
levels of ALA-S activity present in the liver following 
starvation, or dosing with arachis oil followed by 
starvation.
Treatment of mice with a single intraperitoneal dose 
of DDC under standard conditions resulted in a condition 
of hepatic protoporphyria (increased ALA-S activity, 
inhibition of Fk activity and accumulation of 
protoporphyrin). Hepatic ALA-S activity was compared in 
the 2 mice strains at several different doses of DDC 
(Table 3.1). A significant induction of enzyme activity 
was observed at the lowest dose level of 25 mg DDC/kg in 
both strains. On a per g liver basis, ALA-S activity of 
the C3H/He/01a strain was twice that found in the NIH/Ola 
strain, and represented an 18-fold increase over the basal 
activity of the corresponding fed mice controls. Higher 
doses of DDC, up to a maximum of 200 mg/kg, lead to 
further small increases in enzyme levels in both strains, 
with the average activity of C3H/He/01a higher than that 
of NIH/Ola at all doses. In the former strain, maximal 
activity was 22 times as great as basal activity, compared 
to the 8-fold increase in the NIH/Ola strain. The 
difference in induced ALA-S activity between the strains 
was still of a similar degree when expressed per total 
liver of 100 g body weight.
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These studies confirmed the strain-dependent variation 
in the inducibility of ALA-S with DDC reported by Gross 
and Hutton (1971). Hepatic ALA-S levels after a dose of 
50 mg/kg were routinely used by these workers to designate 
strains into high and low activity strains. Using this 
criterion, the C3H/He/01a strain which had an average 
ALA-S activity of 551 nmol ALA/h/g liver (in agreement 
with their value of 276 ± 11 nmol ALA/30 min/g liver) 
represents a "high activity" strain. The ALA-S activity 
of the NIH/Ola strain (418 nmol/h/g liver) is comparable 
to levels in the "low activity" strains of these workers.
As discussed in Chapter 1, inhibition of Fk activity 
by DDC, as initially reported by Onisawa and Labbe (1963) 
will tend to reduce the concentration of liver 
'regulatory' haem available for negative feed-back control 
of ALA-S and consequently result in a stimulation of this 
latter enzyme. It was therefore plausible that the strain 
difference in ALA-S induction in response to DDC could 
result from a difference in the extent of Fk inhibition. 
The same dose range of DDC (25-200 mg/kg) was used in 
studies of Fk inhibition in the 2 inbred mice strains.
Mice injected with arachis oil and fasted were used as 
controls, as this treatment did not appreciably alter the 
Fk activity, compared to non-treated controls (results not 
shown).
In both strains, Fk activity, as measured in vitro, 
was found to be inhibited by approximately 80%, 16 h after 
administration of 25 mg DDC/kg, with further loss of
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activity, up to 90%, with higher doses (Fig 3.1).
Porphyrin levels in control livers were low (less than 1 
nmol/g liver) and treatment with DDC caused a dose-related 
accumulation of hepatic porphyrins, with protoporphyrin 
predominating (Fig 3.2). A correlation between the 
activity of ALA-S and the concentration of porphyrins, up 
to 275 nmol/g liver was noted (Fig 3.3). The coefficient 
of linear correlation was 0.70 with 15 degrees of 
freedom. A correlation has been reported by Hutton and 
Gross (1970) and De Matteis et al (1973), although these 
workers found that the linearity only extended to 
protoporhyrin levels up to 20 nmol/g liver and that above 
100 nmol/g liver, the correlation became inverse. This 
aspect has been studied in more detail in Chapter 4, using 
GF to induce higher porphyrin levels.
3.3 Early changes in hepatic enzyme activities in 
response to DDC
In the previous section, near maximal inhibition of 
hepatic Fk activity occurred at a dose of 25 mg DDC/kg in 
both of the inbred mice strains, yet ALA-S induction was 
to differing extents and levels.
De Matteis et al*. (1973) demonstrated that a rapid 
decrease in Fk activity occurs before an increase in the 
activity of ALA-S, and also showed that stimulation of the 
latter enzyme is first seen when the activity of the 
chelatase is decreased by about 70%. It was therefore 
possible that a difference in Fk response between the 2
Fig 3.1 Inhibition of hepatic FK activity in inbred
strains of mice after administration of DDC
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Female mice were treated with DDC as described in the 
legend to Table 3.1, and controls received arachis oil.
FK was assayed as described in the "Methods" section, and 
enzyme activity expressed as a percent of control levels. 
Each point represents the mean of duplicate determinations 
on 2 liver homogenates. Control values for the C3H/He/oia 
( a )  and NIH/Ola (±) strains were 13.40, 13.96 and 13.85, 
15.15 nmol mesohaem/30 min/mg protein, respectively.
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Fig 3.2 Hepatic porphyrin accumulation in inbred strains
of mice after treatment with DDC
300-1
200“
•H
•H
►» 100-
0 50 100 150 200
DDC (mg/kg body wt)
Female C3H/He/0la (a ) and NIH/Ola (a ) mice were treated 
with DDC as described in the legend to Table 3.1, and 
controls received arachis oil. Hepatic porphyrins were 
determined as described in the "Methods" section. Each 
point represents the mean of duplicate determination on 
individual liver homogenates.
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Fig 3.3 Relationship between hepatic ALA-S activity and
porphyrin concentration in inbred strains of 
mice treated with DDC.
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Female C3H/He/ola (A) and NIH/Ola (A) mice were treated 
with DDC (25-200 mg/kg body wt). Hepatic ALA-S activity 
and porphyrin levels were determined as described in the 
"Methods" section. Symbols represent the enzyme activity 
and porphyrin levels in individual livers.
strains might have been missed at 16 h, the only time 
point investigated in the experiments of Fig 3.1. It was 
therefore of interest to examine early changes in the 
activities of both enzymes in the 2 strains of mice to 
ascertain the importance of inhibition of the chelatase in 
relation to the induction of ALA-S, and to determine 
whether or not a strain difference is present in the FK 
inhibition caused by DDC.
In the studies to be described, the experimental 
protocol was altered in 2 ways:
1) Lower doses of DDC (2.5-10 mg/kg) were administered so 
that FK would not be maximally inhibited
2) Mice were fasted for 16 h (to increase assayable ALA-S 
activity), dosed by intraperitoneal injection with DDC 
and starved a further 5 h prior to determination of 
enzyme levels. (De Matteis et al. (1973) 
demonstrated maximal ALA-S induction at this time 
point).
3.3.1 Effect of altered protocol on control liver ALA-S 
activity
Control mice were treated as above with the exception 
that they received the drug vehicle (arachis oil) alone.
A difference was found between the 2 strains in the 
'control* level of ALA-S activity when the altered 
experimental protocol was used, with enzyme activity of 
the NIH/Ola strain 2.5 times greater than the C3H/He/0la 
strain (Table 3.2b). No strain difference had been found
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Table 3.2 Effect of starvation time and arachis oil on
the hepatic ALA-S activity of inbred female
mice
Treatment
ALA-S Activity 
(nmol ALA/h/g liver)
C3H/He/01a NIH/Ola
a) Oil i.p., starved 
16 h.
111.56*21.67 (7) 79.92*31.27 (7)
b) Starved 16 h, 
oil i.p., starved 
5 h.
90.67*28.41 (6) 228.82*46.37 *(4)
c) Starved 16 h 134.10*39.33 (7) 168.31*43.45 (7)
d) Starved 21 h ** 348.16 
(345.68; 350.'64)
Mice were treated as indicated in the table, with the 
number of animals per treatment group given in 
parentheses. ALA-S activity of individual liver 
homogenates was assayed in duplicate. Results are 
presented as the mean * SD of values obtained from up to 3 
individual experiments.
* p<0.01, when compared with value for C3H/He/01a mice 
receiving the same treatment.
in enzyme activity in earlier experiments where mice had 
been injected with arachis oil and fasted for 16 h, or 
following 16 h starvation alone (Table 3.2, a and c 
respectively).
This suggested that the extra period of starvation 
included in the new protocol may partially explain the 
higher ALA-S activity in the NIH/Ola strain, compared to 
the C3H/He/01a strain. To examine this possibility 2 
NIH/Ola mice were starved for a total of 21 h: ALA-S 
activity was found to be 2-fold greater than that present 
after 16 h starvation (Table 3.2; compare values for c and 
d). However it was found that increased starvation time 
could also lead to higher ALA-S levels in the C3H/He/01a 
strain: in an experiment in which mice of this strain were 
fasted overnight, injected intraperioneally with saline 
and then starved for up to 4 hours, ALA-S activity at 0,
1, 2 and 4 h following saline injection was 110.89,
197.44, 210.40 and 377.52 nmol ALA/h/g liver, 
respectively. This suggested that the strain difference 
observed with the new protocol (fast 16 h, oil i.p., fast 
5 h) was due to a combined effect of oil and further 
starvation, but more work is required on this aspect.
An alternative explanation could be related to 
circadian rhythms and the influence of oestrogens on ALA-S 
activity; hormone levels vary with the time of day, and 
Held and Przerwa (1976) have shown that hepatic ALA-S 
activity of female rats varies during the phases of the 
sexual cycle, with the level measured during preoestrus
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twice the level found at dioestrus. Assuming a similar 
phenomenon in female mice, enzyme activity measured may be 
dependent upon the time at which the animal is killed, and 
also upon the stage of the sexual cycle. It is likely 
that the mice 'used in separate experiments were not at the 
same phase of the sexual cycle, and a hormonal effect on 
ALA-S activity would partially explain the variability in 
enzyme levels which were found within each strain and 
between strains.
3.3.2 ALA-S activity 5 h after DDC treatment
The effect of low doses of DDC on ALA-S induction in 
the 2 strains of mice is shown in Fig 3.4. Results have 
been expressed as a percent of control activity, rather 
than on absolute values, due to the different control 
levels in the 2 strains. Results showed that 5 h after a 
dose of DDC as low as 2.5 mg/kg, there was a small 
induction of ALA-S activity. Enzyme activities found 
after higher doses of the drug confirmed the observations 
reported in Section 3.2, that is, the extent of induction 
of ALA-S activity over control levels was greater in the 
"high activity" strain. Judging from the percentage 
increase over control values, this difference increased 
with dose and became appreciable only with 10 mg DDC/kg, 
when the "high activity" strain showed a 4.4-fold 
increase, compared to a 2.7-fold increase in the "low 
activity" strain.
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Fig 3.4 Hepatic ALA-S activity in inbred female mice 
after treatment with low doses of DDC
5001
£ 300“
>
•H
CO
100
7.5
DDC (mg/kg body wt)
C3H/He/01a (A) and NIH/Ola (A) mice were fasted for 16 h 
and then received arachis oil (5 ml/kg) or DDC (2.5-10 
mg/kg) intraperitoneally. The mice were transferred to 
clean cages, and killed after a further 5 h fast. Hepatic 
ALA-S was determined as described in the "Methods" section 
and expressed as a percent of the control values given in 
Table 3.2 (b). Each point represents the average of 
duplicate determinations on 2 liver homogenates, and 
results were confirmed at least once.
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3.3.3 Reversal of FK inhibition by in vitro incubation
Initial experiments to study the decrease in chelatase 
activity caused by low doses of DDC produced variable 
results when 30 min incubations were employed for the in 
vitro assay.
It was therefore decided to study in more detail the 
relationship between incubation time and the activity of 
FK! in both porphyric and control liver homogenates. 
C3H/He/01a mice were treated with either oil, or DDC (2.5 
mg/kg, or 20 mg/kg) as outlined in the beginning of this 
section and Fk activity measured in vitro as in "Materials 
and Methods", with varying incubation periods.
The amount of endogenous haem present in zero time, 10 
and 30 min incubations was shown to be the same in both 
control and porphyric homogenates, indicating that it was 
not formed during the incubation.
An initial lag period of approximately 6 min was 
observed in the time course of mesohaem synthesis by the 
control liver homogenate, followed by a linear rate of 
activity which started to tail off after 20 min (Fig 
3.5). The latter decrease in reaction rate could be due 
to product inhibition (Jones and Jones, 1970). The lag 
phase was not initially detected when setting up the 
assay, due to time points used (See Fig 2.2). Lag phases 
in iLn vitro Fk activity have been reported (Nishida and 
Labbe, 1959; Porra and Jones, 1963a) and has been 
attributed by the latter workers to incomplete anaerobis.
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Fig 3.5 Time course of in vitro FK activity in liver 
Homogenates of C3H/He/01a mice 5 h after the 
administration of DDC.
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Female mice were treated with arachis oil (*), DDC 2.5 
mg/kg (o) or DDC 20 mg/kg (•) as described in Section 
3.3. Fk activity was measured as described in the 
"Methods" section except that incubation time was varied 
Each point represents a single determination and results 
were confirmed twice.
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Two lines of evidence suggest that this is not the 
case in the present experiments. Firstly, incubation 
mixtures were repeatedly evacuated and flushed with 
02“ftee nitrogen (bubbled through a pyrogallol solution) 
at least 10 times; when this process was carried out for 
up to 10 min, the lag phase was still present. Secondly, 
when FK activity of cultured chick embryo hepatocytes was 
measured (Chapter 5), the inclusion of a glucose oxidase 
system to the incubation mixtures (in addition to the 
flushing with N2 ) did not increase the rate of reaction, 
as would have been expected if the system was not 
completely anaerobic.
It was noted that most workers measured Fk activity of 
solubilised mitochrondrial preparations. As the active 
site of Fk is situated in the inner surface of the inner 
mitochondrial membrane (Jones and Jones, 1969), the 
possibility existed that the lag phase of homogenate FK 
activity could be a reflection of the time required for 
the substrate to gain access to the enzyme. An 
experiment was conducted in which the homogenate was 
incubated with Tween 80 for 30 min on ice, before starting 
the reaction, as Mazanowska et al. (1969) demonstrated 
that detergent can release the enzyme from the 
mitochrondrial membrane. However, this procedure did not 
abolish the lag phase, and as the primary interest of the 
experiment was not in this direction, no further studies 
were conducted.
Fk activity of the liver homogenate from mice treated 
with 2.5 mg DDC/kg showed very similar kinetics to that
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of control homogenate (Fig 3.5). In contrast, when enzyme 
activity was measured in liver homogenates from mice 
treated with DDC 20 mg/kg, the S-shaped curve was not 
seen. Instead the measured chelatase activity was found 
to deviate from linearity between 10 and 30 min, but in 
the opposite direction, that is, increasing with time. 
These experiments show that the degree of inhibition of Fk 
produced by in vivo DDC treatment, when measured in vitro, 
is dependent upon the time at which measurements are 
taken. Thus, the inhibition caused by 2.5 mg DDC/kg was 
29% at 10 min, 17% at 20 min and 15% at 30 min, with 
values of 81%, 80% and 70% for these time points 
respectively, with 20 mg DDC/kg. Selection of time period 
for determination of chelatase activity in porphyric liver 
homogenates is therefore important, especially if a 
dose-response is to be studied and it was decided to use 
10 min incubations, when the greatest inhibition of Fk 
activity was found.
An increase with incubation time in the measurable Fk 
activity of porphyric rat and chick embryo liver 
homogenates was noted by Tephly et al^ . (1971) and Cole et 
al. (1979) although no interpretation was given. It is 
now established (see Chapter 1) that chelatase inhibition 
is caused by N-MePP, produced during the metabolism of . 
DDC. It has recently been reported (De Matteis et a l ., 
1985) that the inhibition of Fk, caused by the addition to 
rat liver mitochondria of synthetic N-alkylated por­
phyrins, including N-ethyl PP, could be reversed by 
prolonged incubation with excess mesoporphyrin substrate.
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The results obtained in the present study extend this 
finding by demonstrating that a partial reversal of Fk 
inhibition can occur with incubation time in a preparation 
where the enzyme is already inhibited due to the in vivo 
production of N-MePP.
3.3.4 FK activity 5 h after DDC treatment
When hepatic Fk activity was studied in the 2 mice 
strains after treatment with DDC (2.5-10 mg/kg), a gradual 
dose-related loss of enzyme activity was found, with about 
84% inhibition after 10 mg DDC/kg (Table 3.3). It can be 
seen that in both strains the degree of decrease in 
chelatase activity was essentially the same at each dose 
level (Fig 3.6).
When these observations are considered with those 
obtained for mice treated with higher doses of DDC, it is 
clear that the 2 strains do not differ in the extent of Fk 
inhibition following DDC treatment, but they do appear to 
differ in their response to the drug with respect to the 
activity of ALA-S, which is induced to a greater extent in 
the C3H/He/01a strain. This difference is most marked 
when the chelatase activity is maximally inhibited and 
suggests that the genetic variation in response of ALA-S 
between the 2 strains of mice depends on a factor other 
than inhibition of Fk activity.
3.4 Inhibition of haem biosynthesis by succinyl acetone
In an experiment which aimed to determine whether 
inhibition of haem biosynthesis per se was sufficient to
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Table 3.3 Effect, of low doses of DDC on hepatic
FK activity of female inbred mice
DDC (mg/kg)
FK Activity 
(nmol mesohaem/10 min/mg protein)
C3H/He/Ola NIH/Ola
0 5.72 ± 0.67 5.60 ± 1.10
2.5 3.16 ± 0.50 3.40 ± 0.60
5.0 1.84 ± 0.21 1.90 ± 0.88
10.0 0.93 ± 0.23 0.95 ± 0.24
Mice were treated with different doses of DDC as indicated 
in the legend to Fig 3.4, with 4 animals per treatment 
group. FK activity of individual liver homogenates was 
determined as described in the "Methods" section except 
the incubations were for 10 min. Results are presented as 
the mean ± SD.
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Fig 3.6 Effect, of low doses of DDC on the loss of
hepatic FK activity in inbred mice strains
100 n
✓— \ 
rHOU
4->
PiOO
o
0 - i
DDC (mg/kg body wt)
Female C3H/He/01a (A) and NIH/Ola (A) mice were treated 
with DDC as described in the legend to Fig 3.4. The 
values for FK activity reported in Table 3.3 are presented 
graphically as a percent of control enzyme activity; each 
data point represents the average of 4 observations.
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produce a genetic difference in the response of the ALA-S 
enzyme, mice were treated with succinyl acetone (SA) as 
indicated in the legend to Table 3.4. SA is an analogue 
of ALA in which the amino group of the latter is replaced 
by an acetyl group, and it is a specific,irreversible 
inhibitor of ALA-D (Tschudy et al, 1981).
SA treatment caused an extensive (95%) inhibition of 
ALA-D activity in both strains of mice (Table 3.4).
Despite this, the increase in ALA-S activity was only 
marginal and no real difference was found between the 
strains (Table 3.4). This suggests again that some factor 
additional to inhibition of haem biosynthesis is required 
for ALA-S induction, and that as discussed before, the 
genetic difference may apply to this later stage involving 
the lipid soluble effects of drugs.
Further evidence that both "specific" and 
"non-specific" effects of a drug are necessary to produce 
a genetic difference in the level of the ALA-S enzyme was 
provided by experiments with another porphyrogenic drug, 
GF, as will now be discussed.
3.5 Strain differences in the response of inbred mice 
to GF
3.5.1 The response of female mice
Female mice of the C3H/He/01a and NIH/Ola strains were 
treated with GF for 3 days (see the Methods section) as 
porphyria is established by this time (De Matteis and 
Gibbs, 1975). Treated groups had almost the same body
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Table 3.4 Effect of succinyl acetone on hepatic ALA-D and 
ALA-S activities of female inbred mice strains
Strain Treatment
ALA-D Activity 
(pmol PBG/h/g 
liver)
ALA-S Activity 
(nmol ALA/h/g 
liver)
C3H/He/0la Control
SA
3.51
0.20
± 0.15 
± 0.01
155.14 ± 32.31 
207.53 ± 43.51
NIH/Ola Control
SA
2.58
0.14
± 0.10 
± 0 . 0 2
248.87 ± 98.52 
285.53 ± 62.64
Mice (6 in each group) were fasted for 17 h and then 
received succinyl acetone (SA, 100 mg/kg, i.p.) and were 
starved a further 4 hours. Controls received saline. 
Enzyme activities were assayed in duplicate on individual 
liver homogenates as described under "Materials and 
Methods", and results expressed as mean ± SD of the values 
obtained for the individual animals.
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weight as the control groups. However their livers were 
dark red-brown in colour, without marked change in 
consistency and were significantly enlarged compared to 
those of the respective control groups (Table 3.5). There 
was no significant difference between the 2 treated groups 
in relative liver weight (i.e. when expressed as a percent 
of body weight). However, as relative liver weight of 
controls differed in the 2 strains, the extent of increase 
in liver weight was greater in the NIH/Ola strain than in 
the C3H/He/01a strain (44% and 30% increase, respectively, 
over control values).
Content of protein per g of liver of treated groups 
was not significantly different from controls, but 
expressed as absolute values (i.e. g per 100 g body 
weight) it was significantly higher (Table 3.5). The 
increased liver weight would therefore appear to be due to 
an increased protein content in this organ. As many lipid 
soluble (non-porphyrogenic) drugs possess the property of 
stimulating the synthesis of several liver proteins and of 
increasing the size of the liver, the changes observed 
with GF are most probably attributable to its lipid 
solubility.
There was no significant difference between controls 
of the 2 strains in the activities of hepatic Fk, and
ALA-S, or porphyrin levels (Table 3.6).
In both strains the Fk activity decreased to 12-14% of
that observed in control mice after 3 days of GF treatment
(Table 3.6). A similar degree of inhibition was reported 
by Tangeras (1986).
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ALA-S activity was increased, but to a greater extent 
in the C3H/He/0la strain, where the level of activity was 
about 19-fold higher than in controls. This difference in 
the response of ALA-S to GF-feeding is similar to that 
shown following i.p. injection of DDC (i.e. C3H/He/01a are 
more sensitive), as is the lack of difference between the 
two strains in the degree of inhibition of the chelatase 
activity.
When hepatic porphyrins were measured in the treated 
groups, a very marked accumulation was found with 
protoporphyrin predominating. A relatively large 
variation was noted for individual animals of each strain, 
which may be related to the food intake per animal, which 
cannot be controlled, or may be a reflection of individual 
variation in response to the drug. Interestingly, the 
C3H/He/01a strain had an average hepatic porphyrin level 
lower than the NIH/Ola strain (Table 3.6). As Fk was 
inhibited to the same extent in the 2 strains, but ALA-S 
activity was higher in the C3H/He/01a strain, these mice 
would be expected to have a higher liver porphyrin 
accumulation than the NIH/Ola strain, and this was not 
found.
3.5.2 The response of male mice
Male mice of the 2 inbred strains were treated for 3 
days with GF. Relative liver weight and total liver 
protein content was found to be elevated by a similar 
magnitude as in their female counterparts, with a greater
104
increase (over control values) in the NIH/Ola strain 
(Table 3.7).
There was no significant difference between strains in 
the control levels of ALA-S and porphyrins. FK activity 
was slightly higher in the NIH/Ola mice, but treatment 
with GF for 3 days was found to decrease enzyme activity 
to similar levels in both strains (Table 3.8). ALA-S 
activity was increased by drug treatment, with average 
levels in the C3H/He/01a livers twice those found in 
NIH/Ola. This is similar to the strain difference 
observed in female mice, although in males the difference 
was not significant because of the wide variation in 
individual response of the mice to the drug. A massive 
accumulation of porphyrins were found. Levels were 
generally higher in the NIH/Ola strain where a 1900-fold 
increase over control porphyrins occurred (Table 3.8).
Comparison of the data on both sexes of the 2 strains 
treated with GF (Tables 3.6 and 3.8) shows that FK 
activity is decreased to a similar extent in all cases, 
but the C3H/He/0la strain has a higher ALA-S activity than 
the NIH/Ola strain. Thus, in both males and females, the 
strain difference in the response of ALA-S to GF would 
appear to be similar to that following DDC treatment, and 
suggests the involvement of a secondary factory which is 
under genetic control. The answer to exactly which step 
is involved necessitated the use of in vitro studies to 
examine the effects of drugs on both the amount and 
catalytic activity of ALA-S, and for these a purified 
preparation of ALA-S was required.
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In addition to the strain differences found after GF 
treatment, a sex difference was also noted,with a higher 
porphyrin accumulation and lower ALA-S activity in the 
males of each strain, compared to females. The sex 
difference in response to this drug has been studied in 
more detail in Chapter 4.
3.6 Purification of ALA-S
In an attempt to purify mouse liver mitochrondrial 
ALA-S, the method described by Borthwick et al (1983) was 
followed. An outline of the procedure was given in the 
Methods section (see Fig 2.3) and modifications to the 
method and problems encountered will now be described.
3.6.1 Induction of hepatic ALA-S
Mice of the C3H/He/01a strain were used because of the 
greater induction of hepatic ALA-S found in this strain 
after DDC treatment (see Section 3.2). In initial 
experiments mice received DDC (100 mg/kg, i.p.) and were 
fasted overnight, as this treatment had been shown to 
increase liver ALA-S to 17-fold control levels (Table 
3.1). However, the low recovery of ALA-S during 
purification necessitated the enzyme levels to be 
increased even further. This was achieved by altering the 
treatment protocol: mice were given DDC (100 mg/kg, i.p. ) 
followed 2 h later by PIA (2-propyl-2-isopropylacetamide, 
100 mg/kg, i.p.) and fasted overnight. The specific 
activity of mitochrondrial ALA-S increased nearly 2-fold
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with this treatment, to about 7 Units/mg mitochondrial 
protein (compared to about 4 Units/mg protein, with DDC 
alone). The increase in ALA-S is due to the combined 
effects of the drugs:- the haem level is depleted by 
inhibition of synthesis (by DDC), and both drugs exert the 
"non-specific" lipid soluble effect.
3.6.2 Mitochondrial yield
The yield of mouse liver mitochondria, prepared by 
differential centrifugation, was low in preliminary 
experiments, (about 9-12 mg mitochondrial protein/g 
liver), and this was increased to 20-25 mg/g liver by the 
following procedures:
a) The shearing force during homogenisation of the liver 
was increased by using a 10% (w/v) homogenate (rather 
than 20%) and by increasing the number of passes of 
the Potter-type homogenizer from 5 to 15.
b) The nuclear pellet was washed twice to obtain 
'trapped' mitochondria.
3*6*3 Preparation of mitoplasts and extraction of ALA-S 
activity
Mitoplasts were prepared from mitochondria by 
incubation with digitonin, to remove the outer 
mitochondrial membrane. The ratio used by Borthwick et 
al. (1983) of 6.6 mg protein: 1 mg detergent, was found to 
be suitable for use with mouse liver mitochondria, and 
recovery of ALA-S at this stage was always greater than 
85%.
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Initial experiments to extract ALA-S from mitoplasts 
following Borthwick's method resulted in less than 20% 
recovery of the mitoplast ALA-S activity in the 
final extract. Further studies showed that in order to 
extract the ALA-S effectively when the freeze-dried 
mitoplasts were resuspended in water prior to 
centrifugation, the concentration of mitoplast protein 
(mg/ml) was important. In addition, it was found that 
sufficienttime had to be allowed for the freeze-dried 
mitoplasts to 'hydrate' thoroughly. Recovery of mitoplast 
ALA-S in the final extract was increased to 55-70% when 
freeze-dried mitoplasts were resuspended at a 
concentration of 20-25 mg protein/ml, with higher 
concentrations of protein resulting in a lower recovery. 
Freeze-drying was found to be a more effective method for 
extracting ALA-S from mitoplasts, and for producing a 
higher specific activity of the enzyme, than 
freeze-thawing followed by ultrasonication of mitoplasts.
3*6.4 Protein determination
Protein was estimated using the method of Lowry et 
al. (1951). However, the buffer used to elute ALA-S from
Sephacryl S-200 interfered with this method by causing the 
formation of a dark blue precipitate. The most likely 
explanation for this is a reaction between the magnesium 
ions of the buffer and the phenol reagent (Peterson,
1977).
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When the dye-binding method of Bradford (1976) was 
used to measure protein, it was found that the reagent 
blank (i.e. in the absence of protein) had an absorption 
value greater than 1.0, and that variable values were 
obtained for the BSA standard. These two factors 
suggested the presence of undissolved dye in the Bradford 
protein reagent: when the reagent was filtered through a 
glass-scintered funnel prior to use in the assay, the 
absorbance of the reagent blank was dramatically 
decreased, to less than 0.1. Consequently, protein 
estimates were more accurate and very reproducible. No 
interference by the Sephacryl elution buffer was noted 
with this method, and since it is more sensitive than the 
conventional Lowry technique, it was used at the remaining 
purification steps where protein concentration was lower.
3.6.5 Chromatofocusing
The details of the purification starting with 49 g of 
liver from drug-treated mice is shown in Table 3.9. A 
reasonable recovery was obtained up to, and including, the 
gel filtration step (Sephacryl S-200) and it is clear from 
the table that most of the enzyme was lost at the next 
step of chromatofocusing. The low amount of enzyme 
obtained for affinity chromatography, and the relatively 
small increase in specific activity achieved up to this 
stage lead to difficulties in obtaining an accurate 
estimate of ALA-S activity at the last purification step.
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The most likely explanation for the loss of ALA-S 
occurring at chromatofocusing is that insufficient enzyme 
was loaded onto the column. Borthwick (1982) also found a 
much lower recovery with lesser amounts of enzyme.
A second possibility is that, unlike chick embryo and 
rat liver ALA-S (which has also been purified by this 
method - see Srivastava et a l ^  1982), the mouse liver 
enzyme may be unstable under the conditions of 
chromatofocusing, where there are alterations in both pH 
and ionic strength: the pH was maintained at 7.6 for the 
earlier purification steps, but was adjusted to 8.6 for 
chromatofocusing. A linear pH gradient was then generated 
between pH 8.6 to 6.6. Since only a small amount of ALA-S 
eluted where expected (approximately half-way through the 
gradient) this suggested that under the pH conditions for 
chromatofocusing, the mouse liver enzyme a) did not bind 
to the chromatofocusing column, or b) was unstable and 
degradation occurred. The latter would appear more likely 
as low molecular weight proteins were found in the extract 
obtained from the final purification step of affinity 
chromatography (see later). In addition to the pH change, 
the ionic strength of the enzyme fraction was decreased 
4-fold for chromatofocusing. Borthwick (1982) found that 
enzyme activity was lost when enzyme was kept in 
conditions of low ionic strength. Although a high ionic 
strength buffer was added to the fraction tubes prior to 
collection of column eluent, the time for which the enzyme 
was subjected to conditions of low ionic strength
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while on the chromatofocusing column (about 18 h) may have 
been sufficient for degradation to occur.
Since chick embryo and rat liver mitochondrial ALA-S 
have been successfully purified by this method, the loss 
of enzyme in the present attempted purification of mouse 
liver ALA-S may reflect a species difference in the 
sensitivity of the enzyme to changes in pH and ionic 
strength and requires further investigation.
The loss of enzyme activity at the chromatofocusing 
step is supported by the protein profiles at the various 
stages of purification, as analysed by SDS polyacrylamide 
gel electrophoresis (Fig 3.7). The molecular weights of 
ALA-S from chick embryo - and rat liver mitochondria have 
been estimated as 68,000 and 70,000 respectively 
(Borthwick et a l ., 1983; Srivastava et al., 1982). Fig
3.7 shows that'a protein band with a similar molecular 
weight, which may be ALA-S, was present during the early 
purification steps. However, only lower molecular weight 
proteins were found after chromatofocusing (Lane e) 
suggesting that loss or degradation of the enzyme had 
occurred at this stage. 3 protein bands were found in the 
affinity chromatography eluate (Lane f ); the major band 
had a molecular weight of about 47,000, and the minor 
bands were 56,000 and 34,000 molecular weight. The major 
band may be a degradation production of the native enzyme, 
since the molecular weight is similar to the reported 
value for degraded chick embryo liver ALA-S (Borthwick et 
al., 1983; Whiting and Granick, 1976). However, unlike
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Fig 3.7 SDS PAGE of samples from various stages of the
purification of mouse liver mitochrondrial ALA-S
M W  x 10'3
92.5 — ►
66.2 — ► ■  ■
g f e d c b a
Dodecylsulphate/polyacrylamide gel electrophoresis was 
performed as described in the "Methods" section. About 
40 pg of protein was analysed at the first 4 stages and 
the amount taken from the later steps is given in 
parentheses. Lane a, mitochondria; Lane b, mitoplasts; 
Lane c, extract from mitoplasts; Lane d, Sephacryl S200; 
Lane e, chromatofocusing (1.2 pg); Lane f, CoA agarose 
(1.4 pg). Values for molecular weight markers (Lane g) 
are shown.
115
degraded enzymes obtained in other laboratories, which 
were found to be still enzymatically active, very little 
enzyme activity was retained in the present experiments.
It was intended to use the purified enzyme to raise a 
specific antibody to ALA-S. The antibody would then have 
been used in in vitro experiments to investigate the 
control mechanisms by which ALA-S induction is regulated. 
An outline of the intended experimental protocol is given 
in Fig 3.8. Unfortunately, attempts to raise a homogenous 
preparation of enzyme failed, and in view of the limited 
time available, efforts in this direction were 
discontinued.
3.7 Discussion
The stimulation of ALA-S activity by drugs has been 
suggested to occur by a 2-stage mechanism (De Matteis and 
Gibbs, 1972? Sinclair and Granick, 1975? Maxwell and 
Meyer, 1976? De Matteis, 1978b). The first stage involves 
the depletion of 'regulatory' haem (e.g. by inhibition of 
synthesis or increased degradation) and is sometimes 
termed the "specific" effect of the drug as specific 
chemical groupings are necessary for the depletion effect 
to take place, for example, an unsaturated olefinic bond 
in the case of AIA and similar drugs. Due to the 
regulatory control that haem exerts on ALA-S, a small 
induction of the enzyme results. In addition, haem 
depletion somehow renders the ALA-S sensitive to a second 
"non-specific" effect, common to lipid-soluble drugs, and
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Fig. 3.8 Outline of in vitro experiments to investigate 
the effects of drugs on amount and activity of 
ALA-S
Mouse liver
isolate mRNA
(2)
mitochondria*
translate in a cell-free 
system in the presence of 
radioactively labelled 
amino acid
specific antibody
measure
ALA-S
activity
radioactivity of 
immunoprecipitated ALA-S 
protein measured; amount 
of ALA-S made in vitro 
should give a measure of 
the ALA-S-specific mRNA
immunoprecipitated 
ALA-S protein: enzyme 
precipitated should 
give a measure of the 
amount of enzyme 
present
Liver would be obtained from control and drug-induced mice 
of the 2 inbred strains.
In (1) the translation assay and antibody precipitation of 
labelled ALA-S protein would show whether the in vivo 
induction of ALA-S in the high responders, i.e. C3H/He/01a 
mice, involves a greater expression of the ALA-S gene 
(i.e. greater transcription), as compared to the low 
responding strain, NIH/Ola.
In (2) the antibody would also show whether or not the 
greater ALA-S activity induced in vivo in the C3H/He/01a 
strain is due to the presence of more enzyme compared to 
the NIH/Ola strain, i.e. de novo enzyme synthesis, rather 
than enzyme activation.
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the induction of ALA-S becomes potentiated. DDC treatment 
in vivo causes a high induction of ALA-S activity because 
both mechanisms are operational. The drug "specifically" 
inhibits haem biosynthesis at the level of FK, due to the 
production of the antimetabolite, N-MePP, and also exerts 
a "non-specific" effect due to its lipid soluble 
properties.
The results presented in this chapter show that inbred 
strains of female mice differ in their response to DDC, 
with respect to ALA-S activity, over a range of doses, and 
confirm the. observations of Gross and Hutton (1971). The 
enzyme was induced to 22 times control levels in the 
C3H/He/0la strain following a dose of 200 mg DDC/kg, but 
there was only an 8-fold induction in the NIH/Ola strain.
Use has been made of the genetic difference found 
between mice strains to examine whether the difference is 
at the level of the "specific" or "non-specific" effect of 
the drug. The effect of DDC on the inhibition of FK 
activity has been studied in the 2 strains of mice and it 
has been found that over a range of dose levels, the 
extent of inhibition of enzyme activity is identical in 
both strains. A dose-dependent loss of FK activity has 
been demonstrated (Fig 3.6) with near-maximal inhibition 
(84%) following treatment with 10 mg DDC/kg. Doses up to 
20 times this lead to only a very small further decrease 
in activity (Fig 3.1). At each dose level hepatic ALA-S 
activity of the C3H/He/0la strain was found to be induced 
to a higher level than in the NIH/Ola strain. The 
difference between the 2 strains in ALA-S activity was
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most marked when the chelatase activity was maximally 
inhibited. The results therefore demonstrated that there 
was no difference between the strains in the "specific" 
action of DDC, and suggested that the difference in the 
sensitivity of ALA-S to induction was due to a genetic 
difference at the "non-specific" stage.
Evidence that a specific inhibition of haem 
biosynthesis per se is insufficient to produce genetic 
variation in ALA-S activity was provided by the finding 
that extensive inhibition of ALA-D activity caused by in 
vivo SA treatment, did not lead to a difference between 
the strains in ALA-S activity (Table 3.4). In fact, there 
was no real enzyme induction. As ALA-D levels are 
relatively high compared to other enzymes of the haem 
biosynthetic pathway, it is possible that under the 
inhibitory conditions produced by SA, there is sufficient 
enzyme activity to facilitate normal haem biosynthesis.
Additional evidence that the induction of ALA-S is 
genetically controlled at a stage other than at the level 
of haem biosynthesis was obtained when female mice were 
treated with GF. This drug, like DDC, inhibits FK 
activity via the formation of N-MePP (see Chapter 6) and 
is lipid soluble.The strain in which the ALA-S was more 
sensitive to induction by DDC (i.e.C3H/He/01a) has now 
been found to be more sensitive in response to GF. In 
addition, this difference applied to male mice of the 2 
strains and in all cases, the "specific" effect of the 
drug, i.e. inhibition of FK, was found to be of similar
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degree;. However, care must be taken in the 
interpretation of the results obtained with GF. Extremely 
high levels of protoporphyrin accumulated in the livers of 
all treated mice (Tables 3.6 and 3.8), and this porphyrin 
has been reported to inhibit the induction of ALA-S 
activity caused by drugs in vitro (Scholnick et al., 1969; 
Schoenfeld et a l., 1983). If a similar inhibition occurs 
in vivo it would explain the observation that mice of the 
NIH/Ola strain, which accumulate greater amounts of 
hepatic porphyrins than the C3H/He/01a strain, have a 
lower ALA-S activity than the latter strain.
An alternative explanation for the lower ALA-S 
activity, yet greater protoporphyrin accumulation in 
NIH/Ola liver, could lie in a difference of sensitivity 
between the 2 strains to the cholestatic effects of GF 
(De Matteis et al., 1966). A greater impairment of bile 
secretion in the NIH/Ola mice would result in a more 
pronounced accumulation of hepatic protoporphyrin, since 
the porphyrin is excreted in the bile. However, although 
the porphyrinogenic activity of GF has been suggested to 
interfere with the mechanism involved in bile secretion, 
by causing extra-hepatic biliary obstruction (Yokoo et 
al. , 1979), cholestasis develops only after a relatively 
long exposure to the drug (Cantoni et al..-# 1983) and may 
therefore be a result of the drugs' long-term toxic 
effects. Thus, the cholestatic effects of GF may not be 
relevant in the present short-term study.
Another possibility for the difference in ALA-S 
activities could be at the level of the Fk enzyme;
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although the extent of FK inhibition was found to be 
identical in the 2 strains after 3 days GF feeding, a more 
rapid loss of activity may have occurred in the C3H/He/01a 
strain, consequently resulting in a greater induction of 
ALA-S by 3 days.
To investigate which of the 3 explanations is most 
likely, the relationship between hepatic porphyrin 
accumulation and ALA-S activity following GF feeding has 
been studied in more detail in Chapter 4, and the 
experiments to be described there show that a depression 
of ALA-S activity is in fact seen when porphyria is very 
marked.
In conclusion, the studies presented in this chapter 
demonstrate that the strain difference found in 
DDC-mediated ALA-S induction is not due to a difference at 
the level of inhibition of haem biosynthesis, but probably 
reflects a genetic difference in the sensitivity of ALA-S 
to the second "non-specific" action of the drug. It is 
not clear whether strain differences in response to GF are 
in the same direction as those observed following DDC 
treatment, as interpretation of results was complicated by 
additional effects of the drug.
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CHAPTER 4
Sex differences in drug-induced porphyria
122
4.1 Introduction
The investigations described in the previous chapter 
of this thesis revealed that after 3 days of GF treatment 
(1% in the diet), the livers of male mice of 2 genetically 
different strains were more porphyric than females. In 
addition, male and female mice were found to differ in the 
extent of the increase of hepatic ALA-S activity after 
drug treatment, although in this respect females appeared 
to be the more responsive sex. Since FK activity was 
shown to be inhibited by a similar extent in both sexes, a 
greater accumulation of porphyrins would be expected in 
females, due to the higher ALA-S activity, and this was 
not found.
Accumulation of liver porphyrins has been reported to 
be more pronounced in male mice following prolonged 
treatment with GF (De Matteis et al., 1966), and ALA-S 
activity has been studied in short-term studies in male 
mice (De Matteis and Gibbs, 1975; Denk et al., 1981), but 
there is very litte data in the literature comparing, in 
the 2 sexes, the early porphyric changes caused by this 
drug. The development of GF hepatic porphyria has now 
been studied in male and female mice, with particular 
reference to the relationship between hepatic ALA-S 
activity and porphyrin levels. The experiments had 2 
aims: Firstly, to determine whether a sex difference in 
porphyrin accumulation in the liver is present at early 
time points and, secondly, to determine whether there is a 
true sex difference in hepatic ALA-S activity, or whether
some other factor is involved.
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4.2 The development of GF-porphyria in male and female
mice
GF was fed (1% in the diet) to male and female MF1 
mice for 1, 2, 3 or 7 days. No change in body weight was 
observed during the experiments. However, within 24 h of 
feeding, the drug caused enlargement of the liver and an 
increase in total liver protein (expressed as g per total 
liver per 100 g body wt), and with further treatment, 
these efects became more pronounced (Table 4.1). An 
almost linear relationship was found between the length of 
GF-feeding and relative liver weight (Fig 4.1), and by 7 
days the relative liver weight of males and females had 
increased 62% and 58% respectively, when compared to 
controls. No significant difference in relative liver 
weight was found between the sexes at any time point 
considered.
Total liver protein content also increased with length 
of GF-feeding (Table 4.1) with the magnitude of increase 
(over control levels) similar to the increase in relative 
liver weight in the 2 sexes. Indeed, Fig 4.2 shows a 
linear relationship between total liver protein and 
relative liver weight after GF treatment, and demonstrates 
that increased liver protein parallels the increase in 
liver weight.
Hepatic porphyrins and FK activity in control male and 
female MF1 mice were found to be the same. GF produced a 
sex difference in the accumulation of porphyrins in the 
liver (Table 4.2). A relatively small elevation in
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Fig 4.1 Effect of GF feeding on relative liver weight
11 n
10 -
■MrdW)
•rH
%
<u>
•H4-JtoH<u
pcj
0 31 2 4 5 6 7
Length of GF treatment (days)
Male and female MF1 mice were treated with GF (1% w/w, in 
the diet) for varying lengths of time. Each point 
represents the mean ± SD of the relative liver weight of 8 
mice (16 for controls). Note that the data for male and 
female mice have been pooled (see also Table 4.1).
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Fig 4.2 Relationship between relative liver weight and 
total liver protein content after GF treatment
10 - »
■
<D
>
•H■MCOr—I<U
I 1.4 1.6 1.8 2.0
Liver protein (g/total liver of 100 body wt)
Male (■) and'female (□) MF1 mice were treated with GF as 
described in the legend to Table 4.1. Each data point 
represents the average value of relative liver weight and 
total liver protein of 4 mice receiving the same length of 
drug treatment, and of 8 mice for controls (•, male; o, 
female). The coefficient of linear correlation was 0.96 
with 46 degrees of freedom, for the individual values.
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porphyrins (predominantly protoporphyrin) was observed in 
both sexes after 1 day of GF-feeding. As treatment was 
continued, a considerble accumulation of porphyrins 
occurred, and by 7 days the livers of males had levels 
600 times greater than controls. Fig 4.3 shows that the 
enlarged livers of these mice were considerably darker 
in colour than control liver, because of the accumulated 
porphyrins. Throughout the experiment, male livers were 
found to have a higher porphyrin content than females, 
although the difference was only significant (p<0.001) 
after 3 days of drug treatment, when levels were about 
twice as great. A correlation was found between levels of 
hepatic porphyrins and liver weight after short-term 
GF-feeding (Fig 4.4), despite the observation that the 
sexes differed in porphyria, but not in relative liver 
weight, and this is discussed later.
An inhibitory effect on hepatic Fk activity was found 
in both sexes within 24 h of GF-feeding, with 
approximately 50-60% loss of activity when compared to 
controls. With longer treatment, a progressive 
dose-related decrease in enzyme activity occurred (Table
4.2), and about 90% inhibition was present after 3 days. 
Treatment with the drug for an additional 4 days did not 
cause a further loss of Fk activity, demonstrating that 
maximal inhibition had occurred at 3 days. The extent of 
the inhibition (as compared to controls) and the actual 
levels of activity of Fk, were identical in the two sexes, 
and to explain the higher porphyrin content of male
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Fig 4.4 Relationship between hepatic porphyrin levels
and liver weight of MF1 mice treated with GF
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livers, studies were next directed towards the effect of 
the drug on hepatic ALA-S activity.
Results presented in Table 4.2 show that treatment 
with GF for up to 3 days caused a progressive dose-related 
increase in the activity of ALA-S. The average enzyme 
level in the livers of male mice was found to be slightly 
higher than in the livers of females after 1, 2 and 3 days 
of drug treatment, and in the latter case was increased to 
14 and 12 times the control levels in males and females, 
respectively. After 7 days of GF feeding, a significant 
sex difference was found in hepatic ALA-S activity, and 
enzyme levels in females were twice those found in males. 
Comparison of enzyme activities after 3 and 7 days 
treatment (Table 4.2) show that an increase had occurred 
in females, whereas in males, the activity had decreased 
considerably (Fig 4.5).
The presence of high porphyrin levels in male MF1 
mouse livers therefore appeared to be associated with a 
decrease in ALA-S activity. In Chapter 3, where the 
effect of feeding GF to 2 inbred mice strains was studied, 
a greater hepatic porphyrin accumulation was noted in the 
NIH/Ola strain, which had the lower levels of ALA-S after 
drug treatment. These results prompted the comparison of 
data obtained in the different experiments: The hepatic 
porphyrin levels, FK and ALA-S activities found in males 
and females of the 3 strains after 3 days on the GF-diet 
are presented in Table 4.3. It is seen that in each 
strain, male livers accumulated significantly greater
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Fig 4.5 Hepatic ALA-S activity in male and female MF1
mice after treatment with GF
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Male (■) and female (□) mice received GF in the diet at a 
concentration of 1% (w/w) for up to 7 days. The levels of 
hepatic ALA-S activity reported in Table 4.2 are presented 
graphically; each data point represents the average enzyme 
activity of 4 mice.
133
0
0
P
5
m
o
0
o
•H
g
(U
I—I
rd
g0)
vp
fd
G
<d
0 
r—I 
0 
g
O
•P
0
fd
fd
ro
S-l
O
»p
Ph
0
6 
G 
•H
fdd)
0
m
o
■P 
CJ 
0) 
m 
m 
a)
<u
1-4
a)
>■H
rH
o
5
tp
O
0 
a)
■H
■P
•H
>
■H
•P
U
<d
w
1
<
P
G
a)
■p
G
o
o
G
H
p
>1
&
P
o
&4
a)
LG
•p
G
o
(0
G
■H
rd
>-4
P
to
ro
0rH
,0fd
Eh
Cn ■X
>i g VO O O  CO vO iH
CN Cft <y> in O  rH
•H G • • • • • •
> -H ^ r*- r- co CO VO
•rl E C rH
-P \  -H
u C  0 -H -H +1 -H •H -H
<  p  pSi o O  f"* co cn cn in
W  P 00 ro cm in CN CO
1 iH CU • • • • • 9
<  0 00 rH lO CD oo r-
p  g <rtf CO rH CNSi Of
w
P  H
•H O
> U
•H -P CN O rH CN VO ^
P  G rH rH rH rH rH
U O
<  O
&  dP
Cn —
* •X ■X
to * ■X ■X
G CO c \ ^  CN C\ CO
•H P O  co 00 O in  rH
P O • • • • • •
>1 > CN <T> in cn CO -vj*
,G -H rH rH CO 00 r-4 rH
O4H i—I iH rH rH
P \
O CnA . S. +1 -H -H -H -H -HPm
rH Cn Cn CN CO CO CN
H  O C\ ^ G\ CN ^  VO
fd g • • • • • •
P  G CO rH Htf CO CO C"
O oo in CN VO VO CO
Eh ^  CN r> CTi VO
in in -vf
—  w w- --
0) 0 0
X ' iH iH rH
0 0 fd 0 0 0 0
W rH g H  g H  g
<d 0 0 0 0 0
S  to S  to S  PH
0
rH
O
G \ 0
•H . 0 rH
(d sc o
P *vx» ■
■P rH sc sc
CO Pm CO H
s U S3
fd
G 0
0 0  O
rH
0 *
rH 0  P
0 0  0
> •p
0 0  00
rH G
0  ip
G Cn 0
•H. O ' •
U g  Q 0
> i O CO 0
.G ,C rH
04 +1 0
J-t p g
O 0  G
04 >  0 P
-r-4 0 0
rP g M-l
0 rH 0 0
0 0  0 3
0 3 rH
0  0 0 0
,G •H 0 >
-P >  -p
G •H G Cn
0 fd  0 G
P G 0 •H
0 •H  0 fd
04 P G
G 04 O
G O 04
•H 0 0
0  P 0
G •P 0 P
0 0 P
> U 0 0
•H •H  -P o
tT1 1—1 «—1
Ok 3 A
0 3  0 +J
•H *0  0 •H
o ; $
04 G
0 •H fd
0 • 0
p T3 G p
Cn 0  O 0
G -H &
,G •H +> g
t j g  o 0
0 P  0 o
0 0  0
-P G
G 0  0 0
•H fd  rd rG
0
0 0  ,G
rH p  p
0 0  0 rH
g ^  s . o
•H •
G 0  0 o
0 0  ,G V
*H +> 04
vp •P •
0 •H C 0 ■X
G ■X
P •H 0
0 -P »d •H
,0 O 0 •P in
0  ^3 0 o
•H > •
G W  P P o
1 u 0 V
0 0 0 O.
;G P  0  ^3
P < ; fd 0 X
134
amounts of protoporhyrin despite the similarity to females 
in the extent of FK inhibition. A higher level of ALA-S 
was present in livers of females of the 2 inbred strains, 
in contrast to the similar enzyme activity found in the 2 
sexes of the MF1 strain following the same length of GF 
treatment. However, females of this strain were found to 
have an ALA-S activity which was twice that of males, 
after a week's drug treatment (Table 4.2), when porphyrin 
levels in male livers were very high. Furthermore, if 
males, or females, of the 3 strains are compared (Table 
4.3) it is apparent that the NIH/Ola strain accumulated 
the greatest amount of protoporphyrin in the liver, and 
that this strain had the lowest level of ALA-S activity.
It has been reported that protoporphyrin has a 
dose-dependent inhibitory effect on the induction of ALA-S 
caused by AIA in chick embryo liver cells in vitro 
(Schoenfeld et al., 1983). It was therefore possible that 
such an inhibitory effect could also occur in vivo, when 
protoporphyrin levels are high. This was confirmed by the 
DDC data to be described below.
4.3 Porphyria caused by DDC in the diet
DDC was fed to male and female MF1 mice for 7 days at 
a concentration of 0.1% (w/w) in the diet. A massive 
accumulation of hepatic porphyrins (predominantly 
protoporphyrin) occurred in both sexes, with levels 
1300-1800 times greater than control levels (Table 4.4).
In contrast to the GF-induced porphyria, the porphyrin
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content of the liver was slightly higher in females; 
relative liver weight and total liver protein content were 
significantly greater in this sex but there was no 
difference in the inhibition of FK activity at this time 
point. Interestingly, hepatic ALA-S activity was not 
significantly different from control levels and this was 
strong evidence for the depression of enzyme activity 
caused by high protoporhyrin levels.
The results of all the experiments described in this 
chapter were considered together in an attempt to relate 
the activity of hepatic ALA-S to protoporphyrin 
accumulation, whatever the porphyrogenic treatment and the 
sex of the animal. ALA-S activity has been expressed as 
nmol ALA synthesised/h/g liver for comparison of the 
results of Hutton and Gross (1970) (see later). Fig 4.6 
clearly shows that porphyrin accumulation is associated 
with an increase in ALA-S activity, as would be expected. 
However, above a protoporphyrin concentration of about 450 
nmol/g liver, the relationship becomes inverse, with 
higher protoporphyrin levels associated with a decrease in 
ALA-S activity.
4.4. Discussion
4.4.1 Sex differences in the development of GF porphyria 
in mice
The investigations reported in this chapter revealed 
that within 24 h of GF feeding a number of changes
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occurred in the livers of male and female MF1 mice. These 
included an increase in the relative liver weight, total 
liver protein, porphyrins and ALA-S activity, and a loss 
of FK activity. As treatment continued, the increase in 
liver size and porphyrin content, and the inhibition of 
Fk, became more marked, and sex differences in porphyrin 
accumulation and ALA-S activity became apparent.
The hepatomegaly induced by GF was dependent on the 
time of exposure to the drug (Fig 4.1) and by 7 days, 
relative liver weight was 60% greater than controls.
This increase is larger than De Matteis (1966) reported, 
where only a 33% rise over control values was found. 
However, this could be a reflection of a strain difference 
in response to the drug, and is supported by the 
observation in Chapter 3 of a 49% increase in relative 
liver weight of male NIH/Ola mice, compared to the 25% 
increase found in male C3H/He/01a, after 3 days GF 
feeding.
De Matteis et al (1966) reported gross liver 
enlargement (up to 20% body weight) which was more 
pronounced in male mice, compared to females, after 
feeding 1% GF for 1 year. However, no sex difference was 
found in the present studies, in the increase in relative 
liver weight (over control values) in 3 strains of mice at 
any time point studied. The obvious difference between 
these experiments and those of De Matteis et a_l. (1966) is 
the length of drug treatment, and perhaps with time 
females are more adaptive to the toxic effects of GF. In 
addition, with prolonged GF feeding, other effects such as
139
deposition of protoporphyrin pigment, with plugging of the 
biliary system and bile duct proliferation, are more 
pronounced in male livers (De Matteis et a l ., 1966). This 
is likely to account for a proportion of the increase in 
the weight of the liver observed in mice under these 
conditions. It will be noticed that in mice treated with 
GF, total liver protein content increased in direct 
proportion to liver size (Fig 4.2) with no change in liver 
protein concentration (Table 4.2). The same observation 
was reported following i.p. administration of AIA to 
starved rats (Marver et ad., 1966).
The most prominent effect of GF within 24 h was the
50% loss of Fk activity (Table 4.2) with maximal 
inhibition of this enzyme (about 90%) occurring after 3 
days. No significant difference was found in the 
inhibitory effect of GF on FK activity in males and 
females of the MF1 strain at any time interval examined, 
up to 7 days, or between sexes of 2 inbred mice strains
treated for 3 days. As inhibition of Fk caused by GF is
mediated via N-MePP (see Chapter 6), these results suggest 
that the rate of production of this modified porphyrin is 
the same in the 2 sexes, unless Fk enzymes of males and 
females differ in their sensitivity to the inhibitor, 
which does not appear very likely. Results to be 
presented in Chapter 6 will show that similar amounts of 
N-MePP can be isolated from the livers of both sexes of 
mice treated with GF for 3 days and this is in agreement 
with the same inhibition of the enzyme found in vivo, when 
comparing male and female mice.
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GF caused a considerable accumulation of hepatic 
porphyrins, which consisted almost entirely of 
protoporphyrin, increased with time of treatment (Table
4.2) and correlated with an increase in relative liver 
weight (Fig 4.4). The latter finding does not necessarily 
imply that the deposition of porphyrins is directly 
responsible for the enlargement of the liver; following 
DDC treatment (0.1% in the diet for 7 days), relative 
liver weight increased 60% over control values in females, 
but only a 24% increase was found in males, yet the amount 
of porphyrin accumulating in the liver was massive in both 
sexes (Table 4.4). In addition, a number of studies have 
suggested that porphyria is dissociated from other changes 
which occur following GF-feeding, such as liver 
enlargement, hypercholesterolaemia and increased activity 
of microsomal and cytosolic enzymes (see De Matteis,
1966). Many lipid soluble non-porphyrogenic compounds 
such as phenobarbitone, HETGF and PIA cause liver 
enlargement and increased protein synthesis without 
inducing a condition of porphyria, and it has been 
suggested that in the case of GF, these effects result 
from a different action of the drug (De Matteis, 1966), 
and reflect its lipid solubility.
With regard to hepatic porphyrin accumulation, a sex 
difference was found with higher levels present in males 
at all time points studied, although the difference was 
only significant after 3 days of GF treatment. Porphyrin 
levels are a balance between the rate of synthesis and the 
rate of further utilization, or elimination. Since both
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sexes of MF1 mice exhibited a similar depression of Fk 
activity over the first 3-day period of GF feeding, the 
greater porphyria in males would appear to be due to the 
slightly higher ALA-S activity found in this sex at these 
time points (Table 4.2). However, after 7 days of drug 
treatment, males had significantly less ALA-S activity, 
compared with females, although porphyrin levels were 
still higher in the former sex. Therefore it is likely 
that ALA-S is not the only factor involved in determining 
the sex difference in the degree of porphyria. Perhaps 
there is a difference between the sexes in porphyrin 
disposal, with a slower elimination in males of the MF1 
strain. A similar difference in porphyrin disposal may 
also occur in the 2 inbred strains of mice where livers of 
males were found to have a higher porphyrin content than 
females after drug treatment. In addition, in these mice 
and the male MF1 receiving GF for 7 days, the very large 
amounts of protoporphyrin appeared to be associated with a 
lower ALA-S activity and this is discussed below.
4.4.2 Relationship between hepatic ALA-S activity and 
accumulation of porphyrins
Hutton and Gross (1970) described a decrease in the 
level of induction of ALA-S activity in mice caused by 
i.p. injection of DDC, when protoporphyrin levels in the 
liver were greater than 100 nmol/g.
It has now been shown that a similar reduction in 
ALA-S activity occurs in the livers of male and female 
mice which contain large amounts of protoporphyrin after
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treatment with GF. In addition, when the livers of mice 
are made extremely porphyric by feeding DDC, ALA-S 
activity is not significantly different from control 
levels (Table 4.4). Fig 4.6 shows that hepatic 
protoporphyrin accumulation in mice is correlated with an 
increase in ALA-S activity (measured in vitro) but the 
relationshnip becomes inverse at protoporphyrin levels 
above 450 nmol/g liver. This two-way relationship applies 
to the livers of both male and female mice, and suggests 
that the sex difference observed in inbred strains (lower 
porphyrin levels and higher ALA-S activities in females 
than in the respective male counterparts) is not a true 
difference, but rather a reflection of the time at which 
measurements were taken: if the females had been treated
with GF for a longer period of time, so that porphyrins 
could have reached the same levels as in the males, a 
similar ALA-S activity would probably have been found.
This interpretation is supported by the demonstration of 
similar porphyrin levels and ALA-S activities in female 
MF1 mice fed GF for 7 days, and male MF1 mice treated for 
3 days (Table 4.2).
The mechanism by which high protoporphyrin levels 
reduce ALA-S activity is not known. Protoporphyrin and 
haem have a dose-dependent inhibitory effect on the 
AIA-induced ALA-S activity in chick embryo liver cell 
cultures (Schoenfeld et al., 1983). However, more recent 
studies by Schoenfeld et al., (1984) have shown that
protoporphyrin decreased both non-induced, and AIA-induced
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activity of ALA-S only after transformation of 
protoporphyrin to haem. In the present experiments, GF 
was found to reduce Fk activity markedly, so it is 
unlikely that sufficient haem would be generated within 
the mitochrondria to inhibit ALA-S activity, in vivo. In 
addition Wolf son et aJL (1979) have shown that generation 
of haem in rat liver mitochrondria to up to 75 times the 
basal rate occurring in vivo does not affect the activity 
of ALA-S. More recently Pirola et al. (1984) reported 
that haem does not inhibit purified ALA-S isolated from 
drug-induced chick embryo liver. It seems unlikely that 
end-product inhibition by haem on ALA-S activity occurs in 
either of these situations, or in the mitochrondria of 
GF-treated mice either in vivo or in vitro.
The most likely explanation for the depression of 
ALA-S activity by protoporphyrin in vivo is by a feedback 
repression mechanism similar to that found with haem.
This could occur in 2 ways: a) protoporphyrin could 
prevent the synthesis of ALA-S at the level of 
transcription or translation, or b) ALA-S is synthesised, 
but protoporphyrin inhibits its translocation into the 
mitochondria and conversion to the catalytically active 
form. Studies using a specific antibody to the enzyme 
would clarify the situation.
An additional effect of GF which should be considered 
is the uncoupling of mitochondria which has been related 
to accumulation of protoporphyrin in this organelle
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(Sandberg and Romslo, 1981; Tangeras, 1986). In the 
experiments described in this chapter, the level of 
protoporphyrin above which a reduction of ALA-S activity 
was found, is comparable to the amount reported by these 
workers to be associated with mitochondrial uncoupling and 
damage. Under such conditions, it is possible that ALA-S 
could leak out of the mitochondria into the cytosolic 
fraction of the homogenate, where no succinyl-CoA 
formation occurs, or, alternatively, that the formation of 
succinyl-CoA is interferred with by the occurrence of a 
mitochondrial damage. Since succinyl-CoA is one of the 2 
substrates of ALA-S, and the assay used in these 
experiments does not include exogenous succinyl-CoA, the 
lower enzyme activity measured in vitro would be 
compatible with the existence of mitochondrial damage.
In conclusion, the studies presented in this chapter 
demonstrate a sex-difference in GF-porphyria in mice with 
a greater porphyrin accumulation in livers of males. This 
sex also has a slightly higher ALA-S activity after drug 
treatment, but when protoporphyrin levels are very high, 
levels of this enzyme are significantly lower than in 
females. A two-way relationship has been shown to exist 
between ALA-S activity and porphyrin accumulation, with a 
repression of ALA-S activity occurring in vivo when liver 
protoporphyrin-content is very high. The sex difference 
in ALA-S activity can therefore be explained by a 
reduction of ALA-S by protoporphyin in male mice where the 
accumulation of the porphyrin is greater, and possible 
mechanisms by which this occurs have been discussed.
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CHAPTER 5
Studies on porphyria in cultured 
chick embryo hepatocytes
146
5.1 Introduction
In 1966, Granick introduced a procedure for 
maintaining chick embryo liver cells in culture, and this 
system has proved to be valuable in the study of 
experimental porphyria. The cultured cells are exposed to 
drugs, under controlled conditions, and the response 
assessed in terms of the excess porphyrins recovered from 
the cells and the culture medium. Analysis of the types 
of porphyrins that accumulate in response to a drug can 
provide information on the mechanism of action of a 
porphyrogenic compound.
DDC has been shown to be porphyrogenic in chick embryo 
liver cells in culture (Granick, 1966), and, as had been 
found in animal studies in vivo, causes a marked 
inhibition of Fk and accumulation of protoporphyrin (Cole 
et al., 1981a; 1981b). A similar response has been 
demonstrated for N-MePP, the DDC-derived antimetabolite 
(Cole and Marks, 1982; De Matteis and Marks, 1983).
The effects of GF and its 2 analogues, ISOGF and HETGF 
(see Fig 5.1), on porphyrin biosynthesis in chick 
hepatocytes have now been investigated. Granick (1966) 
and Cole et al. (1981b) reported that GF is porphyrogenic 
in cultured chick hepatocytes, but in contrast to 
observations in rodents, the drug does not cause a 
significant inhibition of Fk activity in the in vitro 
culture system (Cole et al., 1981b). However, rodents 
require a considerably longer period of exposure to GF, 
than to DDC, in order to depress Fk activity significantly
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Fig 5.1 The structures of GF and its analogues
GF
ISOGF
HETGF
0 SCH,CH,0H
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(De Matteis and Gibbs, 1975; De Matteis et al., 1973).
This may also be necessary in chick embryo hepatocytes and 
could explain the absence of an effect of GF on Fk 
activity. The accumulation of porphyrins observed by 
Granick (1966) and Cole et al. (1981b) may have resulted 
from the property common to a large number of lipid 
soluble drugs of inducing porphyrin biosynthesis in the 
culture system (De Matteis, 1978b; Marks, 1978; Sinclair 
et al., 1986).
The GF analogue, ISOGF, is more porphyrogenic than GF 
in mice (De Matteis and Gibbs, 1975). It was of interest 
to determine whether this drug would also be more 
porphyrogenic in cultured chick hepatocytes. The first 
objective was therefore to quantitatively compare 
drug-induced porphyrin biosynthesis in the iji vitro system 
after treatment with GF, ISOGF, HETGF (the analogue which 
is inactive as a porphyrogenic agent in rodents) and also 
DDC, and to examine the nature of the accumulated 
porphyrins. The second objective was to determine the 
effect of these drugs on Fk activity.
5.2 Determination of appropriate drug concentrations
ISOGF, GF and HETGF were dissolved in DMSO, and DDC 
was dissolved in ethanol for addition to cell cultures. 
Controls received the same volume of the appropriate 
solvent (5 pl/2 ml well or 20 pl/lOml plate).
The accumulation of porphyrins in chick hepatocyte 
cultures in response to various doses of ISOGF and GF is
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shown in Fig 5.2. Porphyrin accumulation produced by 
ISOGF was maximal at doses of 15-45 jag/ml of medium, with 
levels 10-12 fold higher than controls. At a 
concentration of 60 jig/ml of medium, the response 
declined. Examination of the cells by light microscopy 
showed that some cell injury and death had occurred, as 
evidenced by the appearance of the cultures, compared to 
controls, and the detachment of a number of cells from the 
culture plate. This latter observation was reflected in 
the lower protein concentration of the cells which had 
received this dose of ISOGF. Thus, at the relatively high 
concentration of 60 pg/ml of medium, ISOGF exerted toxic 
effects on hepatocytes in culture. GF was less 
porphyrogenic than ISOGF in cell cultures, and doses of 
15-60 jig/ml of medium caused only a doubling of porphyrin 
levels. These results showed that ISOGF induces porphyrin 
formation to a greater degree than GF in cultures chick 
hepatocytes, and is in accordance with iri vivo studies in 
mice (De Matteis and Gibbs, 1975).
A dose of 30 jag drug/ml of medium was selected for use 
in subsequent experiments, since this produced the optimal 
porphyrin induction for both drugs without causing obvious 
toxicity to cells, as judged by light microscopy 
examination, and protein content of cells. In addition, 
there was less variability in porphyrin accumulation 
within an experiment at this dose level.
A similar dose-response study with DDC showed that a 
10-fold increase in porphyrin levels occurred at a dose of
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Fig 5.2 Effect of increasing doses of ISOGF and GF on
porphyrin accumulation in cultured chick embryo 
hepatocytes
T
10 ~
o— o-
60
Dose of drug (pg/ml of medium)
ISOGF (•) and GF (o) were dissolved in DMSO for addition 
to chick embryo hepatocyte cultures. The hepatocytes were 
incubated with varying concentrations of either drug for 
22 h, and total porphyrins (i.e. combined cells and 
medium) were measured in 2 ml well cultures, as described 
in the "Methods" chapter. The results represent the mean 
± SD of 4 observations and are expressed as the fold- 
increase over ..control values (i.e. as the ratios of the 
experimental values over the control value).
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10 pg/ml of medium. Although the induction of porphyrin 
biosynthesis by various concentrations of HETGF was not 
examined, a dose of 30 jig/ml of medium was used for 
comparison to ISOGF and GF. Porphyrin accumulation after 
treatment of cultures with each of the 4 drugs was found 
to be similar between 22-28 h, and 22 h incubations with a 
drug were routinely used.
The effect of ISOGF, GF, HETGF (30 pg/ml of medium) 
and DDC (10 jig/ml of medium) on porphyrin accumulation and 
on the activity of FK was examined, with the drugs 
(dissolved in the appropriate solvent) added directly to 
the chick hepatocyte cultures. DDC was found to be 
porphyrogenic, causing accumulation of mainly 
protoporphyrin, and 80-90% inhibition of FK activity. 
However, inconsistencies were found following treatment 
with GF and its 2 analogues in the degree of porphyrin 
accumulation, the porphyrin profiles (that is, the 
relative proportions of the 3 porphyrins, copro-, uro- and 
protoporhyrin), and in FK activity. GF, ISOGF and HETGF 
were added to the cultures dissolved in DMSO: De Matteis 
et al. (1980b) observed that mice injected with DMSO had 
significantly less hepatic porphyrins and ALA-S activity 
than mice receiving saline. Thus, the variability in the 
response of cultured hepatocytes to GF and its analogues 
may be related, in part, to an effect of DMSO on haem 
biosynthesis. This is supported by the finding that 
individual control cultures receiving DMSO alone also 
varied in porphyrin levels and profiles, in contrast to
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the results obtained for control cultures treated with 
ethanol. It was also noted that GF and its analogues 
sometimes precipitated out of solution immediately after 
addition to the cultures, although no drug particles were 
visible when hepatocytes were examined 2 h later. These 
observations suggested that the variable response of the 
cultured hepatocytes to these drugs was related to some 
effect of DMSO, and also to the insolubility of the drugs 
themselves; it was therefore necessary to overcome these 
problems in order to obtain more reliable results.
5.3 Development of alternative method to treat cultures 
with drugs
Attempts to find an alternative solvent to dissolve 
the drugs in showed that ISOGF and HETGF were fairly 
soluble in EtOH/ether (1:1, by vol), if warmed slightly. 
However, GF was only partially soluble in this solvent. 
Since all 3 drugs were soluble in DMSO, it was decided to 
use this solvent, but to reduce the volume which the 
cultured hepatocytes received. This was achieved as 
follows:- ISOGF, GF and HETGF were dissolved in DMSO which 
was then added to warm cell culture medium, and left for 
2 h at 37°C to ensure complete solubility. The medium, 
containing the drug, was then added to the cell cultures. 
Using this method for the addition of drugs to cultures, 
the amount of DMSO which the hepatocytes were exposed to 
was reduced 10-fold.
In order to determine which method to use to dose 
cells for subsequent studies, the porphyrogenic effect of
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ISOGF, GF, HETGF and DDC added to cultures by the method 
described above, was compared to the effect of the drugs 
(dissolved in EtOH/ether) added "directly" to the 
cultures.
Results presented in Table 5.1 show that DDC was 
porphyrogenic, and that GF and HETGF caused only a 
relatively small but significant porphyrin accumulation, 
when added to cultures by either of the methods. ISOGF 
produced a marked increase in porphyrin levels when 
cultures were treated by the DMSO/medium method? however 
when added "directly" to the cells, dissolved in 
EtOH/ether, the response was much weaker. Inconsistencies 
were found between separate experiments in the degree of 
porphyrin accumulation and the porphyrin profiles in 
cultures treated "directly" with ISOGF, HETGF, and 
especially with GF. In addition, larger variations in 
porphyrin levels were generally found within individual 
experiments using the "direct addition" method, compared 
to the DMSO/medium method. These variations were probably 
a reflection of the incomplete solubility of the drugs in 
EtOH/ether, and the effective dose which the cells 
received. Treatment of cultures by the DMSO/medium method 
produced more reproducible results; a small difference in 
the extent of porphyrin accumulation was noted between 
experiments but since the degree of the response of the 
cultures to ISOGF and DDC, compared to the response to GF 
and HETGF was similar, the difference was suggested to be 
related to biological variation between different
154
Ta
bl
e 
5.
1 
Co
mp
ar
is
on
 
of
 
po
rp
hy
ri
n 
a
cc
um
ul
at
io
n 
in
 
cu
lt
ur
ed
 
ch
ic
k 
e
m
b
r
y
o
 
h
e
p
a
t
o
c
y
t
e
s
 
af
te
r 
-t
re
at
me
nt
 
wi
th
 
dr
ug
s 
by
 
2 
m
e
t
h
o
d
s
>1
H
b
o
0 4c 4c 4c 4c
p o r- O O O
-H rl 03 CO O'
0 • • • • •
rH rH OJ
0 <0 iH 03 03 in
b 0
0 TJ +1 -H -H -H -H
P *0
C4 0 OJ 00 rl CO OJ
in rH CO rl
cn 0 > • • . • •
£ 0 10 CO o OJ in
\  p 03 in O'- CO 03
rl P CO oo OJ
0
£
&
w
0
0 £
•P 0 4c 4c 4c 4c
P -P CO O' 00 in
>1 *0 Ip OJ O' 10
b  ® • • • •
04 £ 10 o * 03 03 o
p rH CO in OJ
0 0 rl rl
04 *P
-H -H -H -H -H
rl np
0 0 in 00 CO rl 03
b *0 rl OJ •H O' in
0 *0 . • • • •
Eh 0 CO 03 CO in
03 O' o in rl
O' o CO 00 OO
P 1—1 rl
P
P
0
0 £ *—«.
•P 0 rl
b *p 0
d  0 d p
0  p 0 b r>.
»0 b £ 0 o
TJ 0 0 00 «■—'
0 0 ip o o o
U  0 rl o oo
03 0 ----- IP oo — '
0 0 H 0 0 '—-
p u g 0 u O
p  ^ 0 p CO (p W
» 0  0 3 Jz; p H O W
0  0 .
0
(I) Q> 
b b
0 b
ro
03 
*0 
o
b •
u in
e a
o•H 
>lb
b o 
0
03 CO 
03 
0 0 
P *P
OJ
b 
U
<u
p 
-P
m *0 
0
<u 
»0 
»0 0
03 
0
b 0 
>ib o -P
o
■p 00 -H
cu
0 f0 ^
b 0 sc 
>
o h  
>i o 
p w 
b 0
e -h 0 *0
p
0
5
0
b
U
•rl
•s
0
P
P
■P
rl
0
O 
03 
0
03 -H 
0 *0
cj> cn 
P P 
p p
u'd *0
np 
0 0 
b P •H O 
Tf P-P
0 u b 
0 0 0 
•H 0 > 
b *0 P 
£ 0 
0 0 0 
0 0 b  
0
• ^
0 0 ^
• 03 
•H P b 
^  P O *0 
0 P
P b M 
• H  b  •
P -H -H 0 
>i £ o 0
b p  p  ?
f t C  0 O  rl
P O 0 0
O -P £ b >
C4b 0
0 0 0 i—I
H b b  0 o
0 p b  p  p
b  u b
O C b  b  0
E-i-p 0 0 o0 u
p 0 *b 
. 0 0 0  0
>0 b P £ >
O b  &  P -p
b  0 0 *p bb P «w o
0 b 0 0g 0 0 C4N 0 O 0
0 03 0 0
b r l  0 P
0 *0 0 P 
•P 0 > 0 0
p 0 £ bbi*P 0 b
o s b 0
p PE^b b
040 r l  b
C^b 0 *p0 0 . 0  >
d p 0 
0 0 P *0
b 0 b 0
b P bi'O P
0 0 0 0
>i^b 0 &b o £
—  b o
b  g =  0 u
0 0 0 0 
0 - p d  e 0
> *0 O -P 0
rl 0 b P b
o  e  b  0 £
0 (D ft
a x -p
*0 0 s 0 O
0  0  O
> 0 0  
•P 0  b  0  o
0 rl b  O  V
O rl C4
0 0 0 0 
p U -p -p ' *
155
preparations of the chick embryo hepatocytes. In the 
following studies, drugs were added to cultured chick 
hepatocytes by the DMSO/medium method.
5•4 Porphyrin accumulation following drug treatment by
the DMSO/medium method ”
The pattern of porphyrin accumulation in cultured 
chick hepatocyte cultures after treatment with the various 
drugs was compared quantitatively (Table 5.1) and 
qualitatively (Fig 5.3). In control cultures, 
protoporphyrin and coproporphyrin were present in similar 
amounts, with smaller quantities of uroporphyrin (about 
18%, see Fig 5.3a). 22 h incubation with DDC (10 pg/ml of
medium) increased porphyrins to about 10 times control 
levels, and protoporphyrin accounted for approximately 85% 
of the total porphyrins (Fig 5.3b). An identical 
porphyrin profile was obtained after treatment with ISOGF 
(30 /jg/ml of medium), that is protoporphyrin was again the 
main porphyrin component (Fig 5.3c) although the drug 
caused a more marked accumulation of porphyrins compared 
to DDC (see Table 5.1). GF and HETGF, at a concentration 
of 30 jig/ml of medium, increased porphyrin levels 
approximately 3-4 fold, and GF caused a small increase in 
the proportion of protoporphyrin (Fig 5.3d). In contrast, 
the porphyrin profile obtained after HETGF treatment was 
found to be similar to controls (Fig 5.3e).
Thus DDC and ISOGF are highly porphyrogenic in 
cultured hepatocytes, and lead to accumulation of
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predominantly protoporphyrin. GF and HETGF are less 
porphyrogenic in the iri vitro system; whereas GF induces 
protoporphyrin to a small extent, HETGF does not alter the 
porphyrin profile.
5•5 Porphyrin profiles produced by drugs in the presence 
of ALA
In cultured chick embryo liver cells, 2 factors 
contribute to the accumulation of porphyrins in response 
to drug treatment; one is an increase in ALA-S activity. 
This property is common to a large number of lipid-soluble 
drugs (De Matteis, 1978b) and leads to increased 
production of porphyrins. The porphyrins accumulate in 
excess when a drug also, a) promotes an increase in haem 
degradation (eg AIA), or b) produces a block in the 
activity of one of the intermediary enzymes of haem 
biosynthesis (eg. Fk inhibition by DDC). Both a) and b) 
result in a depletion of cellular haem, and therefore a 
diminished haem-mediated feedback inhibition of ALA-S.
Thus a further increase in the activity of this enzyme 
occurs. Consequently, in the case of b), the porphyrin 
substrate of the inhibited enzyme will tend to accumulate 
in greater amounts than the other porphyrins. Thus, a 
build up of porphyrins occurs because of 1) increased 
synthesis, and 2) increased haem turnover, or a block in 
porphyrin utilization.
Porphyrin biosynthesis can be increased in cultured 
hepatocytes by the addition of exogenous ALA (Sinclair et
158
al., 1983). Under these conditions the rate-limiting step 
(ALA-S) is bypassed, and the type of porphyrins 
acccumulating in response to a drug and ALA may be a 
better reflection of the state of the other enzymes of the 
pathway. Thus in an attempt to verify that protoporphyrin 
was the major porphyrin to accumulate in response to DDC, 
ISOGF and possibly GF, but not in response to HETGF, 
hepatocyte cultures were treated with these drugs in the 
presence of exogenous ALA (25 jig/ml of medium).
Addition of ALA to control cultures resulted in a 
massive porphyrin accumulation to levels about 60 times 
higher than control (Table 5.2). Protoporphyrin was found 
to be the major porphyrin to accumulate, accounting for 
75% of the total porphyrins, and most of the remainder was 
uroporphyrin (16%). Extensive porphyrin accumulation 
occurred after incubation of cultured hepatocytes with all 
4 drugs in the presence of ALA (Table 5.2). However, the 
drugs did not produce an increase in the proportion of 
protoporphyrin (results not shown).
When total porphyrins (expressed as pmol/well) 
produced in response to ALA were compared to the levels 
accumulating in response to ALA and a drug (Table 5.2) it 
was clear that a significantly lower amount of porphyrin 
was produced by the combined treatment. In addition, 
there was evidence of toxicity since a decreased protein 
content was found, most notably with DDC and HETGF. This 
probably resulted from the combined treatment as no
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significant reduction in protein was observed in cultures 
treated with addition of either ALA or a drug alone, 
except with HETGF, which caused a 17% loss of protein 
(result not shown). The occurrence of toxicity at an 
early stage of the incubation would explain the lower 
levels of porphyrins produced in response to the drugs and 
ALA, as compared with ALA controls. Obviously the results 
cannot be considered reliable if toxicity is evident.
Thus, to find an appropriate non-toxic dose level, the 
effects of lower concentrations of DDC and ISOGF 
co-administered with ALA were studied. A dose-dependent 
decrease in the total porphyrins produced was observed 
with both drugs (Fig 5.4), with no change in the porphyrin 
profiles, compared to ALA-treated controls. Some loss of 
protein was found with all concentrations of DDC (up to 
7.5 >ig/ml of medium), but not with ISOGF (up to 20 pg/ml 
of medium).
In conclusion when ALA was given together with the 
drugs under investigation, cytotoxicity became apparent, 
and the porphyrin profiles did not differ from controls 
treated with ALA alone; a possible explanation for the 
latter finding will be discussed later. Nevertheless, 
treatment of cultured hepatocytes with a drug alone was 
shown to cause a marked accumulation of protoporphyrin in 
response to DDC and ISOGF, and to a lesser degree with 
GF. This suggested that the drugs inhibited Fk activity 
and this aspect was therefore studied, as described below.
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Fig 5.4 The effect of various doses of DDC and ISOGF on 
porphyrin accumulation in cultured chick embryo 
hepatocytes in the presence of ALA
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Porphyrin accumulation was measured after 22 h incubation 
with varying concentrations of DDC (■) or ISOGF (•) in the 
presence of ALA (25 pg/ml of medium). DDC and ISOGF were 
added to cultures by the DMSO/medium method and ALA was 
added "directly", dissolved in saline. Each point 
represents a single determination, except for controls (o) 
receiving DMSO and ALA, where the data point represents 
the mean ± SD 'of 4 observations.
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5.6 The effect of drugs on FK activity
To examine the effect of DDC, ISOGF, GF and HETGF on 
FK activity of cultured chick hepatocytes, cells were 
grown in 10 cm plates, and drugs were added by the 
DMSO/medium method. Enzyme activity was measured in cell 
homogenates as described in the "Methods" section. Some 
loss of protein was encountered in these experiments 
compared to controls, in contrast with studies using 
hepatocytes grown in wells.
The effect of the drugs on FK activity after 22 h 
incubation is shown in Fig 5.5. DDC and ISOGF reduced 
Fk activity to about 16% and 30% of control values, 
respectively. GF and HETGF also inhibited FK activity but 
to a lesser extent. Previous work, when cultures were 
treated with drugs by the "direct addition" method, also 
showed that DDC and ISOGF were much more effective than 
either GF or HETGF at inhibiting FK activity (results not 
shown).
5.7 Discussion
The 2 major problems encountered during preliminary 
studies on the effect of GF and its analogues on the haem 
biosynthetic pathway of cultured chick embryo hepatocytes 
were a) the limited solubility of the drugs, especially 
GF, in various solvents, except for DMSO, which itself 
appeared to effect haem biosynthesis, and b) the variable 
response of the cultured hepatocytes to drug treatment 
between and within separate experiments. The latter can,
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Fig 5.5 The effect of drugs on FK activity of cultured 
chick embryo hepatocytes
100
75
•H>
•H■MO
< 1
O
4J
COO
S'S
50 -
25“
DDC ISOGF HETGF
FK activity was measured as described in the "Methods" 
section after 22 h incubation with DDC (10 ng/ml of 
medium), ISOGF, GF and HETGF (30 jag/ml of medium). Each 
drug was added by the DMSO/medium method. The results of 
FK activity have first been calculated on a mg protein 
basis, then expressed as a percent of control activity 
(5.04 nmol mesohaem formed per 30 min per mg protein); 
each bar represents the mean ± SD of 4 observations.
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in part, be attributed to individual cultures receiving a 
variable dose of these drugs because of their incomplete 
solubility in solvents, and also because these drugs often 
precipitated out of solution immediately after addition to 
the cultures. These problems were overcome by the 
development of an alternative method by which to dose 
cultures with drugs, and which markedly reduced the 
concentration of DMSO to which the cultures were exposed. 
The low concentration of DMSO was much less toxic as 
judged from cellular protein levels, porphyrin levels and 
profiles, which were all more reproducible between 
separate experiments.
ISOGF was found to be more porphyrogenic than GF in 
cultured chick embryo hepatocytes (Table 5). This finding 
is in accordance with previous results obtained vivo 
with mice (De Matteis and Gibbs, 1975). However, the 
analogue, HETGF, which is inactive as a porphyrogenic 
agent in mice, was found to increase porphyrin 
accumulation in cultured hepatocytes to a similar degree 
as GF. The pattern of porphyrin accumulation produced by 
HETGF was found to be very similar to that obtained for 
control cultures, and differed from those found in 
response to DDC and ISOGF, where a marked increase in the 
proportion of protoporphyrin occurred. A small increase 
in the percentage of protoporphyrin was also noted after 
the addition of GF to chick embryo liver cells, and 
suggested that HETGF caused accumulation of porphyrins by 
a different mechanism to. the other drugs. In an attempt
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to obtain additional evidence that the porphyrin profile 
produced in response to HETGF differed to those produced 
in response to DDC, ISOGF and GF, cultures were treated 
with each drug in the presence of ALA, to increase total 
porphyrin biosynthesis. No increase in the proportion of 
protoporphyrin over ALA-treated controls was found with 
any of the drugs. This observation is not at first sight 
consistent with the finding of predominantly 
protoporphyrin accumulation in response to DDC and ISOGF, 
in the absence of ALA, or with the fact that DDC is known 
to inhibit Fk activity.
The difficulty with using exogenous ALA to detect an 
enzyme defect in cultured chick embryo liver cells, as 
compared with rodent liver in vivo, is that the activity 
of Fk is low compared to the levels found in rat and mouse 
liver (see Cole et «al. , 1979, and also Fig 2.2 which shows 
the time course of Fk activity in cultured hepatocytes and 
mouse liver homogenate). In addition, the activity of Fk 
is low compared to the other enzymes of haem biosynthesis 
(except for ALA-S), and thus under conditions of increased 
porphyrin biosynthesis, this enzyme may become 
rate-limiting. The finding of predominantly 
protoporphyrin accumulation in control cultures treated 
with exogenous ALA strongly suggests that Fk of chick 
hepatocytes is already rate-limiting under these 
conditions where porphyrin levels are very high. 
Consequently, a block in Fk, produced by a drug 
co-administered with ALA may go unnoticed. Thus, failure
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to detect increased protoporphyrin accumulation after 
exogenous ALA and, for example, DDC, is not incompatible 
with a drug-induced inhibition of Fk activity. This 
interpretation obviously suggests the possibility that FK 
may be rate-limiting in cultures treated with DDC or 
ISOGF alone, since both drugs lead to accumulation of 
very large amounts of porphyrin (Table 5.1). However, 
dose-response experiments with DDC and ISOGF alone 
demonstrated that when lesser amounts of total porphyrins 
were produced (comparable to those accumulating in 
response to GF and HETGF), protoporphyrin was still the 
predominant porphyrin accumulating (results not shown). 
This would suggest that the preferential accumulation of 
protoporphyrin seen with the DDC and ISOGF alone is due to 
these drugs inhibiting FK. ALA load experiments are more 
appropriate where an intermediary enzyme (such as 
uroporphyrinogen decarboxylase) is inhibited (Sinclair 
et al., 1983) so that a porphyrin which does not normally 
accumulate from exogenous ALA (such as uroporphyrin) 
becomes more noticeable.
DDC has been reported to be a potent inhibitor of FK 
in cultured chick embryo liver cells (Cole et al., 1981a; 
1981b). This has now been confirmed and is in accordance 
with the finding that protoporphyrin was the major 
porphyrin accumulating in response to the drug. The 
porphyrin profile produced by ISOGF was identical to the 
pattern produced by DDC (Fig 5.3) and, as expected,
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ISOGF was also found to markedly reduce FK activity (Fig 
5.5). Enzyme activity was inhibited by a lesser degree 
following GF treatment, and this was in accordance with 
the smaller proportion of accumulated protoporphyrin 
found, compared to DDC and ISOGF. Thus ISOGF was found to 
be a more potent inhibitor than GF of chick hepatocyte FK 
activity in agreement with the relative inhibitory effects 
of the 2 drugs in mice in vivo (De Matteis and Gibbs, 
1975).
The results obtained with GF contrast to those 
reported by Cole et al^ . (1981b) where no inhibitory effect 
on FK activity was observed. In addition, these workers 
found that protoporphyrin was only a minor porphyrin (7%) 
to accumulate in response to the drug. It is suggested 
that the discrepancy between the present study and that of 
Cole et al. is a result of the different method used to 
administer GF to the cell cultures. This is supported by 
results obtained in preliminary studies when GF (dissolved 
in DMSO) was added "directly" to the culturd cells; a) 
porphyrin accumulation was approximately half that 
observed in later experiments using the new dosing method, 
b) the proportion of protoporphyrin was decreased, 
compared to controls, and c) very little inhibition of FK 
activity was demonstrated (results not shown). The 
greater accumulation of porphyrins, the increased 
proportion of protoporphyrin and the inhibition of FK 
activity found after treatment of cultures with GF by the 
new method suggests that the drug was more readily
metabolized since it was presented in a more soluble form.
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HETGF was also found to cause some loss of Fk activity 
in cultured chick hepatocytes. This was not anticipated 
on the basis of the porphyrin profiles obtained, and also 
because the drug is inactive in vivo as an inhibitor of 
mouse liver FK activity (De Matteis and Gibbs, 1975).
These contrasting effects of HETGF in vitro and in vivo, 
are probably attributable to a species difference, and it 
would be of interest to study the effect of HETGF in chick 
embryo liver iji vivo. Alternatively, there may be a 
difference between in vitro and in vivo systems in their 
"handling" of the drug; unlike intact animals, isolated 
chick hepatocytes cannot terminate the action of a drug by 
redistribution to other organs, or by excretion. An 
alternative explanation can be provided by the finding 
that HETGF caused some cell death of cultured chick 
hepatocytes, as judged from the cellular protein measured, 
and therefore very likely caused cell damage. The loss of 
Fk activity could be a reflection of generalized cell or 
mitochondrial damage.
In summary, the literature reports on the response 
of chick embryo liver cells in culture to DDC have been 
confirmed. Results have also been obtained to show that 
ISOGF is a more potent inhibitor of FK activity, and 
causes a greater accumulation of protoporphyrin than does 
GF in the in vitro culture system, in agreement with the 
findings reported in vivo in rodents.
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CHAPTER 6
Investigation of the green pigments produced in 
the liver by porphyria-inducing drugs
170
6.1 Introduction
The porphyrogenic compounds DDC, GF and ISOGF all 
promote the accumulation in the liver of rodents of an 
abnormal porphyrin (or green pigment) which has strong 
inhibitory activity towards mitochondrial Fk in vitro 
(Tephly et al., 1979; 1980; De Matteis and Gibbs, 1980).
Conclusive identification of the DDC pigment as 
N-MePP has been obtained by comparing its absorption, 
chromatographic, NMR and mass spectral properties with 
those of authentic N-MePP (De Matteis et al., 1980a; Ortiz 
de Montellano et a_l. , 1981c; Tephly et al., 1981), and by 
showing that the synthetic porphyrin was a powerful 
inhibitor of mitochondrial FK, in vitro (De Matteis et 
al., 1980a; Ortiz de Montellano et al.,1980).
Subsequent work has clarified the source of the
methyl group and of the porphyrin nucleus of N-MePP. De 
Matteis et al." (1981a) isolated the N-alkylated porphyrins 
from the livers of mice treated with a series of DDC
analogues which differed at the 4-alkyl group (see Fig
6.1). They showed, by mass spectroscopic characterization 
that the alkyl group of the N-alkylated porphyrins 
originated from the 4-alkyl group of the drug, and was 
donated intact. These workers obtained conclusive 
evidence for the transfer of the 4-alkyl group by 
administering the deuterated DDC analogue
(4-CD3~dihydropyridine) and isolating N-D3-protoporphyrin 
from mouse liver. Ortiz deMontellano et al. (1981) and 
Tephly et al. (1981a) reached a similar conclusion 
utilising HPLC and NMR spectroscopy.
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Fig 6.1 Structure of DDC and N-MePP
HcCoOOC COOCoHi
trio 
ii * •
CH CH3
CH = CH2
CH
COOHCOOH
The structure of DDC (a) showing in bold type the methyl 
group which is transferred to the haem prosthetic group of 
cytochrome P-450 to produce N-MePP (b).
The 4-ethyl and 4-propyl analogues of DDC have an ethyl 
and a propyl substituent, respectively, at the 4 
position, rather than a methyl grouping. These drugs give 
rise to the corresponding N-ethyl- and N-propyl-PP.
4 structural isomers of' N-MePP are possible; Ng,
Nc and Nq , depending on which pyrrole nitrogen is 
methylated. The one shown here is isomer N^, where 
vinyl-substituted ring A is N-methylated.
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The ability of DDC to cause a rapid loss of hepatic 
cytochrome P-450, and the concurrent conversion of 
prelabelled microsomal haem into unidentified products was 
noted some time ago (Wada et al_. , 1968; Abbritti and De 
Matteis, 1973). However it is only more recently that
studies have provided evidence which strongly suggests
v
that the porphyrin nucleus of N-MePP originates from the 
haem prosthetic group of cytochrome P-450. When DDC and 
its 4-ethyl and 4-propyl analogues (see Fig 6.1) were 
incubated with isolated rat hepatocytes and the effects of 
the drugs were compared, a correlation was found between 
loss of cytochrome P-450 and production of N-alkylated 
porphyrins. The yield of N-alkylated porphyrins could be 
increased by pretreatment of rats with phenobarbitone (De 
Matteis jet al., 1982a), whereas SKF 525A, an inhibitor of 
cytochrome P-450, had been shown to decrease the 
production of N-MePP after DDC (Tephly €it al., 1980). 
Destruction of cytochrome P-450 was observed only when 
NADPH, the cofactor essential for cytochrome P-450 drug 
metabolism was present (Marks et al., 1985). In addition, 
the activity of the liver haem pool from which the 
N-alkylated porphyrins originated was found to decay with 
a half-life similar to that reported in the literature for 
the rapidly turning over component of cytochrome P-450 (De 
Matteis et al.,1982a). The N-alkylated porphyrins were 
also shown to exhibit chiral properties, as expected from 
the alkylation reaction taking place on an enzymic 
template (Ortiz de Montellano et al., 1981c? De Matteis et 
al., 1982b).
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On the basis of the mechanism proposed for the 
oxidative aromatization of dihydropyridines in chemical 
systems (Loev and Snader, 1965), it has been suggested 
that N-MePP is produced in vivo by oxidative metabolism of 
DDC by cytochrome P-450, resulting in the transfer of the 
intact 4-methyl group of the drug to a pyrrole nitrogen of 
the prosthetic haem, and aromatization of the 
dihydropyridine (De Matteis et al., 1981a? Ortiz de 
Montellano et al., 1981a? Marks et al., 1985). This has 
been suggested to occur by a one-electron oxidation of the 
nitrogen of DDC to form a radical cation, which aromatizes 
by elimination of the 4-alkyl group as an alkyl radical 
(Augusto et al.,1982).
4 structural isomers of N-MePP are possible because 
of the asymmetric arrangement of the vinyl and propionate 
side chains in protoporphyrin IX, and these isomers depend 
on which of the 4 pyrrole nitrogens is N-alkylated (see 
Fig 6.1). The isomers of authentic N-MePP can be 
individually resolved by HPLC? it has been shown that all 
4 are formed biologically after DDC treatment, and that 
predominantly isomer NA is produced i^n vivo (Ortiz de 
Montellano et al., 1981c? Tephly et al., 1981).
The green pigments isolated from the liver of mice 
given either GF or ISOGF have been less extensively 
studied, but their spectral properties have been reported 
to closely resemble those of the DDC pigment (De Matteis 
and Gibbs, 1980). The pigments have now been purified and
174
their spectral and HPLC chromatographic characteristics 
found to be identical to those of authentic N-MePP. The 
isomeric composition of the N-MePP derived from these 2 
drugs has been determined and found to be similar to that 
reported for N-MePP accumulating after intraperitoneal DDC 
treatment (Ortiz de Montellano et al., 1981c) and, as is 
now found, to the N-MePP isolated after feeding of this 
latter drug to mice in their diet; each drug produces 
predominantly isomer in vivo.
An additional green pigment has been isolated from 
the liver of mice treated with GF. The pigment is present 
in much greater amounts than the N-MePP produced by this 
drug, and evidence has been obtained to suggest it is 
probably an N-monosubstituted porphyrin.
A pigment with inhibitory properties on Fk activity 
and similar spectral characteristics to N-MePP has 
previously been isolated, in trace amounts, from the 
livers of control mice (Tephly et al^., 1979? 1981) and 
determination of the isomeric composition of this 
"control" pigment has now been attempted.
6 .2 The green pigment accumulating after DDC treatment
6.2.1 Isolation and purification
Mice were given a porphyrogenic dose of DDC (100 
mg/kg, i.p.) and were killed 1.5 h later. The green 
pigment was extracted from liver homogenate with 
acetone/HCl and the dark brown extract purified by
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Sephadex LH-20 chromatography. Using acetone to elute, 3 
distinct bands became apparent on the column. The first, 
representing haem, was dark brown, and eluted in about 40 
ml. It was followed immediately by the green pigment 
band, eluting (in about 10 ml) before the small amount of 
protoporphyrin, which was pale brown. Fractions 
containing the green pigment were analysed spectrally and 
a clear soret absorption peak at 404 nm was detected.
Since the green pigment eluted so close to haem, it was, 
after defatting, further separated from haem by TLC using 
CHCl3/MeOH/HAc (40:10:3). A single green band with an R f  
valvue of 0.58 (similar to authentic N-MePP) was separated 
from the brown haem band ( R f  0.80). The TLC band 
displayed a scarlet-red fluorescence under UV light, which 
was the same as that of synthetic N-MePP, and differed 
from authentic protoporphyrin ( R f  0.70) which fluoresced a 
pink colour. The pigment was eluted from silica, 
converted to the more stable dimethyl ester, and the 
chloroform extract was chromatographed by TLC using a 
developing system of CHCl3/MeOH (20:3). No material 
remained at the origin, showing that conversion to the 
dimethyl ester was complete, since free acids are not 
mobile in the non-polar solvent system used. 2 green 
(red-fluorescing) bands migrated with R f  values (0.34 and 
0.31) close to that of authentic N-MePP ( R f  0.38). The 
bands were individually eluted from silica and subjected 
to HPLC.
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6.2.2 HPLC analysis of the DDC pigment(s)
Chromatography on a Nucleosil 5 HPLC column, as 
described in the "Methods" chapter, resolves authentic 
N-MePP dimethyl ester into 2 isomeric fractions (Fi and 
F2 ) with retention times 4.69 and 8.00 min. respectively 
(Fig 6.2a). Each fraction is known to contain 2 isomers 
(De Matteis et al.,1982b); F^ contains the 2 structural 
isomers where the vinyl substituted pyrrole ring is 
N-methylated (i.e. NA and Ng isomers). The 2 isomers 
where the propionic acid substituted rings are 
N-methylated (i.e. Nc and Np isomers) are found in 
fraction F2 .
The chromatographic behaviour on HPLC of the 2 green 
pigment methyl esters purified from the livers of 
DDC-treated mice were found to be identical. A typical 
HPLC trace is presented in Fig 6 .2b and shows that the DDC 
pigment(s) eluted as 2 peaks with retention times 
identical to isomeric fractions of authentic N-MePP. The 
major peak corresponded to fraction F^ of the standard, 
that is the fraction containing the and Ng isomers, 
and is in agreement with work reported in other 
laboratories (see Section 6.1).
Despite the observation that the extract from DDC- 
treated livers was resolved by TLC into 2 bands with 
slightly different Rf values, it was shown that both of 
these bands behaved identically to authentic N-MePP on 
HPLC. Since N-methyl porphyrins readily chelate zinc 
(Jackson and Dearden, 1973), it seemed possible that one
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Fig 6.2 HPLC analysis on Nucleosil 5 of authentic
N-MePP and the green pigment(s) isolated~from 
the liver of DDC-treated mice
(Na + n b)
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A Nucleosil 5 column eluted with DCM/MeOH/Conc NH3 
(50:50:0.1) was used for the analysis of the dimethyl 
esters of a) authentic N-MePP and b) the DDC green 
pigments. Both DDC-derTved pigments behaved identically 
on the system used.
Fraction F^ of authentic N-MePP (containing the N& and 
Nb isomers) and Fraction F2 (containing the Nc and 
Nd isomers) eluted with retention times of 4.69 and 8.00 
min, respectively.
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of the TLC green pigment bands was the zinc complex of 
N-MePP, and had been formed during the work-up procedure; 
removal of zinc would have occurred when the pigment was 
eluted from the silica plate with acidified methanol.
Comparison of the chromatographic behaviour on TLC of 
authentic N-MePP dimethyl ester with its zinc-complex 
demonstrated that the zinc-complex migrated further. This 
finding suggested that the DDC-derived TLC band with the 
higher R f  value (0.34) was the zinc-complex of N-MePP, 
and the band with R f  0.31 was N-MePP. it was noted that 
both of the DDC-derived bands migrated slower than 
authentic N-MePP, and this could have been due to the 
presence of lipid contamination.
In summary, intraperitoneal treatment of mice with 
DDC lead to accumulation in the liver of a green pigment 
which was identified as N-MePP by comparison of its 
chromatographic behaviour on Nucleosil 5 HPLC with that of 
authentic N-MePP. Predominantly vinyl-substituted, 
isomers were present, the relative proportions of the 4 
individual isomers was not determined, since the main 
purpose of these experiments was to demonstrate that the 
author could isolate and purify green pigments using 
published methods. However, more detailed results are 
presented later on the N-MePP isolated from the liver of 
mice fed DDC in the diet.
6 .3 The pigment in control liver
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6.3.1 Isolation and purification
The pigment present in the liver of control mice 
which have received no treatment was isolated by 
methylation of whole liver homogenate as described in the 
"Methods" chapter. The chloroform extract of the methyl 
esters was subjected to TLC using CHCl3/MeOH (20:3) as a 
developing system. Although no band with the red 
fluorescence of N-MePP was observed at this stage, a pale 
brown band with R f  0.31 was separated from haem. This 
band was eluted from silica, since its R f  value was 
identical to a green (red-fluorescing) band present in an 
extract from livers of mice treated with GF (purified at 
the same time) and which was shown to contain N-MePP (see 
later). The control band was eluted, dried, dissolved in 
chloroform and analysed spectrally. Although a Soret 
absorption peak at 400 nm was detected, the spectrum was 
weak and the absorption bands were not clearly defined. 
Nevertheless, the Soret absorption maximum indicated the 
presence of a porphyrin. The pigment was re-chromato­
graphed by TLC. In addition to a band with the same R f  
value as protoporphyrin, a rather wide band was just 
visible, and under UV light was found to consist of 2 
regions with the top part exhibiting weak fluorescence. 
This red-fluorescing region was marked with pencil and the 
R f  value was calculated to be identical to authentic 
N-MePP run at the same time.
6.3.2 HPLC analysis of the control pigment
After elution from silica, the control pigment was
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subjected to HPLC on Nucleosil 5. Fig 6.3 shows a 
relatively large amount of early-eluting material which 
had retention times similar to that of authentic 
protoporphyrin, and also 2 peaks eluting with retention 
times very close to those of isomeric fractions of 
authentic N-MePP. Thus retention times obtained for these 
2 fractions were 5.42 and 8.82 min, and those of authentic 
N-MePP run at the same time were 5.30 and 8.88 min 
respectively. Interestingly, the trace shows that 
fractions F^ and F2 were present in equal amounts, and 
this differs to the N-MePP produced by DDC treatment, 
where fraction Fi predominates (Fig 6.2b).
Attempts to isolate and purify the control pigment by 
the technique of acetone/HCl extraction followed by LH-20 
chromatography were unsuccessful, most probably due to the 
low levels of pigment normally present in the liver. The 
method whereby whole liver homogenate is methylated is 
preferable in this case because the dimethyl esters are 
formed prior to any purification steps, and these are more 
stable than the free acids which are purified by the LH-20 
method. However, due to the limited time available the 
control pigment could not be further studied and its 
identity as N-MePP cannot be considered as conclusively 
established.
6.4 The green pigment produced by GF treatment
6.4.1 Behaviour on Sephadex LH-20
Mice were given GF in the diet (1% w/w) for 3 or 7
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Fig 6.3 HPLC analysis on Nucleosil 5 of authentic
protoporphyrin and the pigment isolated from 
control mouse liver
<u
0 5 10
Retention time (min)
A Nucleosil 5 column eluted with DCM/MeOH/conc.NH3 
(50:50:0.1) was used for the analysis of the dimethyl 
esters of a) authentic protoporphyrin and b) the pigment 
isolated from control mouse liver. Authentic 
protoporphyrin eluted as 2 peaks with retention times of 
0.93 and 1.52 min. It is not known why this porphyrin was 
resolved into 2 peaks since it does not have structural 
isomers. The third and fourth peaks on trace b (control 
pigment) eluted with retention times very close to 
isomeric fractions of authentic N-MePP (see Section
6.3.2).
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days and the green pigment extracted from liver homogenate 
with acetone/HCl. On application to Sephadex LH-20 the 
liver extract showed 2 distinct green bands. The first, 
like the DDC green pigment peak, eluted immediately after 
haem in a small volume. The second broader green band 
followed shortly afterwards, with the elution volume 
varying between 25-40 ml in separate experiments. A large 
amount of protoporphyrin was present, as expected, since 
GF is highly porphyrogenic, and some of this co-eluted 
with the trailing end of the second green pigment peak. 
Fractions (3.3 ml) were collected immediately after 
elution of the majority of the haem, and the absorption 
between 460 and 360 nm examined. The elution profile of 
the GF-derived green pigments is shown in Fig 6.4. The 
first fraction collected usually contained both haem and 
the majority of the green pigment, as estimated from the 
absorption units of the Soret. The folowing fractions 
contained only green pigment and exhibited a Soret 
absorption peak in the region of 410-419 nm. The most 
intensely coloured fractions were scanned from 700-360 
nm. A typical absorption spectrum is presented in Fig 
6.5. The spectra obtained were characteristic of a 
dication, exhibiting 2 absorption bands in addition to the 
Soret absorption peak. Due to the similarity of the 
spectra, fractions from Sephadex LH-20 comprising the 2 
green pigment peaks were pooled for purification.
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6.4.2 TLC purification of the GF green pigment
Sephadex LH-20 fractions containing the crude pigment 
were defatted and further separated from haem and 
protoporphyrin by TLC of the free acid, as described in 
the "Methods" chapter. 2 green bands were apparent on the 
plate; under UV light they showed red fluorescence 
characteristic of N-alkylated porphyrins. R f  values were 
about 0.57 and 0.47, although there was some variation 
between separate experiments, possibly owing to lipid 
contamination. The 2 green TLC bands were individually 
eluted from the silica, converted to the dimethyl esters 
and extracted into chloroform. On scanning in the visible 
region both of the TLC bands were found to have a neutral 
spectrum of the aetiotype, typical of a porphyrin free 
base (Fig 6 .6 ). The absorption maxima of the Soret and 
the 4 absorption bands of the 2 TLC samples were almost 
identical. In addition the shape of the spectra, and the 
absorption maxima were very similar to those obtained for 
authentic N-MePP (Fig 6.7).
The observation that the GF-derived pigment was 
resolved by TLC into 2 green bands, which were found to 
have identical absorption spectra, suggested that the 
faster migrating TLC band was a zinc-complex, as had been 
found for DDC-derived N-MePP.
Since the 2 TLC bands exhibited identical spectral 
characteristics they were pooled for HPLC analysis. In 
some experiments the green pigment bands were not clearly 
resolved from haem and protoporphyrin when chromatographed
186
Fi
g 
6.
6 
Ne
ut
ra
l 
ab
so
rp
ti
on
 
sp
ec
tr
um
 
of
 
th
e 
di
me
th
yl
 
es
te
r 
of
 
th
e 
gr
ee
n 
p
i
g
m
e
n
t
s
 
pr
od
uc
ed
 
fr
om
 
G
F
omvo
oo
vo
omm
o
oo
187
Wa
ve
le
ng
th
 
(n
m)
Legend to Fig 6.6
Fractions from LH-20 chromatography were combined and 
purified by TLC. The 2 green TLC pigments were eluted, 
converted to the dimethyl esters and then scanned from 
700-360 nm (dissolved in CHCI3 ).
The spectra were aetiotype; an aetiotype spectrum is 
characterized by 4 absorption bands, in addition to the 
intense Soret absorption band. The intensity of the bands 
is always Soret>IV>III>11>1, and another small band (la) 
is sometimes found between bands I and II.
Absorption maxima of the 2 green TLC pigments were as 
follows:
Pigment 1 (Rf 0.57 on TLC); 417, 511, 544, 596, 626, 654 
Pigment 2 (Rf 0.47 on TLC); 417, 510,. 543, 597, 626, 654
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by TLC as the free acid; in these cases it was necessary 
to re-chromatograph the pigment bands after conversion to 
the dimethyl ester, as described in the "Methods" chapter.
6.4.3 HPLC analysis of the GF green pigment on 
Nucleosil 5
A purified preparation of the GF pigment 
dimethyl ester was compared chromatographically on 
Nucleosil 5 HPLC with authentic protoporphyrin and 
N-MePP. The pigment was resolved into 4 distinct 
components on this system (Fig 6 .8 ). The first and second 
peaks (in order of elution) represented the majority of 
the isolated pigment (about 90%) and had retention times 
(1.03 and 1.53 min) which were similar to those of 
authentic protoporphyrin (See Fig 6.3). The third and 
fourth peaks eluted with retention times identical to 
isomeric fractions of N-MePP. The peak corresponding to 
the Na and Nb isomers of N-MePP was predominant, and 
in this respect the picture was similar to that observed 
for the N-MePP isolated after DDC treatment (see Section
6.2.2). The third and fourth peaks were collected from 
the HPLC eluent and combined. The first and the second 
peaks were individually collected. The three fractions 
thus obtained were evaporated to dryness, and taken for 
spectral analysis. As will be shown in the following 
section, the major peak eluting (with Rf 1.53 min) from 
Nucleosil 5 HPLC, exhibited spectral characteristics of an 
N-monosubstituted porphyrin. The possibility that this 
pigment (termed pigment X) was a porphyrin, possibly
Fig 6.8 HPLC analysis on Nucleosil 5 of the green
pigment isolated from the liver of GF-treated 
mice
s
d
4J
d
<uo
d
d
rO
u
ocorG<
0 5 10
Retention time (min)
A Nucleosil 5 column eluted with DCM/MeOH/conc. NH3 
(50:50:0.1) was used for the analysis of the dimethyl 
ester of the GF green pigment. The pigment was resolved 
into 4 components with retention times (in order of 
elution) of 1.03, 1.53, 4.76 and 8.00 min., respectively. 
Note the retention times of the third and fourth peaks are 
identical to those of isomeric fractions of authentic 
N-MePP (see Fig 6.2).
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N-MePP, conjugated with some other moiety, for example 
glutathione or glucuronic acid, was considered. However, 
comparison of the HPLC elution profile of pigment X before 
and after either acidic or alkaline hydrolysis (both 
followed by re-methylation of the carboxylate groups) did 
not support this, since the profiles were found to be 
identical. An alternative possibility considered was that 
N-MePP was converted to pigment X under certain 
conditions. No increase was found in the amount of 
pigment X at the expense of N-MePP, when the dimethyl 
esters were stored on the bench, or alternatively at -70°C 
for up to 2 months. However, the possibility that a 
chemical reaction had occurred during the work-up 
procedure cannot be discounted.
6.4.4 Spectral studies on Nucleosil 5 HPLC fractions
6 .4.4.1 The early eluting HPLC component
Attempts to obtain a neutral spectrum of the peak 
which eluted from Nucelosil 5 with a retention time of
1.03 min were not very successful, due to the small 
quantity of material available. The spectrum was very 
weak and the absorption bands were not clearly 
discernable. Nevertheless, a Soret absorption peak at 
407 nm was noted. This suggested its identity as 
protoporphyrin since an identical value was obtained for 
the authentic porphyrin (see Table 6.1).
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6.4.4.2 The GF pigment which eluted as N-MePP
Initially, the amount of the minor GF-derived green 
pigment collected from the HPLC eluent was insufficient 
for spectral studies. However, by pooling the pigment 
obtained from a number of experiments it was possible to 
obtain a neutral spectrum. Fig 6.9 shows the spectrum was 
of the aetiotype type. All absorption maxima were 
shifted towards the red, as compared with those of 
authentic protoporphyrin (Table 6.1). There was very good 
agreement of the absorption maxima with those of authentic 
N-MePP, and the relative intensity of the absorption bands 
was also very similar (compare Figs 6.7 and 6.9).
The spectral evidence and the elution profile on 
Neucleosil 5 HPLC strongly suggested the minor GF-derived 
pigment was N-MePP and additional evidence for this was 
obtained by further HPLC analysis on a Partisil 10-Pac 
column (see later).
6 .4.4.3 The major GF pigment eluted from Nucleosil 5
a) Neutral spectrum
The major pigment (pigment X) which eluted from 
Nucleosil 5 HPLC with a retention time of 1.53 min was 
found to have a neutral spectrum of the aetiotype.
Despite the identical HPLC retention time of pigment X to 
one of the peaks of authentic protoporphyrin, the spectrum 
exhibited by the pigment differed from that of 
protoporphyrin in that all absorption maxima were shifted 
towards longer wavelengths (Table 6.1). These so called 
bathochromic shifts are characteristic of N-alkylated
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porphyrins, and were similar (but not identical) to those 
exhibited by authentic N-MePP.
b) Dication spectrum
The absorption maxima of the dication spectra of 
authentic protoporphyrin and N-MePP are shown in Table 
6.2. The spectrum of the latter was obtained only after 
addition, to the dimethyl ester in chloroform, of 5-fold 
the concentration of trifluoroacetic acid (TFA) usually 
required for N-alkylated porphyrins. Attempts to obtain a 
dication spectrum for pigment X were not successful. A 
monocation spectrum was still evident even when TFA was 
added to a final concentration higher than used for 
authentic N-MePP. This suggested that like N-methylated 
porphyrins, pigment X was more basic than protoporphyrin.
c) Zinc-complex spectrum
Fig 6.10 shows the absorption spectra of the zinc 
complexes of authentic protoporphyrin and N-MePP, and 
highlights the difference between the 2 porphyrins. On 
incorporation of zinc into protoporphyrin there was no 
significant shift of the Soret maximum (as compared with 
the neutral spectrum), and 2 absorption bands, denoted 
and P, were present. These absorption bands are typical 
of a metalloporphyrin. The zinc-complex spectrum of 
N-MePP differed from that of protoporphyrin; the Soret 
band underwent a bathochromic shift, as compared with the 
free porphyrin, from 419 to 431 nm (see also Table 6.2).
In addition to the and P absorption bands, a minor 
absorption band («') was present about 200 nm towards the 
red from the Soret maximum. These spectral
196
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characteristics are common to N-mono-substituted 
porphyrins (De Matteis and Gibbs, 1980), and were found to 
be shared by pigment X (Table 6.2). Absorption maxima of 
the Soret and the absorption bands of the zinc-complex of 
pigment X were similar, but not identical, to those of 
N-MePP, as had been found for the neutral spectrum.
In conclusion, these studies have provided evidence 
for 2 abnormal green pigments in the liver of mice treated 
with GF; one possesses the characteristic HPLC properties 
of N-MePP (mostly vinyl-substituted isomers), and 
exhibits a neutral spectrum identical to that of authentic 
standard; the other pigment, present in much greater 
amounts, would appear to be also N-monosubstituted, but 
chromatographic and spectral properties are distinct from 
those of N-MePP. For further characterization, the 2 
pigments were analysed on a Partisil 10-PAC HPLC column, 
as described in the following section.
6.4.5 HPLC analysis of the GF pigments on Partisil 10- 
PAC
Authentic N-MePP was resolved into its 4 structural 
isomers by chromatography on a Partisil 10-PAC HPLC column 
(Fig 6.11a). The isomers eluted in the following order 
with retention times given in parenthesis: NB (5.75 
min), (6.30 min), (11.56 min), Np (12.93 min),
the suffixes A-D indicating the pyrrole ring which is 
N-methylated.
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Fig 6.11 HPLC analysis on Partisil 10-PAC of authentic 
N-MePP and the N-MePPisolated from the liver 
of GF-treated mice
e
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Retention time (rain)
A Partisil 10-PAC column eluted with hexane/tetrahydro- 
furan/MeOH (97:97:6) was used to resolve the 4 structural 
isomers of the dimethyl ester of authentic N-MePP(a). The 
isomers eluted in the following order (retention times 
(min) in parenthesis): Nq (5.75), (6.50), Nq
(11.56), Nd (12.93).
The elution profile of the N-MePP (dimethyl ester) 
isolated from .the liver of GF-treated mice is shown in 
(b). Note that all 4 isomers are present, with isomer 
Na  predominating. A very similar elution profile was 
obtained for ISOFG-derived N-MePP (see also Table 6.3).
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The isomeric composition of the N-MePP isolated from 
the livers of GF-treated mice is shown in Fig 6.11(b).
All 4 structural isomers were demonstrated, with isomer 
clearly predominating. The and Nq isomers 
were present in small and similar amounts, and only a 
trace of the NB isomer was demonstrated (see also Table 
6.3).
Pigment X was resolved into 4 components when 
chromatographed on Partisil 10-PAC, with retention times 
of 2.61, 3.3, 4.61 and 5.54 min respectively (Fig 6.12). 
The first (minor) peak was identified as protoporphyrin by 
comparison with the chromatographic behaviour of the 
authentic porphyrin on the HPLC system. The third peak 
(Rt = 4.61 min) represented the majority of the isolated 
material, and together with the fourth peak (Rt = 5.54 
min) accounted for more than 90% of the area under the 
HPLC curve. It was noted that these 2 components both 
eluted with shorter retention times than any of the 
isomers of authentic N-MePP.
The third and fourth peaks were collected together 
from the HPLC eluent, and analysed spectrally. The 
neutral and zinc-complex spectra exhibited absorption 
maxima almost identical to those given in Tables 6.1 and
6.2 for unresolved pigment X. This finding was not 
surprising since the contribution by protoporphyrin to the 
spectrum of unresolved pigment X would have been small.
In conclusion, these HPLC studies provided additional 
evidence for the identity of one of the GF-derived
201
Fig 6.12 HPLC analysis on Partisil 10-PAC of pigment X 
isolated from the liver of GF-treated mice
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A Partisil 10-PAC column eluted with hexane/tetrahydro- 
furan/MeOH (97:97:6) was used for the analysis of the 
dimethyl ester of pigment X isolated from the liver of 
GF-treated mice. The green pigment was resolved into 4 
components with retention times of 2.61, 3.30, 4.61 and 
5.54 min, respectively. Note that retnetion times of all 
peaks are shorter than those of authentic N-MePP on this 
system (see Fig 6.11).
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pigments as N-MePP, and demonstrated that predominantly 
isomer NA is produced. The elution profile of pigment X 
on Partisil 10-PAC was shown to be distinct from that of 
N-MePP, in agreement with its spectral properties.
6.4.6 Distribution of the 2 GF green pigments in 
fractions from LH-20 chromatography
When a liver extract from GF-treated mice was 
chromatographed on a Sephadex LH-20 column, 2 green bands 
were eluted (see Section 6.4.1). These bands were 
combined for purification and the results described in the 
previous sections revealed that 2 abnormal pigments were 
present, that is, N-MePP and pigment X. It was of 
interest to determine the distribution of these pigments 
in the 2 LH-20 bands, and also to determine whether the 
pigments could be separated from each other at an early 
stage of the purification. Thus LH-20 fractions 
comprising the 2 green pigment peaks were purified 
individually. It was found that each contained N-MePP and 
pigment X, although the relative proportion of the total 
N-MePP and of total pigment X in each of the LH-20 bands 
varied between experiments. Pigment X was always found in 
much greater amounts than N-MePP in both LH-20 bands. In 
general, the abnormal pigments could only be individually 
resolved by HPLC on a Nucleosil 5 column, and not at an 
earlier stage, such as TLC.
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6.4.7 A study on the effect of the 2 GF green pigments
on FK activity ’
Authentic N-MePP and the 2 green pigments purified 
from the liver of GF-treated mice were examined for their 
ability to inhibit FK activity jji vitro. The samples were 
first converted to the free acid as described in the 
"Methods" chapter.
The inhibition caused by various amounts of authentic 
N-MePP on FK activity of mouse liver homogenate is shown 
in Fig 6.13. It was calculated that 50% loss of enzyme 
activity would be obtained, under standard assay 
conditions, with a concentration of 10.82 nM N-MePP. This 
is quite close to the value (8.5 nM) reported by De 
Matteis et al. (1980c).
The GF-derived N-MePP was found to inhibit FK 
activity; 37% inhibition of enzyme activity was 
demonstrated at a concentration of 27 nM N-MePP. In view 
of the fact that only one concentration was studied (due 
to the limited amount purified), and the experiment 
carried out only once, it is not possible to calculate 
accurately the specific inhibitory activity of the 
GF-derived N-MePP.
The inhibitory activity of pigment X on the FK enzyme 
was studied over a range of concentrations. The amount of 
pigment X was calculated from the Soret absorbance of the 
dimethyl ester, and expressed as nmol N-MePP equivalents. 
The pigment was found to be inactive as an inhibitor of FK 
activity, even at a concentration as high as 166 nM.
205
Fig 6,13 Inhibition of mouse liver homogenate FK 
activity produced by authentic N-MePP 
in vitro
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Livers homogenate FK activity was measured as described in 
the "Methods" chapter in the presence of varying 
concentrations of N-MePP. N-Mepp (free carboxylate 
porphyrin, dissolved in ethanol) was added to the reaction 
mixture in the Thunberg tube prior to anaerobis. After 5 
min. incubation at 37°C, the homogenate was tipped into 
the reaction mixture and incubations carried out for 10 
min. Each point represents a single determination.
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Thus, this study indicated that only one of the 
abnormal pigments produced by GF-treatment, that is 
N-MePP, has an inhibitory effect on FK activity.
Additional studies are required to confirm this finding, 
and to determine the specific inhibitory activity of the 
GF-derived N-MePP, since it would be of interest to 
compare this to values reported in the literature for the 
N-MePP produced after DDC treatment.
6 .5 The green pigment produced by DDC in the diet
6.5.1 Purification and spectral analysis
The studies described earlier in this chapter 
demonstrated that N-MePP accumulates in the livers of mice 
treated intraperitoneally with DDC, and after 
adminstration of GF in the diet. The finding in the 
latter case, of an additional abnormal porphyrin (pigment 
X) which possessed the characteristic spectral properties 
of an N-monosubstituted porphyrin, suggested that pigment 
X may be N-MePP which had be modified in vivo in some 
way. It was possible that prolonged exposure to GF and 
the different route of administration were involved, and 
that treatment of mice with DDC in the same manner may 
also give rise to pigment X. This possibility was 
investigated by feeding DDC in the diet (0.1% w/w) to mice 
for 3 or 7 days. The pigment accumulating in the liver, 
was isolated by LH-20 chromatography and purified by TLC, 
first as the free acid, and then as the dimethyl ester.
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In both chromatographic runs a single green band 
(exhibiting red fluorescence under UV light) was found, 
with an Rf value very similar to authentic N-MePP.
The DDC-pigment exhibited a neutral aetiotype 
absorption spectrum. There was very good agreement of the 
absorption maxima of the Soret and the absortion bands 
with those of authentic N-MePP (Table 6.1). Thus, 
chromatographic behaviour on TLC, and the spectral 
characteristics strongly suggested the DDC pigment was 
N-MePP.
6.5.2 HPLC studies on the DDC pigment
A purified preparation of the dimethyl ester of DDC 
pigment was resolved into 2 peaks when chromatographed on 
a Nucleosil 5 HPLC column, with retention times identical 
to those of the 2 isomeric fractions of authentic N-MePP. 
No early eluting material was apparent (results not 
shown). The fraction corresponding to the 
vinyl-substituted isomers of N-MePP (that is, NA and 
Ng) was predominant. Both fractions were collected from 
the HPLC eluent and combined. The isomeric composition of 
the DDC-derived N-MePP was obtained by HPLC chromatography 
on a Partisil 10-PAC column. All 4 structural isomers 
were demonstrated (Fig 6.14 ) and the percentage isomeric 
composition (calculated from the area integrated under the 
curve) were as follows; NA (78%), Ng (5%), Nq (13%)
Np (4%). The isomeric profiles of hepatic N-MePP from 
DDC-fed male and female mice were found to be identical,
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Fig 6.14 HPLC analysis on Partisil 10-PAC of the
N-MePP isolated from the liver of mice fed 
DDC in the diet
sc
0 5 10 15 20
Retention time (min)
Mice were fed DDC in the diet (0.1%, w/w) for 7 days. 
N-MePP, isolated from the liver, was purified as the 
dimethyl ester and the isomeric composition determined by 
chromatography on a Partisil 10-PAC column as described in 
the "Methods" chapter. The Ng, N&, Nq and Np 
isomers of DDC-derived N-MePP eluted with retention times 
of 6.01, 6.79, 12.71 and 14.51 min, respectively.
Retention times of authentic N-MePP isomers run at the 
same time were 6.09, 6 .86, 12.79 and 14.69 min., 
respectively.
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and in good agreement to that reported for the N-MePP 
which has been isolated from the livers of rats treated 
with DDC intraperitoneally (Ortiz de Montellano, 1981c).
It was noted that the profile of DDC-derived N-MePP 
differed to that of N-MePP isolated after GF treatment; 
here, the N q and Np isomers were found to be present 
in similar amounts, whereas more of the Nc isomer was 
produced after DDC treatment (see Table 6.3).
In summary, spectral and chromatographic studies have 
provided evidence that only N-MePP accumulates in the 
liver of mice following feeding of DDC, as has been found 
after intraperitoneal administration of this drug (Section 
6.2.2). This finding would suggest that pigment X which 
accumulates after GF-feeding, is not produced solely 
because of either a prolonged exposure to the drug, or 
because of the route of administration, but that the GF 
structure itself is important for its formation. If this 
interpretation is correct, pigment X would be expected to 
accumulate in mouse liver after feeding of the GF 
analogue, ISOGF, and the findings with the latter drug 
will now be described.
6.6 The green pigment produced by ISOGF treatment
6.6.1 Isolation and purification
Mice were given ISOGF in the diet at a concentation 
of 1% (w/w) for 3 days. This treatment produced hepatic 
porphyria as evidenced by the marked inhibition of Fk
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activity, accumulation of porphyrins (mainly 
protoporphyrin) and elevation of ALA-S activity (results 
not shown). The green pigment was isolated by LH-20 
chromatography, and separated from haem and protoporphyrin 
by TLC of the free acid. 2 green (red-fluorescing) bands 
were observed on the TLC plate; these were eluted together 
and rechromatographed by TLC after conversion to the 
dimethyl ester. There was a single green 
(red-fluorescing) band with an Rf value identical to 
authentic N-MePP run at the same time, and this was taken 
for HPLC studies.
6.6.2 HPLC studies on the ISOGF pigment
The ISOGF pigment (dimethyl ester) was resolved into 
2 peaks when chromatographed on a Nucleosil 5 HPLC 
column. No early eluting material was observed. The 
retention times of the 2 peaks were identical to those of 
isomeric fractions of authentic N-MePP, and the fraction 
containing the vinyl-substituted isomers was predominant 
(results not shown). The 2 peaks were collected from the 
HPLC eluent and combined and the individual isomers of 
ISOGF-derived N-MePP were resolved by HPLC on a 
Partisil 10-PAC column. The elution profile was almost 
identical to that of GF-derived N-MePP, with all 4 
possible structural isomers present (see Fig 6.11). The 
percentage isomeric composition was also found to be 
similar to that obtained for GF-derived N-MePP, that is 
isomer N^ was clearly predominant and the N^ and Np 
isomers were present in similar amounts (see Table 6.3).
In summary, ISOGF treatment lead to accumulation of 
one abnormal green pigment in the liver of mice, that is 
N-MePP. This finding, together with the results obtained 
with DDC, suggests that the production of pigment X is 
peculiar to GF.
6.7 Discussion
The occurrence of N-MePP in the livers of mice 
treated with GF and ISOGF in the diet has been confirmed 
by comparison of the absorption spectrum, and 
chromatographic behaviour on TLC and HPLC and also by 
showing that the GF-derived N-MePP inhibits FK activity, 
as first reported by De Matteis and Gibbs (1980). In 
addition, the current work has shown that this abnormal 
porphyrin accumulates in the liver of both male and female 
mice after feeding of DDC or GF.
The isomeric composition of the N-MePP produced in 
vivo by these 3 drugs has now been studied. In each case 
all 4 possible structural isomers were demonstrated, with 
isomer (where the methyl group is on the 
vinyl-substituted pyrrole ring A) clearly predominant. 
Small amounts of the Nc and Np isomers were found, and 
only traces of the isomer Ng. A similar isomeric 
profile has been reported in rats pretreated with 
phenobarbitone and then injected with DDC (Ortiz de 
Montellano et al., 1981c). A difference was noted between 
the N-MePP isolated after different drug treatment in the 
relative amounts of the N q and Np isomers; whereas
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these 2 isomers were quantitatively similar after GF or 
ISOGF treatment, the Nc isomer was found to be present 
in an amount 2-3 times greater than the Np isomer 
following DDC treatment (Table 6.3). The significance of 
this finding is not clear at present. Nevertheless, all 3 
drugs produce primarily the same N-MePP isomer. De 
Matteis et al. (1983) have shown, by the use of chemical 
inducers of cytochrome P-450, that the isomeric 
composition of N-ethylPP (derived from 4-ethyl DDC) 
depends on the type of cytochrome P-450 predominating at 
the time of treatment, and that the main PB-inducible type 
of cytochrome P-450 produces preferentially isomer N^.
The finding of predominantly isomer of N-MePP with 
GF, ISOGF and DDC would perhaps suggest that the drugs are 
preferentially metabolized by this cytochrome rather than, 
for example, cytochrome P-448.
The identification of N-MePP in the livers of 
GF-treated mice would suggest that, as has been found for 
DDC-derived N-MePP, the methyl group originates from the 
drug. Although it is not known which methyl group of GF 
is donated, it is possible to speculate by considering the 
action and the structure of the 2 analogues of this drug; 
since N-MePP accumulation has now been demonstrated 
following ISOGF treatment, but HETGF (the non- 
porphyrogenic GF analogue) does not produce green pigments 
in vivo (De Matteis and Gibbs, 1980), the methyl group of 
N-MePP could conceivably originate from 6 '-methyl group of 
the GF (see Fig 5.1 for structures of the drugs). The
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inability of HETGF to produce N-MePP could be explained by 
the bulky -SCH2CH2OH substituent sterically hindering 
metabolism of the proposed methyl group. Conclusive 
evidence that the alkyl group of N-MePP originates from 
the 6 '-methyl substituent of GF should be obtained by 
using GF labelled with deuterium in this position. The 
synthesis of CD3 selectively-labelled GF is currently 
being undertaken by Dr. Sainsbury of Bath University.
The occurrence of N-MePP in the livers of mice which 
have received no drug treatment has been confirmed and the 
2 isomeric pairs (N^ and Ng? Nq and Np) appear to 
be present in approximately equal amounts. This finding 
would suggest that N-MePP isolated after GF treatment 
results from metabolism of the drug rather than by an 
alternative, but less likely, possibility that GF may 
merely accelerate a normally occurring pathway of 
production of N-MePP (a pathway that is independent of 
drug administration). If the latter occurred, the 
isomeric profiles of control and GF-derived N-MePP would 
be expected to be the same, and this is not found. The 
significance of this control pigment, and the source of 
the methyl group is not yet known, although an endogenous 
methyl donor or xenobiotics present in food or air have 
been suggested (Tephly et a]L., 1981). The latter would 
appear to be more likely since the control pigment has 
been reported only from 2 laboratories.
Comparison of the amount of N-MePP isolated from the 
liver after treatment with GF or DDC showed that, for
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each drug, levels of N-MePP found in male and female mice 
were quantitatively similar (Table 6.4), suggesting a 
similar rate of production in the 2 sexes. The yield of 
N-MePP following GF feeding was less than that obtained 
for either ISOGF or DDC fed in the diet for the same
period of time (3 days) and the finding of higher levels
after further treatment with GF or DDC shows that 
accumulation of N-MePP is dependent on the dose of the 
drug. However, the greatest yield was obtained from 
DDC-treated mice, and since this drug was administered at 
a concentration 10-fold less than GF and ISOGF, other 
factors are obviously involved, and the different levels 
of N-MePP may reflect a difference between the drugs in 
the rate of absorption from the gut, or a difference in
the rate of metabolism.
In addition to N-MePP, a second green pigment has now 
been isolated from the livers of mice following GF 
feeding. This abnormal porphyrin, pigment X, was found in 
both males and females, and mice of 3 strains in amounts 
about 10-15 times greater than N-MePP. It is possible 
that pigment X has not previously been demonstrated since 
other workers have used the method whereby liver 
homogenate is methylated to isolate the GF-green pigment, 
whereas the technique of LH-20 chromatography was used in 
the present experiments.
The following lines of evidence suggest that pigment 
X is an N-monosubstituted porphyrin.
1) It was isolated under conditions which lead to
isolation of this type of porphyrin.
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2) It exhibited a red-fluorescence under UV light.
3) Absorption spectra exhibited the characteristics of
N-monosubstituted porphyrins.
The neutral absorption spectrum of the pigment, 
(purified by HPLC) was aetiotype, and all absorption 
maxima were shifted towards the red compared with the 
spectrum of protoporphyrin (Table 6.1). Bathochromic 
shifts can be caused by three types of modifications to 
the porphyrin nucleus: a) substitution at the bridge 
meso-carbon atom, b) the presence of electron-withdrawing 
substituents at the p-positions of the pyrrole rings, and 
c) substitution at the pyrrole ring nitrogen. In all 
cases, the spectrum is of the aetiotype, but with the 
first 2 types of substitutions, all absorption maxima tend 
to be shifted towards a longer wavelength by a similar 
extent (see De Matteis and Cantoni, 1979). The order 
of intensity of the bathochromic shifts exhibited by 
N-alkylated porphyrins is I>II>Soret>III>IV, and this was 
also found for pigment X, suggesting it has a substituent 
at the pyrrole nitrogen.
In addition, pigment X, like N-alkylated porphyrins 
(Jackson and Dearden, 1973) is very basic, as shown by 
attempts to form the dication species, and this is 
evidence against the presence of electron-withdrawing side 
chains on the protoporphyrin nucleus, since this would 
probably result in a decreased basicity of the pyrrole 
nitrogens (Falk, 1964). The zinc complex spectrum of 
pigment X provided further evidence to its identity as an
217
N-alkylated porphyrin since it exhibited the 
characteristic shift of the Soret maximum, and the 
additional absorption band, a' (Table 6.2).
The bathochromic shifts of the neutral and zinc 
complex spectra were very similar, but not identical, to 
those exhibited by authentic N-MePP (Tables 6.1 and 6.2) 
and suggested that the substituent at the pyrrole nitrogen 
is small, as is the case with N-MePP.
Further evidence that pigment X is an 
N-monosubstituted protoporphyrin could be obtained by 
Cu2+-catalysed dealkylation of the methyl ester (De 
Matteis et al., 1985) and by following the spectral 
changes. An N-substituent would be displaced and the 
spectrum of Cu-protoporphyrin would be obtained. More 
conclusive evidence would, of course, be obtained from 
mass and NMR spectroscopic studies.
In conclusion, these studies have provided 
chromatographic and spectral evidence for the 
accumulation of N-MePP in the livef of mice treated with 
GF, ISOGF and DDC. Each drug treatment produced 
predominantly the same isomer of N-MePP, that is the one 
where the methyl group is on the vinyl-substituted pyrrole 
ring A. Evidence has been presented to show that GF 
treatment gives rise to a second abnormal pigment in the 
liver of mice. The identity of pigment X could not be 
conclusively established, but chromatographic and spectral 
properties strongly suggest it is an N-alkylated 
porphyrin.
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CHAPTER 7
General Discussion
)
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7.1 Strain and sex differences in the response of mice 
to drugs which induce protoporphyria
Data presented in Chapter 3 confirmed the finding of 
Gross and Hutton (1971) that inbred strains of female mice 
differ in their response to the porphyrogenic chemical DDC 
with respect to induction of hepatic ALA-S activity. The 
C3H/He/01a strain was found to be a "high" responder, and 
the NIH/Ola strain was a "low" responder, that is, after 
treatment with various doses of DDC, levels of ALA-S 
activity, and the increase over control values, were 
1.5-2.0-fold higher in the C3H/He/01a strain (Table 3.1).
Gross and Hutton (1971) provided evidence that strain 
differences in the inducibility of ALA-S by DDC cannot be 
accounted for by differences between strains in either the 
rate of production of succinyl-CoA (one of the substrates 
of ALA-S), or in endogenous levels of succinyl-CoA; it 
was shown that sufficient succinyl-CoA generating 
potential existed in the liver to supply the demands of 
increased ALA-S, and that addition of a succinyl-CoA 
generating system to liver homogenates from DDC-treated 
mice did not alter the relative strain differences in 
ALA-S activities. These findings would suggest that the 
genetic difference in ALA-S response to DDC lies elsewhere 
and the experiments described in Chapter 3 aimed to obtain 
some information on this aspect.
It was found that DDC treatment produced the same 
degree of inhibition of FK activity in both C3H/He/0la and 
NIH/Ola mice (Table 3.3), yet ALA-S activity was induced
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to a greater level in the C3H/He/01a strain (Table 3.1).
In order to appreciate the significance of identical FK 
inhibition with respect to the genetic difference in ALA-S 
induction, it is necessary to consider the 2 stage model 
which has been proposed for drug-mediated induction of 
ALA-S (De Matteis and Gibbs, 1972; Sinclair and Granick, 
1975; Maxwell and Meyer, 1976). The first stage involves 
a depletion of "regulatory" haem. This is brought about 
by a "specific" effect of the drug which results in either 
an inhibition of haem biosynthesis, or an increased 
degradation of haem. Metabolism of the drug is required 
for this "specific" effect. The second stage - induction 
of ALA-S - occurs because the enzyme is subject to 
negative feedback control by haem (Section 1.4). 
Lipid-soluble drugs can act at this second stage, which 
requires de novo synthesis of ALA-S (Whiting and Granick, 
1976), and, by an unknown mechanism, can potentiate the 
induction of the enzyme produced by the "specific" 
depletion of intracellular haem. This potentiation effect 
is sometimes referred to as the "non-specific" drug 
action, because it is shared by many compounds, even by 
those which by themselves will not cause depletion of 
liver haem and marked stimulation of ALA-S. DDC produces 
a marked induction of ALA-S since the drug exerts both 
"specific" and "non-specific" effects (Fig 7.1): meta­
bolism of DDC produces N-MePP which inhibits FK, thus 
reducing the concentration of "regulatory" haem (the 
"specific" effect). In addition, the unmetabolized drug
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is lipid-soluble and therefore exerts the "non-specific" 
effect on ALA-S induction.
The finding that the "specific" inhibitory effect of 
DDC on Fk was identical in the 2 inbred mice strains would 
suggest that the strain difference in ALA-S induction is 
due to a genetic difference at the second stage of ALA-S 
induction, that is, the stage involving the 
"non-specific", lipid-soluble effects of the drug. This 
is also suggested by 2 other observations. Firstly, 
treatment of mice with succinyl acetone, a chemical which 
is not lipid soluble, produced an extensive (95%) 
inhibition of ALA-D activity, yet there was no difference 
between strains in the levels of ALA-S, which were only 
increased marginally (Table 3.4). Thus, the "specific" 
depletion of haem would appear to be insufficient to 
produce a genetic variation in the response of ALA-S. 
Secondly, there was very little strain difference in 
induced ALA-S activity at low doses of DDC (Fig 3.4)? the 
strain difference was most obvious at those levels of DDC 
which were well above the dose required for maximal 
inhibition of Fk activity. Thus, at the higher DDC doses, 
stimulation of ALA-S resulting from haem depletion would 
be maximal, and the strain differences in ALA-S induction 
would appear to reflect a genetic difference between the 
strains in the response of the enzyme to the "non­
specific", lipid-soluble effects of DDC.
A simple experiment to obtain additional evidence 
that the response of ALA-S to the lipid-soluble effects of
223
drugs is under genetic control would be to determine 
whether the difference between the strains would be more 
pronounced if extra lipid-soluble stimulus was present, 
for example, if phenobarbitone was co-administered with 
DDC, but this was not investigated.
A strain difference in ALA-S response was found in 
female and male mice after GF treatment, with greater 
levels of ALA-.S in the C3H/He/01a strain, despite a 
similar degree of FK inhibition in all mice (Tables 3.6 
and 3.8). This finding might suggest that also with GF 
the genetic difference in the response of ALA-S is due not 
to the inhibition of FK (responsible for the primary 
depletion of the "regulatory" haem), but to a second drug 
action involving the so-called lipid-soluble, or 
"non-specific" effect. It is also possible to conclude 
from this present work that this genetic difference 
applies to both sexes of mice and that, as in the case of 
DDC, the C3H/He/01a strain may be a "high" responder. 
However, the interpretation of the data is complicated by 
the finding of a massive accumulation of protoporphyrin at 
the earliest time point studied (3 days). This was 
unexpectedly found to be greater in the strain (NIH/Ola) 
with the lower ALA-S activity, and the results must 
therefore be considered in the light of the findings in 
Chapter 4^as discussed below.
A 2-way relationship between hepatic porphyrin levels 
and ALA-S activity was demonstrated in mice after 
treatment with porphyrogenic drugs (Fig 4.6)? porphyrin
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accumulation was found to be associated with an increase
in ALA-S activity, but the relationship became inverse at
porphyrin levels above about 450 nmol/g liver, that is,
higher porphyrin levels were associated with a decrease in
ALA-S activity. Examination of the porphyrin levels in 
inbred mice strains after GF-feeding (Table 3.6 and 3.8) 
shows that in all cases, porphyrins were greater than 450 
nmol/g liver. This would imply that ALA-S activity was 
depressed at the time point studied (3 days). The NIH/Ola 
strain had greater hepatic porphyrins than the C3H/He/01a 
strain at this time, and this might suggest that ALA-S 
activity in the former strain was higher at earlier time 
points. This in turn would imply that the strain 
(NIH/Ola) less responsive to DDC is more responsive to GF 
with respect to the stimulation of ALA-S activity, 
although no direct demonstration of this was obtained. 
However, as discussed in Chapter 3, there may be a strain 
difference in porphyrin disposal? NIH/Ola mice may be less 
efficient at eliminating excess porphyrins, and porphyrins 
would therefore accumulate more readily. Interpretation 
of these results is thus difficult and whether or not the 
2 strains really differ in ALA-S response to GF, and if 
so, in what direction, will only be determined by further 
work in which earlier time points are studied, that is, 
the time points when porphyrin levels are below the 450 
nmol/g liver mark.
Nevertheless, the data obtained with DDC suggests 
that the genetic difference between inbred mice strains in
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ALA-S induction is at the level of their response to the 
second "non-specific" action of the drug, the molecular 
basis of which is not at all clear. It has been suggested 
(De Matteis and Gibbs, 1972; De Matteis, 1978b) that this 
second drug action may be related to the ability of DDC 
(the unmetabolized molecule) to increase the level of the 
apoprotein of cytochrome P-450, an effect for which some 
evidence has been obtained (Brooker and O'Conner, 1982; 
Brooker et al., 1983). The induced apoprotein, through 
its haem-binding capacity, will withdraw haem from the 
"regulatory" haem pool for cytochrome P-450 formation. As 
the "regulatory" pool is already partially depleted by DDC 
(through inhibition of haem biosynthesis), increased haem 
utilization for the cytochrome may lead to a further 
marked depletion of the "regulatory" pool and therefore 
ultimately to a marked stimulation of ALA-S. Considering 
the strain differences in ALA-S induction, perhaps there 
are differences between the strains in the extent of 
DDC-induced apocytochrome P-450 levels, subsequently 
producing a differing demand for haem from the partially 
depleted haem pool.
Alternatively, the "non-specific" effect may result 
from the well-known ability of many lipid-soluble 
compounds to stimulate rather appreciably liver protein 
synthesis and liver growth. The strain (C3H/He/01a) in 
which ALA-S was more responsive to DDC might therefore be 
expected to have the greater increase in liver weight. 
However, it must be pointed out that in the present
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experiments no evidence was obtained for liver growth in 
either of the 2 strains after DDC treatment. A strain 
difference in liver weight was found after GF feeding, 
with the NIH/Ola strain showing a greater increase in 
liver size (over the untreated control values) (Tables 3.5 
and 3.7). This might again suggest that the strain which 
responds less to DDC might be the more responsive one to 
GF with respect to ALA-S induction. As discussed above, 
the strain (NIH/Ola) with the larger liver growth also 
accumulated more porphyrins following GF treatment and it 
is therefore possible that some, at least, of the increase 
in the liver size can be attributed to the extensive 
accumulation of porphyrins.
Data presented in Chapter 4 demonstrated a sex 
difference in GF-induced porphyria in MF1 mice, with a 
greater accumulation in male livers, despite identical FK 
inhibition in both sexes (Tables 4.2). Males of this 
strain had levels of ALA-S activity which were slightly, 
but not significantly, higher than in females following GF 
treatment for up to 3 days. However, when protoporphyrin 
accumulation was very marked, after 7 days of GF feeding, 
ALA-S levels in male livers were significantly lower than 
in females (Table 4.2; Fig 4.5). This sex difference 
(that is, greater porphyrins and lower ALA-S activity in 
males) was also observed in the 2 inbred mice strains 
following GF treatment, again when porphyrin levels were 
very high (Table 4.3). On the basis of the 2 way 
relationship found between hepatic porphyrins and ALA-S
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activity (Fig 4.6) it was suggested in Chapter 4, that the 
lower ALA-S activity found in males after GF feeding may 
be due to a reduction of ALA-S brought about by the very 
high protoporphyrin levels present in their livers. This 
was suggested to occur either by (a) a feedback repression 
of ALA-S by protoporphyrin by a mechanism similar to that 
reported for haem (Section 1.4), whereby the synthesis of 
the enzyme (or translocation of the enzyme into 
mitochondria) is inhibited or (b) mitochondrial damage 
produced by the high protoporphyrin levels, leading to 
leakage of the ALA-S from the mitochondria, or to an 
interference with the formation of succinyl-CoA, one of 
the substrates of the enzyme.
With regards to the sex difference in porphyria 
observed in these mice, it has been reported that when GF 
treatment to male mice is withdrawn, ALA-S and Fk 
activities return to normal, but protoporhyrin levels 
remain elevated (Denk et aJ., 1981). This would indicate 
that porphyrin disposal is a factor which should be 
considered in porphyria. Perhaps a sex difference in 
porphyrin disposal, with a slower rate of elimination in 
males of all 3 strains studied in the present experiments, 
may partially explain the greater porphyria observed in 
this sex.
7.2 Studies on porphyria in cultured chick embryo 
hepatocytes "
The major advantages of using cultured chick embryo 
hepatocytes rather than animals in vivo to study the
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porphyrogenic effects of GF and its analogues are probably 
the small amount of drug(s) and the time period required 
to elicit a response: in animal studies these drugs must 
be fed in the diet for a few days, which is costly and 
time consuming since additionally, the animals must first 
be acclimatized to a powdered diet. However, major 
problems encountered were the limited solubility of GF, 
HETGF and ISOGF in various solvents, and the tendancy of 
the drugs, particularly GF, to precipitate out of solution 
after addition to the cultures. These factors probably 
contributed to the variability between separate 
experiments in the porphyric response of the cultures to 
the drugs. The "insolubility" problem was overcome by 
developing an alternative method by which to dose cultures 
with the drugs (Section 5.3), which lead to more 
reproducible results.
Using the new method, ISOGF was shown to be much more 
porphyrogenic than GF in cultured chick hepatocytes (Table 
5.1) in agreement with findings in mice (De Matteis and 
Gibbs, 1975). ISOGF, like DDC, caused the accumulation of 
predominantly protoporphyrin (Fig 5.3), and GF-treated 
cultures also accumulated protoporphyrin, but to a lesser 
extent. HETGF, however, although as porphyrogenic as GF 
in this in vitro system (in contrast to its non- 
porphyrogenic effect in animals? De Matteis and Gibbs,
1975) produced a pattern of porphyrin accumulation 
identical to the controls (Fig 5.3).
Since 2 factors contribute to porphyrin accumulation 
(that is, induction of ALA-S and activity of the
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intermediary enzymes concerned with metabolism of ALA to 
haem) the predominance of protoporphyrin accumulation with 
DDC and ISOGF suggested that these drugs (and possibly GF) 
inhibited Fk activity. Analysis of the porphyrin profiles 
obtained following incubation of cultures with drugs and 
ALA (Sinclair et al., 1983) was not very informative as 
in the presence of ALA all drug-treated (DDC, GF, HETGF 
and ISOGF) and control cultures accumulated protoporphyrin 
as the major porphyrin (Section 5.5). As discussed in 
Chapter 5, ALA load experiments are not suitable for 
detecting a drug-mediated block at the level of Fk, since 
under these conditions, where porphyrin accumulation is 
massive (including in ALA-treated controls), the enzyme 
appears to be rate-limiting. When FK was directly assayed 
in cultured cells, it was found that DDC caused a marked 
inhibition of enzyme activity (Fig 5.5), as originally 
reported by Cole et al. (1981b), consistent with the 
pattern of porphyrin accumulation produced by the drug. 
ISOGF was found to be more potent than GF as an inhibitor 
of Fk activity (Fig 5.5), again consistent with the 
porphyrin patterns produced by the 2 drugs (Fig 5.3) and 
also in agreement with their comparative porphyrogenicity 
in rodents (De Matteis and Gibbs, 1975). However, it was 
noted that the data obtained with GF did not agree with 
those reported by Cole et al. (19811}, where predominantly 
coproporphyrin (rather than protoporphyrin) accumulated, 
and FK activity was not reduced; the present results may 
reflect a more ready metabolism of GF (to produce N-MePP,
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the inhibitor of FK) since with the different dosing 
method now introduced, the drug was presented to the 
cultures in a more 'soluble' form. HETGF also caused some 
loss of FK activity in the culture system (Fig 5.5), this 
was however relatively small, and may have been a 
reflection of some generalized cell or mitochondrial 
damage produced by HETGF. The identical porphyrin 
profiles obtained with controls and HETGF treatment (Fig
5.3), might perhaps suggest that the increased porphyrin 
accumulation produced by HETGF (Table 5.1) results from 
induction of ALA-S, a property shared by many 
lipid-soluble compounds in cultured chick embryo 
hepatocytes (De Matteis, 1978b; Marks, 1978). This lipid 
soluble effect is also likely to play a role in ALA-S 
induction by DDC, ISOGF and GF, and the very high 
porphyrin accumulation produced by DDC and ISOGF can be 
explained by the additional effect of these drugs, that 
is, the marked inhibition of FK, which, by reducing the 
intracellular haem levels, leads to further induction of 
ALA-S; protoporphyrin, the substrate of the inhibited 
enzyme, subsequently accumulates in excess.
7.3 Isolation from porphyric livers and partial
characterization of an inhibitor of FK, and of a 
similar modified porphyrin with no inhibitory 
activity on FK
In 1980 De Matteis and Gibbs reported that inhibition 
of mouse liver FK, produced by feeding GF, was due to a
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green pigment which accumulated in the liver, and showed 
that the pigment had spectral properties similar to 
authentic N-MePP. The experiments described in Chapter 6 
confirmed these findings, and in addition to N-MePP, a 
second green pigment (pigment X) has now been isolated 
from the liver of male and female mice of 3 strains 
treated with GF in the diet. In all experiments, pigment 
X was isolated in amounts about 10 times greater than 
N-MePP (Table 6.4). Spectral studies strongly suggested 
that pigment X was an N-monosubstituted porphyrin and also 
that the N-substituent was small, as is the case with 
N-MePP. However, the abnormal porphyrin was found to be 
distinct from N-MePP as demonstrated by comparison of the 
neutral and zinc-complex spectra (Tables 6.1 and 6.2), and 
by the chromatographic behaviour of both pigments on 2 
HPLC systems (Figs 6.8, 6.11 and 6.12). In addition, at 
concentrations of up to 166 nM, pigment X did not inhibit 
mouse liver homogenate FK in vitro, whereas N-MePP 
isolated from the same livers produced 37% enzyme 
inhibition at a concentration of 37 nM (Section 6.4.7).
It must be pointed out that these jLn vitro inhibition 
studies were only carried out once.
It has been reported that in order to inhibit FK, an 
N-alkyl porphyrin must bind to the porphyrin-binding site 
of the enzyme and that the size and position of the 
N-alkyl group are important for inhibitory activity (De 
Matteis et al. , 1980b; Ortiz de Montellano et ajL. , 1981b; 
De Matteis et al., 1982b). Although it is not yet known
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which pyrrole ring nitrogen is alkylated in pigment X, 
spectral data suggest the substituent is small, which is 
favourable for inhibition of Fk. The lack of inhibitory 
activity might perhaps suggest that in addition to an 
N-substituent, the propionate or vinyl side chains at the 
periphery of the protoporphyrin system have been modified 
in some way: the 2 propionate side chains (in positions 6 
and 7; see Fig 6.1) must be free for inhibition of Fk to 
occur, and these side chains, and possibly the vinyl 
groups (at the 2- and 4-positions) are involved in binding 
of the porphyrin at the active site (De Matteis et a l .,
1985). It was therefore considered that pigment X may be 
N-MePP conjugated with either glucuronic acid or 
glutathione. With respect to the latter it is of interest 
that recently Williams and Simonet (1986) reported a 
doubling of glutathione transferase activity in rats 
treated with GF. However, if pigment X was an N-MePP 
conjugate it would have to be resistant to acidic and 
alkaline hydrolysis, since chromatographic behaviour of 
the abnormal porphyrin on a Nucleosil 5 HPLC column was 
not altered by these procedures, and N-MePP was not 
generated (Section 6.4.3). Additional evidence against an 
N-MePP conjugate is the finding that treatment of mice 
with either ISOGF or DDC in the diet produced accumulation 
in the liver of only N-MePP, and not pigment X (Table
6.4), suggesting that the production of this abnormal 
porphyrin is peculiar to GF. Further work is required to
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establish the identity of pigment X and some procedures 
which would help towards this aim were suggested in 
Chapter 6.
Investigation of the isomeric composition of the 
N-MePP produced dji vivo following treatment of mice with 
GF, ISOGF and DDC in the diet, revealed that in each case, 
all 4 possible structural isomers of N-MePP were present 
(Table 6.3). The isomeric profile was found to be similar 
to that reported by Ortiz de Montellano et al. (1981c) for 
the N-MePP isolated from the liver of phenobarbitone- 
treated rats given DDC. Thus, isomer NA (where the 
methyl group is on the nitrogen of pyrrole ring A) clearly 
predominated, contributing to more than 70% of the total 
N-MePP (Table 6.3); smaller amounts of the Nc and Np 
isomers, and traces of the Ng isomer were present. GF 
and ISOGF treatment produced equivalent amounts of the 
Nq and Np isomers. In contrast, following DDC feeding 
the amount of the Nc isomer was 2-3 times greater than 
the Np isomer. Since the main phenobarbitone-inducible 
type of cytochrome P-450 preferentially produces 
N-alkylated porphyrins with the N-alkyl group on pyrrole 
ring A (De Matteis et a]L., 1983; De Matteis et al.,
1986), the predominance of N-MePP isomer NA with GF,
ISOGF and DDC might perhaps suggest that all 3 drugs are 
preferentially metabolised by this form of cytochrome 
P-450. Additionally, DDC may be a better substrate than 
GF and ISOGF for the cytochrome P-450 isoenzyme which 
produces the Nq isomer, although there are as yet, no
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results to link this isomer to a specific cytochrome P-450 
(De Matteis et aJL. , 1983).
Similar amounts of N-MePP were isolated from the 
liver of male and female MF1 mice treated with GF for 3 
days (Table 6.4) which is in accordance with the same 
degree of hepatic FK inhibition observed in the 2 sexes at
this time (Table 4.2). Similarly, after 7 days drug
treatment the amount of N-MePP isolated, and the extent of
FK inhibition, were the same in male and female mice.
However it was noted that whereas there was no significant 
difference between the inhibited enzyme activity observed 
at 3 and 7 days (Table 4.2), twice as much N-MePP was 
present in the liver at the latter time point (Table
6.4). This might perhaps suggest there is a limit to the 
extent that FK can be inhibited. Indeed, examination of 
the data obtained with DDC show that FK activity is not 
further inhibited when liver N-MePP levels are 5 times 
greater than in 3-day GF-treated mice (Tables 4.4 and
6.4). There is some evidence that N-MePP and 
protoporphyrin compete for the active site of FK in vitro; 
(1) the kinetic studies of Dailey and Fleming (1983) with 
purified FK demonstrated that N-MePP is a reversible 
competitive inhibitor of the enzyme iji vitro with respect 
to the porphyrin substrate? (2) the inhibition of FK 
produced by N-alkylated porphyrins in vitro can be 
reversed by prolonged incubation with excess enzyme 
substrate, and this has been shown to result from 
competition for the active site on FK rather than
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dealkylation of the N-alkylated porphyrin (De Matteis et 
al., 1985)? finally, 3) results presented in Chapter 3 
demonstrated that the degree of FK inhibition by N-MePP 
produced in vivo by treatment with DDC was partially 
reversed by incubation JLn vitro with excess enzyme 
substrate and this too is compatible with N-MePP acting as 
a tight binding competitive inhibitor of Fk.
Exceedingly high levels of protoporphyrin accumulated 
in the liver of mice fed GF or DDC, and a competition 
between N-MePP and protoporphyrin for the active site of 
Fk in vivo might perhaps explain the identical inhibition 
of enzyme activity in the presence of different amounts of 
liver N-MePP produced by these drugs. The degree of 
inhibitor observed with reversible competitive inhibition 
depends upon the concentration of both inhibitor and 
substrate, and in all experiments, protoporphyrin 
concentrations (on a per g liver basis) were 1000-2000 
times greater than N-MePP. It has been reported that 
approximately 25% and 12% of the total drug-induced 
protoporphyrin and N-MePP, respectively, are found in the 
mitochondrial fraction (Sandberg and Romslo, 1981; Tephly 
et al., 1980). Thus the concentration of protoporphyrin 
would seem to be very much greater than that of N-MePP in 
the mitochondria where the Fk enzyme is located (Jones and 
Jones, 1969; Daily and Fleming, 1985), so that 
displacement of some of the inhibitor from the enzyme 
active site may well take place iji vivo. An alternative 
or additional mechanism for partial reactivation may be
displacement of some of the inhibitor from the active site 
by the additional substrate of the enzyme which is added 
in vitro during the assay.
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